false --12-31 Q2 0001825079 http://fasb.org/us-gaap/2025#OtherAssetsNoncurrent http://fasb.org/us-gaap/2025#OtherAssetsNoncurrent 0001825079 2025-01-01 2025-06-30 0001825079 2025-07-31 0001825079 2025-06-30 0001825079 2024-12-31 0001825079 2025-04-01 2025-06-30 0001825079 2024-04-01 2024-06-30 0001825079 2024-01-01 2024-06-30 0001825079 VLDX:A3DPrintersMember 2025-04-01 2025-06-30 0001825079 VLDX:A3DPrintersMember 2024-04-01 2024-06-30 0001825079 VLDX:A3DPrintersMember 2025-01-01 2025-06-30 0001825079 VLDX:A3DPrintersMember 2024-01-01 2024-06-30 0001825079 VLDX:RecurringPaymentMember 2025-04-01 2025-06-30 0001825079 VLDX:RecurringPaymentMember 2024-04-01 2024-06-30 0001825079 VLDX:RecurringPaymentMember 2025-01-01 2025-06-30 0001825079 VLDX:RecurringPaymentMember 2024-01-01 2024-06-30 0001825079 VLDX:SupportServicesMember 2025-04-01 2025-06-30 0001825079 VLDX:SupportServicesMember 2024-04-01 2024-06-30 0001825079 VLDX:SupportServicesMember 2025-01-01 2025-06-30 0001825079 VLDX:SupportServicesMember 2024-01-01 2024-06-30 0001825079 VLDX:OtherMember 2025-04-01 2025-06-30 0001825079 VLDX:OtherMember 2024-04-01 2024-06-30 0001825079 VLDX:OtherMember 2025-01-01 2025-06-30 0001825079 VLDX:OtherMember 2024-01-01 2024-06-30 0001825079 2023-12-31 0001825079 2024-06-30 0001825079 us-gaap:CommonStockMember 2024-03-31 0001825079 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001825079 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0001825079 us-gaap:RetainedEarningsMember 2024-03-31 0001825079 2024-03-31 0001825079 us-gaap:CommonStockMember 2025-03-31 0001825079 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001825079 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-03-31 0001825079 us-gaap:RetainedEarningsMember 2025-03-31 0001825079 2025-03-31 0001825079 us-gaap:CommonStockMember 2023-12-31 0001825079 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001825079 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001825079 us-gaap:RetainedEarningsMember 2023-12-31 0001825079 us-gaap:CommonStockMember 2024-12-31 0001825079 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001825079 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0001825079 us-gaap:RetainedEarningsMember 2024-12-31 0001825079 us-gaap:CommonStockMember 2024-04-01 2024-06-30 0001825079 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-06-30 0001825079 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-04-01 2024-06-30 0001825079 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0001825079 us-gaap:CommonStockMember 2025-04-01 2025-06-30 0001825079 us-gaap:AdditionalPaidInCapitalMember 2025-04-01 2025-06-30 0001825079 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-04-01 2025-06-30 0001825079 us-gaap:RetainedEarningsMember 2025-04-01 2025-06-30 0001825079 us-gaap:CommonStockMember 2024-01-01 2024-06-30 0001825079 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-06-30 0001825079 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-06-30 0001825079 us-gaap:RetainedEarningsMember 2024-01-01 2024-06-30 0001825079 us-gaap:CommonStockMember 2025-01-01 2025-06-30 0001825079 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-06-30 0001825079 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-01-01 2025-06-30 0001825079 us-gaap:RetainedEarningsMember 2025-01-01 2025-06-30 0001825079 us-gaap:CommonStockMember 2024-06-30 0001825079 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001825079 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-06-30 0001825079 us-gaap:RetainedEarningsMember 2024-06-30 0001825079 us-gaap:CommonStockMember 2025-06-30 0001825079 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0001825079 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-06-30 0001825079 us-gaap:RetainedEarningsMember 2025-06-30 0001825079 VLDX:Velo3DMember 2025-06-30 0001825079 2024-06-10 0001825079 2024-06-10 2024-06-10 0001825079 2025-06-27 0001825079 2025-06-27 2025-06-27 0001825079 VLDX:SecondNoteAmendmentMember 2024-04-01 2024-04-01 0001825079 VLDX:SecondNoteAmendmentMember 2024-04-01 0001825079 VLDX:SecondNoteAmendmentMember 2024-04-15 2024-04-15 0001825079 VLDX:BEPOOfferingMember 2024-04-10 0001825079 VLDX:BEPOOfferingMember 2024-04-10 2024-04-10 0001825079 VLDX:ThirdNoteAmendmentMember 2024-07-01 2024-07-01 0001825079 VLDX:DebtForEquityExchangeMember 2024-12-24 0001825079 VLDX:DebtForEquityExchangeMember 2024-12-24 2024-12-24 0001825079 VLDX:ArrayedNotesAcquisitionCorpMember VLDX:DebtForEquityExchangeMember 2024-12-24 0001825079 VLDX:SeniorSecuredConvertiblePromissoryNoteMember 2025-01-07 0001825079 VLDX:SeniorSecuredConvertiblePromissoryNoteMember 2025-04-07 0001825079 VLDX:SeniorSecuredConvertiblePromissoryNoteMember 2025-04-07 2025-04-07 0001825079 VLDX:SeniorSecuredConvertiblePromissoryNoteMember 2025-02-10 0001825079 VLDX:SeniorSecuredConvertiblePromissoryNoteMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2025-02-10 0001825079 srt:ScenarioPreviouslyReportedMember 2025-01-01 2025-03-31 0001825079 srt:RestatementAdjustmentMember 2025-01-01 2025-03-31 0001825079 VLDX:RevisedMember 2025-01-01 2025-03-31 0001825079 2025-01-01 2025-03-31 0001825079 VLDX:CommonStockWarrantsMember 2025-04-01 2025-06-30 0001825079 VLDX:CommonStockWarrantsMember 2025-01-01 2025-06-30 0001825079 VLDX:CommonStockWarrantsMember 2024-04-01 2024-06-30 0001825079 VLDX:CommonStockWarrantsMember 2024-01-01 2024-06-30 0001825079 us-gaap:EmployeeStockOptionMember 2025-04-01 2025-06-30 0001825079 us-gaap:EmployeeStockOptionMember 2025-01-01 2025-06-30 0001825079 us-gaap:EmployeeStockOptionMember 2024-04-01 2024-06-30 0001825079 us-gaap:EmployeeStockOptionMember 2024-01-01 2024-06-30 0001825079 us-gaap:RestrictedStockUnitsRSUMember 2025-04-01 2025-06-30 0001825079 us-gaap:RestrictedStockUnitsRSUMember 2025-01-01 2025-06-30 0001825079 us-gaap:RestrictedStockUnitsRSUMember 2024-04-01 2024-06-30 0001825079 us-gaap:RestrictedStockUnitsRSUMember 2024-01-01 2024-06-30 0001825079 VLDX:EligibleVelo3DEquityholdersMember 2025-04-01 2025-06-30 0001825079 VLDX:EligibleVelo3DEquityholdersMember 2025-01-01 2025-06-30 0001825079 VLDX:EligibleVelo3DEquityholdersMember 2024-04-01 2024-06-30 0001825079 VLDX:EligibleVelo3DEquityholdersMember 2024-01-01 2024-06-30 0001825079 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2025-06-30 0001825079 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2025-06-30 0001825079 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2025-06-30 0001825079 us-gaap:FairValueMeasurementsRecurringMember 2025-06-30 0001825079 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember VLDX:PlacementAgentsWarrantsMember 2025-06-30 0001825079 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember VLDX:PlacementAgentsWarrantsMember 2025-06-30 0001825079 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember VLDX:PlacementAgentsWarrantsMember 2025-06-30 0001825079 us-gaap:FairValueMeasurementsRecurringMember VLDX:PlacementAgentsWarrantsMember 2025-06-30 0001825079 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember VLDX:BepoWarrantsMember 2025-06-30 0001825079 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember VLDX:BepoWarrantsMember 2025-06-30 0001825079 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember VLDX:BepoWarrantsMember 2025-06-30 0001825079 us-gaap:FairValueMeasurementsRecurringMember VLDX:BepoWarrantsMember 2025-06-30 0001825079 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember VLDX:BepoAgentWarrantsMember 2025-06-30 0001825079 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember VLDX:BepoAgentWarrantsMember 2025-06-30 0001825079 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember VLDX:BepoAgentWarrantsMember 2025-06-30 0001825079 us-gaap:FairValueMeasurementsRecurringMember VLDX:BepoAgentWarrantsMember 2025-06-30 0001825079 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2024-12-31 0001825079 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2024-12-31 0001825079 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2024-12-31 0001825079 us-gaap:FairValueMeasurementsRecurringMember 2024-12-31 0001825079 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember VLDX:TwoThousandTwentyTwoPrivatePlacementWarrantsMember 2024-12-31 0001825079 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember VLDX:TwoThousandTwentyTwoPrivatePlacementWarrantsMember 2024-12-31 0001825079 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember VLDX:TwoThousandTwentyTwoPrivatePlacementWarrantsMember 2024-12-31 0001825079 us-gaap:FairValueMeasurementsRecurringMember VLDX:TwoThousandTwentyTwoPrivatePlacementWarrantsMember 2024-12-31 0001825079 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember VLDX:RDOWarrantsMember 2024-12-31 0001825079 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember VLDX:RDOWarrantsMember 2024-12-31 0001825079 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember VLDX:RDOWarrantsMember 2024-12-31 0001825079 us-gaap:FairValueMeasurementsRecurringMember VLDX:RDOWarrantsMember 2024-12-31 0001825079 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember VLDX:PlacementAgentWarrantsMember 2024-12-31 0001825079 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember VLDX:PlacementAgentWarrantsMember 2024-12-31 0001825079 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember VLDX:PlacementAgentWarrantsMember 2024-12-31 0001825079 us-gaap:FairValueMeasurementsRecurringMember VLDX:PlacementAgentWarrantsMember 2024-12-31 0001825079 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember VLDX:TwoThousandTwentyFourPrivateWarrantsMember 2024-12-31 0001825079 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember VLDX:TwoThousandTwentyFourPrivateWarrantsMember 2024-12-31 0001825079 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember VLDX:TwoThousandTwentyFourPrivateWarrantsMember 2024-12-31 0001825079 us-gaap:FairValueMeasurementsRecurringMember VLDX:TwoThousandTwentyFourPrivateWarrantsMember 2024-12-31 0001825079 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember VLDX:BepoWarrantsMember 2024-12-31 0001825079 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember VLDX:BepoWarrantsMember 2024-12-31 0001825079 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember VLDX:BepoWarrantsMember 2024-12-31 0001825079 us-gaap:FairValueMeasurementsRecurringMember VLDX:BepoWarrantsMember 2024-12-31 0001825079 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember VLDX:BepoAgentWarrantsMember 2024-12-31 0001825079 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember VLDX:BepoAgentWarrantsMember 2024-12-31 0001825079 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember VLDX:BepoAgentWarrantsMember 2024-12-31 0001825079 us-gaap:FairValueMeasurementsRecurringMember VLDX:BepoAgentWarrantsMember 2024-12-31 0001825079 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember VLDX:JulyTwoThousandTwentyFourPrivateWarrantsMember 2024-12-31 0001825079 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember VLDX:JulyTwoThousandTwentyFourPrivateWarrantsMember 2024-12-31 0001825079 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember VLDX:JulyTwoThousandTwentyFourPrivateWarrantsMember 2024-12-31 0001825079 us-gaap:FairValueMeasurementsRecurringMember VLDX:JulyTwoThousandTwentyFourPrivateWarrantsMember 2024-12-31 0001825079 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember VLDX:AugustInducementWarrantsMember 2024-12-31 0001825079 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember VLDX:AugustInducementWarrantsMember 2024-12-31 0001825079 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember VLDX:AugustInducementWarrantsMember 2024-12-31 0001825079 us-gaap:FairValueMeasurementsRecurringMember VLDX:AugustInducementWarrantsMember 2024-12-31 0001825079 VLDX:PrivatePlacementWarrantsMember VLDX:WarrantLiabilityMember 2024-12-31 0001825079 VLDX:TwoThousandTwentyTwoPrivatePlacementWarrantsMember VLDX:WarrantLiabilityMember 2024-12-31 0001825079 VLDX:ContingentEarnoutLiabilityMember 2024-12-31 0001825079 VLDX:RDOWarrantsMember VLDX:WarrantLiabilityMember 2024-12-31 0001825079 VLDX:PlacementAgentWarrantsMember VLDX:WarrantLiabilityMember 2024-12-31 0001825079 VLDX:TwoThousandTwentyFourPrivateWarrantsMember VLDX:WarrantLiabilityMember 2024-12-31 0001825079 VLDX:BepoWarrantsMember VLDX:WarrantLiabilityMember 2024-12-31 0001825079 VLDX:BepoAgentWarrantsMember VLDX:WarrantLiabilityMember 2024-12-31 0001825079 VLDX:JulyTwoThousandTwentyFourPrivateWarrantsMember VLDX:WarrantLiabilityMember 2024-12-31 0001825079 VLDX:AugustInducementWarrantsMember VLDX:WarrantLiabilityMember 2024-12-31 0001825079 VLDX:PrivatePlacementWarrantsMember VLDX:WarrantLiabilityMember 2025-01-01 2025-03-31 0001825079 VLDX:TwoThousandTwentyTwoPrivatePlacementWarrantsMember VLDX:WarrantLiabilityMember 2025-01-01 2025-03-31 0001825079 VLDX:ContingentEarnoutLiabilityMember 2025-01-01 2025-03-31 0001825079 VLDX:RDOWarrantsMember VLDX:WarrantLiabilityMember 2025-01-01 2025-03-31 0001825079 VLDX:PlacementAgentWarrantsMember VLDX:WarrantLiabilityMember 2025-01-01 2025-03-31 0001825079 VLDX:TwoThousandTwentyFourPrivateWarrantsMember VLDX:WarrantLiabilityMember 2025-01-01 2025-03-31 0001825079 VLDX:BepoWarrantsMember VLDX:WarrantLiabilityMember 2025-01-01 2025-03-31 0001825079 VLDX:BepoAgentWarrantsMember VLDX:WarrantLiabilityMember 2025-01-01 2025-03-31 0001825079 VLDX:JulyTwoThousandTwentyFourPrivateWarrantsMember VLDX:WarrantLiabilityMember 2025-01-01 2025-03-31 0001825079 VLDX:AugustInducementWarrantsMember VLDX:WarrantLiabilityMember 2025-01-01 2025-03-31 0001825079 VLDX:PrivatePlacementWarrantsMember VLDX:WarrantLiabilityMember 2025-03-31 0001825079 VLDX:TwoThousandTwentyTwoPrivatePlacementWarrantsMember VLDX:WarrantLiabilityMember 2025-03-31 0001825079 VLDX:ContingentEarnoutLiabilityMember 2025-03-31 0001825079 VLDX:RDOWarrantsMember VLDX:WarrantLiabilityMember 2025-03-31 0001825079 VLDX:PlacementAgentWarrantsMember VLDX:WarrantLiabilityMember 2025-03-31 0001825079 VLDX:TwoThousandTwentyFourPrivateWarrantsMember VLDX:WarrantLiabilityMember 2025-03-31 0001825079 VLDX:BepoWarrantsMember VLDX:WarrantLiabilityMember 2025-03-31 0001825079 VLDX:BepoAgentWarrantsMember VLDX:WarrantLiabilityMember 2025-03-31 0001825079 VLDX:JulyTwoThousandTwentyFourPrivateWarrantsMember VLDX:WarrantLiabilityMember 2025-03-31 0001825079 VLDX:AugustInducementWarrantsMember VLDX:WarrantLiabilityMember 2025-03-31 0001825079 VLDX:PrivatePlacementWarrantsMember VLDX:WarrantLiabilityMember 2025-04-01 2025-06-30 0001825079 VLDX:TwoThousandTwentyTwoPrivatePlacementWarrantsMember VLDX:WarrantLiabilityMember 2025-04-01 2025-06-30 0001825079 VLDX:ContingentEarnoutLiabilityMember 2025-04-01 2025-06-30 0001825079 VLDX:RDOWarrantsMember VLDX:WarrantLiabilityMember 2025-04-01 2025-06-30 0001825079 VLDX:PlacementAgentWarrantsMember VLDX:WarrantLiabilityMember 2025-04-01 2025-06-30 0001825079 VLDX:TwoThousandTwentyFourPrivateWarrantsMember VLDX:WarrantLiabilityMember 2025-04-01 2025-06-30 0001825079 VLDX:BepoWarrantsMember VLDX:WarrantLiabilityMember 2025-04-01 2025-06-30 0001825079 VLDX:BepoAgentWarrantsMember VLDX:WarrantLiabilityMember 2025-04-01 2025-06-30 0001825079 VLDX:JulyTwoThousandTwentyFourPrivateWarrantsMember VLDX:WarrantLiabilityMember 2025-04-01 2025-06-30 0001825079 VLDX:AugustInducementWarrantsMember VLDX:WarrantLiabilityMember 2025-04-01 2025-06-30 0001825079 VLDX:PrivatePlacementWarrantsMember VLDX:WarrantLiabilityMember 2025-06-30 0001825079 VLDX:TwoThousandTwentyTwoPrivatePlacementWarrantsMember VLDX:WarrantLiabilityMember 2025-06-30 0001825079 VLDX:ContingentEarnoutLiabilityMember 2025-06-30 0001825079 VLDX:RDOWarrantsMember VLDX:WarrantLiabilityMember 2025-06-30 0001825079 VLDX:PlacementAgentWarrantsMember VLDX:WarrantLiabilityMember 2025-06-30 0001825079 VLDX:TwoThousandTwentyFourPrivateWarrantsMember VLDX:WarrantLiabilityMember 2025-06-30 0001825079 VLDX:BepoWarrantsMember VLDX:WarrantLiabilityMember 2025-06-30 0001825079 VLDX:BepoAgentWarrantsMember VLDX:WarrantLiabilityMember 2025-06-30 0001825079 VLDX:JulyTwoThousandTwentyFourPrivateWarrantsMember VLDX:WarrantLiabilityMember 2025-06-30 0001825079 VLDX:AugustInducementWarrantsMember VLDX:WarrantLiabilityMember 2025-06-30 0001825079 VLDX:PrivatePlacementWarrantsMember VLDX:WarrantLiabilityMember 2023-12-31 0001825079 VLDX:TwoThousandTwentyTwoPrivatePlacementWarrantsMember VLDX:WarrantLiabilityMember 2023-12-31 0001825079 VLDX:ContingentEarnoutLiabilityMember 2023-12-31 0001825079 VLDX:RDOWarrantsMember VLDX:WarrantLiabilityMember 2023-12-31 0001825079 VLDX:PlacementAgentWarrantsMember VLDX:WarrantLiabilityMember 2023-12-31 0001825079 VLDX:TwoThousandTwentyFourPrivateWarrantsMember VLDX:WarrantLiabilityMember 2023-12-31 0001825079 VLDX:BepoWarrantsMember VLDX:WarrantLiabilityMember 2023-12-31 0001825079 VLDX:BepoAgentWarrantsMember VLDX:WarrantLiabilityMember 2023-12-31 0001825079 VLDX:JulyTwoThousandTwentyFourPrivateWarrantsMember VLDX:WarrantLiabilityMember 2023-12-31 0001825079 VLDX:AugustInducementWarrantsMember VLDX:WarrantLiabilityMember 2023-12-31 0001825079 VLDX:PrivatePlacementWarrantsMember VLDX:WarrantLiabilityMember 2024-01-01 2024-03-31 0001825079 VLDX:TwoThousandTwentyTwoPrivatePlacementWarrantsMember VLDX:WarrantLiabilityMember 2024-01-01 2024-03-31 0001825079 VLDX:ContingentEarnoutLiabilityMember 2024-01-01 2024-03-31 0001825079 VLDX:RDOWarrantsMember VLDX:WarrantLiabilityMember 2024-01-01 2024-03-31 0001825079 VLDX:PlacementAgentWarrantsMember VLDX:WarrantLiabilityMember 2024-01-01 2024-03-31 0001825079 VLDX:TwoThousandTwentyFourPrivateWarrantsMember VLDX:WarrantLiabilityMember 2024-01-01 2024-03-31 0001825079 VLDX:BepoWarrantsMember VLDX:WarrantLiabilityMember 2024-01-01 2024-03-31 0001825079 VLDX:BepoAgentWarrantsMember VLDX:WarrantLiabilityMember 2024-01-01 2024-03-31 0001825079 VLDX:JulyTwoThousandTwentyFourPrivateWarrantsMember VLDX:WarrantLiabilityMember 2024-01-01 2024-03-31 0001825079 VLDX:AugustInducementWarrantsMember VLDX:WarrantLiabilityMember 2024-01-01 2024-03-31 0001825079 VLDX:PrivatePlacementWarrantsMember VLDX:WarrantLiabilityMember 2024-03-31 0001825079 VLDX:TwoThousandTwentyTwoPrivatePlacementWarrantsMember VLDX:WarrantLiabilityMember 2024-03-31 0001825079 VLDX:ContingentEarnoutLiabilityMember 2024-03-31 0001825079 VLDX:RDOWarrantsMember VLDX:WarrantLiabilityMember 2024-03-31 0001825079 VLDX:PlacementAgentWarrantsMember VLDX:WarrantLiabilityMember 2024-03-31 0001825079 VLDX:TwoThousandTwentyFourPrivateWarrantsMember VLDX:WarrantLiabilityMember 2024-03-31 0001825079 VLDX:BepoWarrantsMember VLDX:WarrantLiabilityMember 2024-03-31 0001825079 VLDX:BepoAgentWarrantsMember VLDX:WarrantLiabilityMember 2024-03-31 0001825079 VLDX:JulyTwoThousandTwentyFourPrivateWarrantsMember VLDX:WarrantLiabilityMember 2024-03-31 0001825079 VLDX:AugustInducementWarrantsMember VLDX:WarrantLiabilityMember 2024-03-31 0001825079 VLDX:PrivatePlacementWarrantsMember VLDX:WarrantLiabilityMember 2024-04-01 2024-06-30 0001825079 VLDX:TwoThousandTwentyTwoPrivatePlacementWarrantsMember VLDX:WarrantLiabilityMember 2024-04-01 2024-06-30 0001825079 VLDX:ContingentEarnoutLiabilityMember 2024-04-01 2024-06-30 0001825079 VLDX:RDOWarrantsMember VLDX:WarrantLiabilityMember 2024-04-01 2024-06-30 0001825079 VLDX:PlacementAgentWarrantsMember VLDX:WarrantLiabilityMember 2024-04-01 2024-06-30 0001825079 VLDX:TwoThousandTwentyFourPrivateWarrantsMember VLDX:WarrantLiabilityMember 2024-04-01 2024-06-30 0001825079 VLDX:BepoWarrantsMember VLDX:WarrantLiabilityMember 2024-04-01 2024-06-30 0001825079 VLDX:BepoAgentWarrantsMember VLDX:WarrantLiabilityMember 2024-04-01 2024-06-30 0001825079 VLDX:JulyTwoThousandTwentyFourPrivateWarrantsMember VLDX:WarrantLiabilityMember 2024-04-01 2024-06-30 0001825079 VLDX:AugustInducementWarrantsMember VLDX:WarrantLiabilityMember 2024-04-01 2024-06-30 0001825079 VLDX:PrivatePlacementWarrantsMember VLDX:WarrantLiabilityMember 2024-06-30 0001825079 VLDX:TwoThousandTwentyTwoPrivatePlacementWarrantsMember VLDX:WarrantLiabilityMember 2024-06-30 0001825079 VLDX:ContingentEarnoutLiabilityMember 2024-06-30 0001825079 VLDX:RDOWarrantsMember VLDX:WarrantLiabilityMember 2024-06-30 0001825079 VLDX:PlacementAgentWarrantsMember VLDX:WarrantLiabilityMember 2024-06-30 0001825079 VLDX:TwoThousandTwentyFourPrivateWarrantsMember VLDX:WarrantLiabilityMember 2024-06-30 0001825079 VLDX:BepoWarrantsMember VLDX:WarrantLiabilityMember 2024-06-30 0001825079 VLDX:BepoAgentWarrantsMember VLDX:WarrantLiabilityMember 2024-06-30 0001825079 VLDX:JulyTwoThousandTwentyFourPrivateWarrantsMember VLDX:WarrantLiabilityMember 2024-06-30 0001825079 VLDX:AugustInducementWarrantsMember VLDX:WarrantLiabilityMember 2024-06-30 0001825079 VLDX:ComputersAndSoftwareMember 2025-06-30 0001825079 VLDX:ComputersAndSoftwareMember 2024-12-31 0001825079 VLDX:LaboratoryEquipmentMember 2025-06-30 0001825079 VLDX:LaboratoryEquipmentMember 2024-12-31 0001825079 us-gaap:FurnitureAndFixturesMember 2025-06-30 0001825079 us-gaap:FurnitureAndFixturesMember 2024-12-31 0001825079 us-gaap:LeaseholdImprovementsMember 2025-06-30 0001825079 us-gaap:LeaseholdImprovementsMember 2024-12-31 0001825079 VLDX:ConstructionInProgessMember 2025-06-30 0001825079 VLDX:ConstructionInProgessMember 2024-12-31 0001825079 VLDX:EquipmentOnLeaseMember 2025-06-30 0001825079 VLDX:EquipmentOnLeaseMember 2024-12-31 0001825079 VLDX:EquipmentAvailableForLeaseMember 2025-06-30 0001825079 VLDX:EquipmentAvailableForLeaseMember 2024-12-31 0001825079 2024-01-01 2024-12-31 0001825079 VLDX:JanuaryNoteMember 2025-06-30 0001825079 VLDX:JanuaryNoteMember 2024-12-31 0001825079 VLDX:FebruaryNoteFirstTrancheMember 2025-06-30 0001825079 VLDX:FebruaryNoteFirstTrancheMember 2024-12-31 0001825079 VLDX:FebruaryNoteSecondTrancheMember 2025-06-30 0001825079 VLDX:FebruaryNoteSecondTrancheMember 2024-12-31 0001825079 VLDX:SecuredNotesMember 2025-06-30 0001825079 VLDX:SecuredNotesMember 2024-12-31 0001825079 VLDX:JanuaryNoteMember VLDX:SeniorSecuredConvertiblePromissoryNoteMember 2025-01-07 0001825079 VLDX:JanuaryNoteMember VLDX:SeniorSecuredConvertiblePromissoryNoteMember 2025-04-07 0001825079 VLDX:JanuaryNoteMember VLDX:SeniorSecuredConvertiblePromissoryNoteMember 2025-04-01 2025-06-30 0001825079 VLDX:JanuaryNoteMember VLDX:SeniorSecuredConvertiblePromissoryNoteMember 2025-01-01 2025-06-30 0001825079 VLDX:FebruaryNoteMember VLDX:SeniorSecuredConvertiblePromissoryNoteMember 2025-02-10 0001825079 VLDX:FebruaryNoteSecondTrancheMember VLDX:SeniorSecuredConvertiblePromissoryNoteMember 2025-02-10 0001825079 VLDX:FebruaryNoteFirstTrancheMember VLDX:SeniorSecuredConvertiblePromissoryNoteMember 2025-02-10 0001825079 VLDX:FebruaryNoteFirstTrancheMember VLDX:SeniorSecuredConvertiblePromissoryNoteMember 2025-04-01 2025-06-30 0001825079 VLDX:FebruaryNoteSecondTrancheMember VLDX:SeniorSecuredConvertiblePromissoryNoteMember 2025-04-01 2025-06-30 0001825079 VLDX:FebruaryNoteFirstTrancheMember VLDX:SeniorSecuredConvertiblePromissoryNoteMember 2025-01-01 2025-06-30 0001825079 VLDX:FebruaryNoteSecondTrancheMember VLDX:SeniorSecuredConvertiblePromissoryNoteMember 2025-01-01 2025-06-30 0001825079 VLDX:SecuredNotesMember 2023-08-14 0001825079 VLDX:SecuredNotesMember 2025-06-30 0001825079 VLDX:SecuredNotesMember 2025-04-01 2025-06-30 0001825079 VLDX:SecuredNotesMember 2025-01-01 2025-06-30 0001825079 VLDX:AprilTwoThousandAndTwentyFourSecuritiesPurchaseAgreementMember 2024-04-10 0001825079 VLDX:AprilTwoThousandAndTwentyFourSecuritiesPurchaseAgreementMember 2024-04-12 2024-04-12 0001825079 VLDX:PlacementAgencyAgreementMember 2024-04-10 0001825079 VLDX:PlacementAgencyAgreementMember 2024-04-10 2024-04-10 0001825079 VLDX:AprilTwoThousandTwentyFourRegisteredWarrantsMember VLDX:FebruaryTwoThousandAndTwentyFiveSecuritiesPurchaseAgreementMember VLDX:HighbridgeHoldersAndAnsonHoldersMember 2025-02-24 0001825079 VLDX:AugustTwoThousandTwentyFourRegisteredWarrantsMember VLDX:FebruaryTwoThousandAndTwentyFiveSecuritiesPurchaseAgreementMember 2025-02-24 0001825079 VLDX:AprilAndJulyTwoThousandTwentyFourUnregisteredWarrantsMember VLDX:FebruaryTwoThousandAndTwentyFiveSecuritiesPurchaseAgreementMember VLDX:HighTrailHoldersMember 2025-02-24 0001825079 VLDX:DecemberTwoThousandTwentyThreeRegisteredWarrantsMember VLDX:FebruaryTwoThousandAndTwentyFiveSecuritiesPurchaseAgreementMember VLDX:HighTrailHoldersMember 2025-02-24 0001825079 VLDX:FebruaryTwoThousandAndTwentyFiveSecuritiesPurchaseAgreementMember 2025-02-24 0001825079 VLDX:ATMSalesAgreementMember 2023-02-01 2023-02-28 0001825079 VLDX:ATMSalesAgreementMember 2025-06-30 0001825079 VLDX:ATMSalesAgreementMember 2024-01-31 2024-01-31 0001825079 VLDX:TwoThousandTwentyOneEquityIncentivePlanMember 2024-04-30 0001825079 VLDX:TwoThousandTwentyOneEmployeeStockPurchasePlanMember 2024-04-30 0001825079 VLDX:BepoWarrantsMember 2025-06-30 0001825079 VLDX:BepoAgentWarrantsMember 2025-06-30 0001825079 VLDX:BepoAgentWarrantAMember 2025-06-30 0001825079 VLDX:TwoThousandTwentyFourPrivatePlacementWarrantsMember 2025-06-30 0001825079 VLDX:JulyTwoThousandTwentyFourPrivatePlacementWarrantsMember 2024-07-01 0001825079 VLDX:WarrantInducementAgreementMember 2024-08-12 0001825079 VLDX:WarrantInducementAgreementMember 2024-08-11 0001825079 VLDX:NewWarrantsMember 2024-08-12 0001825079 VLDX:WarrantToPurchaseCommonStockMember 2025-06-30 0001825079 VLDX:WarrantToPurchaseCommonStockMember 2024-12-31 0001825079 VLDX:PrivatePlacementWarrantsMember 2020-12-02 0001825079 VLDX:TwoThousandTwentyTwoPrivatePlacementWarrantsMember 2020-12-02 0001825079 VLDX:TwoThousandTwentyThreePrivatePlacementWarrantAMember 2025-06-30 0001825079 VLDX:TwoThousandTwentyThreePrivatePlacementWarrantBMember 2025-06-30 0001825079 VLDX:CommonStockWarrantsMember 2025-06-30 0001825079 VLDX:CommonStockWarrantsMember 2024-12-31 0001825079 VLDX:TwoThousandTwentyFourPrivateWarrantsMember 2025-01-01 2025-06-30 0001825079 VLDX:TwoThousandTwentyFourPrivateWarrantsMember 2024-01-01 2024-12-31 0001825079 VLDX:TwoThousandTwentyFourPrivateWarrantsMember 2025-06-30 0001825079 VLDX:EligibleVelo3DEquityholdersMember 2025-06-30 0001825079 srt:MaximumMember VLDX:JAWSSpitfireAcquisitionCorporationMember VLDX:EligibleVelo3DEquityholdersMember 2021-09-29 2021-09-29 0001825079 VLDX:JAWSSpitfireAcquisitionCorporationMember VLDX:EligibleVelo3DEquityholdersMember 2021-09-29 2021-09-29 0001825079 VLDX:WarrantToPurchaseCommonStockMember 2025-06-30 0001825079 VLDX:WarrantToPurchaseCommonStockMember 2024-12-31 0001825079 us-gaap:StockCompensationPlanMember VLDX:TwoThousandTwentyOneStockOptionPlanMember 2025-06-30 0001825079 us-gaap:StockCompensationPlanMember VLDX:TwoThousandTwentyOneStockOptionPlanMember 2024-12-31 0001825079 VLDX:AtTheMarketOfferingMember 2025-06-30 0001825079 VLDX:AtTheMarketOfferingMember 2024-12-31 0001825079 us-gaap:EmployeeStockMember 2025-06-30 0001825079 us-gaap:EmployeeStockMember 2024-12-31 0001825079 VLDX:PrivateWarrantsMember 2025-01-01 2025-06-30 0001825079 VLDX:PrivateWarrantsMember 2025-06-30 0001825079 VLDX:PublicWarrantsMember 2025-01-01 2025-06-30 0001825079 VLDX:PublicWarrantsMember 2025-06-30 0001825079 VLDX:TwoThousandTwentyTwoPrivatePlacementWarrantsMember 2025-01-01 2025-06-30 0001825079 VLDX:TwoThousandTwentyTwoPrivatePlacementWarrantsMember 2025-06-30 0001825079 VLDX:PlacementAgentWarrantsMember 2025-01-01 2025-06-30 0001825079 VLDX:PlacementAgentWarrantsMember 2025-06-30 0001825079 VLDX:BepoWarrantsMember 2025-01-01 2025-06-30 0001825079 VLDX:BepoAgentWarrantsMember 2025-01-01 2025-06-30 0001825079 VLDX:PrivateWarrantsMember 2024-01-01 2024-12-31 0001825079 VLDX:PrivateWarrantsMember 2024-12-31 0001825079 VLDX:PublicWarrantsMember 2024-01-01 2024-12-31 0001825079 VLDX:PublicWarrantsMember 2024-12-31 0001825079 VLDX:TwoThousandTwentyTwoPrivatePlacementWarrantsMember 2024-01-01 2024-12-31 0001825079 VLDX:TwoThousandTwentyTwoPrivatePlacementWarrantsMember 2024-12-31 0001825079 VLDX:RDOWarrantsMember 2024-01-01 2024-12-31 0001825079 VLDX:RDOWarrantsMember 2024-12-31 0001825079 VLDX:TwoThousandTwentyThreePlacementAgentWarrantsMember 2024-01-01 2024-12-31 0001825079 VLDX:TwoThousandTwentyThreePlacementAgentWarrantsMember 2024-12-31 0001825079 VLDX:TwoThousandTwentyFourPrivateWarrantsMember 2024-12-31 0001825079 VLDX:BepoWarrantsMember 2024-01-01 2024-12-31 0001825079 VLDX:BepoWarrantsMember 2024-12-31 0001825079 VLDX:BepoAgentWarrantsMember 2024-01-01 2024-12-31 0001825079 VLDX:BepoAgentWarrantsMember 2024-12-31 0001825079 VLDX:JulyTwoThousandTwentyFourPrivateWarrantsMember 2024-01-01 2024-12-31 0001825079 VLDX:JulyTwoThousandTwentyFourPrivateWarrantsMember 2024-12-31 0001825079 VLDX:AugustInducementWarrantsMember 2024-01-01 2024-12-31 0001825079 VLDX:AugustInducementWarrantsMember 2024-12-31 0001825079 VLDX:CommonStockWarrantsMember us-gaap:MeasurementInputSharePriceMember 2025-06-30 0001825079 VLDX:CommonStockWarrantsMember us-gaap:MeasurementInputSharePriceMember 2024-12-31 0001825079 VLDX:CommonStockWarrantsMember VLDX:MeasurementInputExpectedVolatilityMember 2025-06-30 0001825079 VLDX:CommonStockWarrantsMember VLDX:MeasurementInputExpectedVolatilityMember 2024-12-31 0001825079 VLDX:CommonStockWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2025-06-30 0001825079 VLDX:CommonStockWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2024-12-31 0001825079 VLDX:CommonStockWarrantsMember us-gaap:MeasurementInputExpectedDividendRateMember 2025-06-30 0001825079 VLDX:CommonStockWarrantsMember us-gaap:MeasurementInputExpectedDividendRateMember 2024-12-31 0001825079 VLDX:TwoThousandTwentyTwoPrivatePlacementWarrantsAndTwoThousandTwentyThreePlacementAgentWarrantsMember us-gaap:MeasurementInputSharePriceMember 2025-06-30 0001825079 VLDX:TwoThousandTwentyTwoPrivatePlacementWarrantsAndTwoThousandTwentyThreePlacementAgentWarrantsMember us-gaap:MeasurementInputSharePriceMember 2024-12-31 0001825079 VLDX:TwoThousandTwentyTwoPrivatePlacementWarrantsAndTwoThousandTwentyThreePlacementAgentWarrantsMember VLDX:MeasurementInputExpectedVolatilityMember 2025-06-30 0001825079 VLDX:TwoThousandTwentyTwoPrivatePlacementWarrantsAndTwoThousandTwentyThreePlacementAgentWarrantsMember VLDX:MeasurementInputExpectedVolatilityMember 2024-12-31 0001825079 VLDX:TwoThousandTwentyTwoPrivatePlacementWarrantsAndTwoThousandTwentyThreePlacementAgentWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2025-06-30 0001825079 VLDX:TwoThousandTwentyTwoPrivatePlacementWarrantsAndTwoThousandTwentyThreePlacementAgentWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2024-12-31 0001825079 VLDX:TwoThousandTwentyTwoPrivatePlacementWarrantsAndTwoThousandTwentyThreePlacementAgentWarrantsMember us-gaap:MeasurementInputExpectedDividendRateMember 2025-06-30 0001825079 VLDX:TwoThousandTwentyTwoPrivatePlacementWarrantsAndTwoThousandTwentyThreePlacementAgentWarrantsMember us-gaap:MeasurementInputExpectedDividendRateMember 2024-12-31 0001825079 VLDX:TwoThousandTwentyTwoPrivatePlacementWarrantsAndTwoThousandTwentyThreePlacementAgentWarrantsMember 2025-06-30 0001825079 VLDX:TwoThousandTwentyTwoPrivatePlacementWarrantsAndTwoThousandTwentyThreePlacementAgentWarrantsMember 2024-12-31 0001825079 VLDX:TwoThousandTwentyFourPrivateWarrantsMember us-gaap:MeasurementInputSharePriceMember 2025-06-30 0001825079 VLDX:TwoThousandTwentyFourPrivateWarrantsMember us-gaap:MeasurementInputSharePriceMember 2024-12-31 0001825079 VLDX:TwoThousandTwentyFourPrivateWarrantsMember VLDX:MeasurementInputExpectedVolatilityMember 2025-06-30 0001825079 VLDX:TwoThousandTwentyFourPrivateWarrantsMember VLDX:MeasurementInputExpectedVolatilityMember 2024-12-31 0001825079 VLDX:TwoThousandTwentyFourPrivateWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2025-06-30 0001825079 VLDX:TwoThousandTwentyFourPrivateWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2024-12-31 0001825079 VLDX:TwoThousandTwentyFourPrivateWarrantsMember us-gaap:MeasurementInputExpectedDividendRateMember 2025-06-30 0001825079 VLDX:TwoThousandTwentyFourPrivateWarrantsMember us-gaap:MeasurementInputExpectedDividendRateMember 2024-12-31 0001825079 VLDX:BepoWarrantsAndBepoAgentWarrantLiabilitiesMember us-gaap:MeasurementInputSharePriceMember 2025-06-30 0001825079 VLDX:BepoWarrantsAndBepoAgentWarrantLiabilitiesMember us-gaap:MeasurementInputSharePriceMember 2024-12-31 0001825079 VLDX:BepoWarrantsAndBepoAgentWarrantLiabilitiesMember VLDX:MeasurementInputExpectedVolatilityMember 2025-06-30 0001825079 VLDX:BepoWarrantsAndBepoAgentWarrantLiabilitiesMember VLDX:MeasurementInputExpectedVolatilityMember 2024-12-31 0001825079 VLDX:BepoWarrantsAndBepoAgentWarrantLiabilitiesMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2025-06-30 0001825079 VLDX:BepoWarrantsAndBepoAgentWarrantLiabilitiesMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2024-12-31 0001825079 VLDX:BepoWarrantsAndBepoAgentWarrantLiabilitiesMember us-gaap:MeasurementInputExpectedDividendRateMember 2025-06-30 0001825079 VLDX:BepoWarrantsAndBepoAgentWarrantLiabilitiesMember us-gaap:MeasurementInputExpectedDividendRateMember 2024-12-31 0001825079 VLDX:BepoWarrantsAndBepoAgentWarrantLiabilitiesMember 2025-06-30 0001825079 VLDX:BepoWarrantsAndBepoAgentWarrantLiabilitiesMember 2024-12-31 0001825079 VLDX:AugustInducementWarrantsMember us-gaap:MeasurementInputSharePriceMember 2025-06-30 0001825079 VLDX:AugustInducementWarrantsMember us-gaap:MeasurementInputSharePriceMember 2024-12-31 0001825079 VLDX:AugustInducementWarrantsMember VLDX:MeasurementInputExpectedVolatilityMember 2025-06-30 0001825079 VLDX:AugustInducementWarrantsMember VLDX:MeasurementInputExpectedVolatilityMember 2024-12-31 0001825079 VLDX:AugustInducementWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2025-06-30 0001825079 VLDX:AugustInducementWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2024-12-31 0001825079 VLDX:AugustInducementWarrantsMember us-gaap:MeasurementInputExpectedDividendRateMember 2025-06-30 0001825079 VLDX:AugustInducementWarrantsMember us-gaap:MeasurementInputExpectedDividendRateMember 2024-12-31 0001825079 VLDX:AugustInducementWarrantsMember 2025-06-30 0001825079 VLDX:JulyTwoThousandTwentyFourPrivateWarrantsMember us-gaap:MeasurementInputSharePriceMember 2025-06-30 0001825079 VLDX:JulyTwoThousandTwentyFourPrivateWarrantsMember us-gaap:MeasurementInputSharePriceMember 2024-12-31 0001825079 VLDX:JulyTwoThousandTwentyFourPrivateWarrantsMember VLDX:MeasurementInputExpectedVolatilityMember 2025-06-30 0001825079 VLDX:JulyTwoThousandTwentyFourPrivateWarrantsMember VLDX:MeasurementInputExpectedVolatilityMember 2024-12-31 0001825079 VLDX:JulyTwoThousandTwentyFourPrivateWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2025-06-30 0001825079 VLDX:JulyTwoThousandTwentyFourPrivateWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2024-12-31 0001825079 VLDX:JulyTwoThousandTwentyFourPrivateWarrantsMember us-gaap:MeasurementInputExpectedDividendRateMember 2025-06-30 0001825079 VLDX:JulyTwoThousandTwentyFourPrivateWarrantsMember us-gaap:MeasurementInputExpectedDividendRateMember 2024-12-31 0001825079 VLDX:JulyTwoThousandTwentyFourPrivateWarrantsMember 2025-06-30 0001825079 us-gaap:MeasurementInputSharePriceMember 2025-06-30 0001825079 us-gaap:MeasurementInputSharePriceMember 2024-12-31 0001825079 us-gaap:MeasurementInputPriceVolatilityMember 2025-06-30 0001825079 us-gaap:MeasurementInputPriceVolatilityMember 2024-12-31 0001825079 us-gaap:MeasurementInputRiskFreeInterestRateMember 2025-06-30 0001825079 us-gaap:MeasurementInputRiskFreeInterestRateMember 2024-12-31 0001825079 us-gaap:MeasurementInputExpectedDividendRateMember 2025-06-30 0001825079 us-gaap:MeasurementInputExpectedDividendRateMember 2024-12-31 0001825079 VLDX:TwoThousandTwentyOneStockOptionPlanMember 2025-06-30 0001825079 us-gaap:RestrictedStockUnitsRSUMember 2025-06-30 0001825079 us-gaap:RestrictedStockUnitsRSUMember 2024-06-30 0001825079 2023-01-01 2023-12-31 0001825079 us-gaap:RestrictedStockUnitsRSUMember 2023-12-31 0001825079 us-gaap:RestrictedStockUnitsRSUMember 2024-12-31 0001825079 us-gaap:EmployeeStockOptionMember 2025-04-01 2025-06-30 0001825079 us-gaap:EmployeeStockOptionMember 2024-04-01 2024-06-30 0001825079 us-gaap:EmployeeStockOptionMember 2025-01-01 2025-06-30 0001825079 us-gaap:EmployeeStockOptionMember 2024-01-01 2024-06-30 0001825079 VLDX:EarnoutShareUnitsMember 2025-04-01 2025-06-30 0001825079 VLDX:EarnoutShareUnitsMember 2024-04-01 2024-06-30 0001825079 VLDX:EarnoutShareUnitsMember 2025-01-01 2025-06-30 0001825079 VLDX:EarnoutShareUnitsMember 2024-01-01 2024-06-30 0001825079 VLDX:CostOf3DPrinterMember 2025-04-01 2025-06-30 0001825079 VLDX:CostOf3DPrinterMember 2024-04-01 2024-06-30 0001825079 VLDX:CostOf3DPrinterMember 2025-01-01 2025-06-30 0001825079 VLDX:CostOf3DPrinterMember 2024-01-01 2024-06-30 0001825079 VLDX:CostOfSupportServicesMember 2025-04-01 2025-06-30 0001825079 VLDX:CostOfSupportServicesMember 2024-04-01 2024-06-30 0001825079 VLDX:CostOfSupportServicesMember 2025-01-01 2025-06-30 0001825079 VLDX:CostOfSupportServicesMember 2024-01-01 2024-06-30 0001825079 us-gaap:ResearchAndDevelopmentExpenseMember 2025-04-01 2025-06-30 0001825079 us-gaap:ResearchAndDevelopmentExpenseMember 2024-04-01 2024-06-30 0001825079 us-gaap:ResearchAndDevelopmentExpenseMember 2025-01-01 2025-06-30 0001825079 us-gaap:ResearchAndDevelopmentExpenseMember 2024-01-01 2024-06-30 0001825079 us-gaap:SellingAndMarketingExpenseMember 2025-04-01 2025-06-30 0001825079 us-gaap:SellingAndMarketingExpenseMember 2024-04-01 2024-06-30 0001825079 us-gaap:SellingAndMarketingExpenseMember 2025-01-01 2025-06-30 0001825079 us-gaap:SellingAndMarketingExpenseMember 2024-01-01 2024-06-30 0001825079 us-gaap:GeneralAndAdministrativeExpenseMember 2025-04-01 2025-06-30 0001825079 us-gaap:GeneralAndAdministrativeExpenseMember 2024-04-01 2024-06-30 0001825079 us-gaap:GeneralAndAdministrativeExpenseMember 2025-01-01 2025-06-30 0001825079 us-gaap:GeneralAndAdministrativeExpenseMember 2024-01-01 2024-06-30 0001825079 VLDX:CustomerOneMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2025-04-01 2025-06-30 0001825079 VLDX:CustomerOneMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-06-30 0001825079 VLDX:CustomerTwoMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2025-04-01 2025-06-30 0001825079 VLDX:CustomerTwoMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-06-30 0001825079 VLDX:CustomerThreeMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2025-04-01 2025-06-30 0001825079 VLDX:CustomerThreeMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-04-01 2024-06-30 0001825079 VLDX:CustomerThreeMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-06-30 0001825079 VLDX:CustomerThreeMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-06-30 0001825079 VLDX:CustomerFourMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-06-30 0001825079 VLDX:CustomerFiveMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-04-01 2024-06-30 0001825079 VLDX:CustomerFiveMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-06-30 0001825079 VLDX:CustomerSixMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-04-01 2024-06-30 0001825079 VLDX:CustomerSevenMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-04-01 2024-06-30 0001825079 VLDX:CustomerEightMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-06-30 0001825079 VLDX:CustomerNineMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-06-30 0001825079 VLDX:CustomerNineMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-12-31 0001825079 VLDX:CustomerTenMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-12-31 0001825079 VLDX:CustomerElevenMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-12-31 0001825079 srt:AmericasMember 2025-04-01 2025-06-30 0001825079 srt:AmericasMember 2024-04-01 2024-06-30 0001825079 srt:AmericasMember 2025-01-01 2025-06-30 0001825079 srt:AmericasMember 2024-01-01 2024-06-30 0001825079 srt:EuropeMember 2025-04-01 2025-06-30 0001825079 srt:EuropeMember 2024-04-01 2024-06-30 0001825079 srt:EuropeMember 2025-01-01 2025-06-30 0001825079 srt:EuropeMember 2024-01-01 2024-06-30 0001825079 VLDX:OtherLocationsMember 2025-04-01 2025-06-30 0001825079 VLDX:OtherLocationsMember 2024-04-01 2024-06-30 0001825079 VLDX:OtherLocationsMember 2025-01-01 2025-06-30 0001825079 VLDX:OtherLocationsMember 2024-01-01 2024-06-30 0001825079 us-gaap:CommonStockMember VLDX:MomentusIncMember VLDX:MasterServiceAgreementMember 2025-04-14 2025-04-14 0001825079 VLDX:MomentusIncMember VLDX:SeriesAConvertiblePreferredStockMember VLDX:MasterServiceAgreementMember 2025-04-14 2025-04-14 0001825079 VLDX:MomentusIncMember VLDX:MasterServiceAgreementMember 2025-04-14 0001825079 srt:MaximumMember VLDX:MomentusIncMember VLDX:MasterServiceAgreementMember 2025-04-12 2025-04-12 0001825079 VLDX:MomentusIncMember VLDX:MasterServiceAgreementMember 2025-04-12 2025-04-12 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 10-Q

 

 

 

(Mark One)
 
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended June 30, 2025

 

OR

 

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ____ to ____

 

Commission File Number: 001-39757

 

 

 

Velo3D, Inc.

 

 

 

(Exact name of registrant as specified in its charter)

 

Delaware   98-1556965
(State or other jurisdiction of incorporation or organization)   (I.R.S. Employer Identification No.)
2710 Lakeview Court, Fremont, CA   94538
(Address of Principal Executive Offices)   (Zip Code)

 

(408) 610-3915

Registrant’s telephone number, including area code

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
N/A   N/A   N/A

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer   Accelerated filer
Non-accelerated filer   Smaller reporting company
      Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No

 

As of July 31, 2025, the registrant had 14,067,551 shares of common stock, $0.00001 per share outstanding.

 

 

 

 

 

 

TABLE OF CONTENTS

 

    Page
Part I. Financial Information
     
Item 1. Financial Statements (unaudited) 3
  Condensed Consolidated Balance Sheets (unaudited) 3
  Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited) 4
  Condensed Consolidated Statements of Cash Flows (unaudited) 5
  Condensed Consolidated Statements of Stockholders’ Equity (unaudited) 6
  Notes to Condensed Consolidated Interim Financial Statements (unaudited) 7
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 29
Item 3. Quantitative and Qualitative Disclosures about Market Risk 45
Item 4. Controls and Procedures 45
     
Part II. Other Information
     
Item 1. Legal Proceedings 47
Item 1A. Risk Factors 47
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 50
Item 3. Defaults Upon Senior Securities 50
Item 4. Mine Safety Disclosures 50
Item 5. Other Information 50
Item 6. Exhibits 51
Signatures 52

 

i

 

 

Explanatory Note

 

Unless otherwise stated in this Quarterly Report or the context otherwise requires, references to:

 

  “Legacy Velo3D” refer to Velo3D, Inc., a Delaware corporation, prior to the closing of the Merger;
     
  Merger” refer to the merger pursuant to that certain Business Combination Agreement, dated as of March 22, 2021, by and among JAWS Spitfire Acquisition Corporation, a Cayman Islands exempted company (“JAWS Spitfire”), Legacy Velo3D and Spitfire Merger Sub, Inc., a Delaware corporation (“Merger Sub”), as amended by Amendment No. 1 to the Business Combination Agreement, dated as of July 20, 2021 (the “Business Combination Agreement”), whereby Merger Sub merged with and into Legacy Velo3D, with Legacy Velo3D surviving the merger as a wholly-owned subsidiary of the Company, on September 29, 2021;
     
  Velo3D” refer to Velo3D, Inc., a Delaware corporation (f/k/a JAWS Spitfire Acquisition Corporation, prior to its domestication), and its consolidated subsidiaries following the closing of the Merger;
     
  we,” “us,” and “our” or the “Company” refer to Velo3D following the closing of the Merger and to Legacy Velo3D prior to the closing of the Merger; and
     
  2024 Form 10-K” refers to our Annual Report on Form 10-K for the fiscal year ended December 31, 2024, filed with the Securities and Exchange Commission (the “SEC”) on March 31, 2025.

 

Velo”, “Velo3D”, “Sapphire” and “Intelligent Fusion” are registered trademarks of Velo3D, Inc; and “Without Compromise”, “Flow” and “Assure” are trademarks of Velo3D, Inc.

 

Cautionary Note Regarding Forward-looking Statements

 

Certain statements in this Quarterly Report may constitute “forward-looking statements” for purposes of the federal securities laws. Our forward-looking statements include, but are not limited to, statements regarding our or our management team’s expectations, hopes, beliefs, intentions or strategies regarding the future, our strategic realignment and related initiatives, our market opportunities, and our future financial performance. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words “anticipate,” “believe,” “can,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “forecast,” “intend,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “seek,” “should,” “target,” “will,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements in this Quarterly Report involve significant risks and uncertainties, and a number of factors, both foreseen and unforeseen, could cause actual results to differ materially from our current expectations. The factors that may affect our results include, among others, the following:

 

  our ability to generate positive cash flow and liquidity sufficient to meet our operating needs and satisfy our obligations;
     
  our market opportunity;
     
  our ability to execute our business plan, which may be affected by, among other things, competition and our ability to grow and manage growth profitably, raise financing in the near-term, fund our operating expenses, maintain relationships with customers and retain our key employees;
     
  changes in applicable laws or regulations;
     
  the inability to develop and maintain effective internal control over financial reporting;
     
  our ability to service and comply with the terms of our indebtedness;
     
  our ability to raise financing in the near-term and in the future;
     
  our success in retaining or recruiting, or changes required in, our officers, key employees or directors;

 

1

 

 

  whether our existing cash and cash equivalents will be sufficient to fund our operating expenses and capital expenditure requirements and our ability to continue as a going concern;
     
  the potential for our business development efforts to maximize the potential value of our portfolio;
     
  regulatory developments in the United States and foreign countries;
     
  the impact of laws and regulations;
     
  our ability to successfully implement our strategic realignment and related initiatives;
     
  our capital requirements and needs for additional financing;
     
  our financial performance;
     
  macroeconomic conditions, including economic downturns or recessions, inflation, interest rate fluctuations and supply chain shortages; and
     
  other factors detailed under the section entitled “Risk Factors” herein and in Item 1A of our 2024 Form 10-K.

 

The forward-looking statements contained in this Quarterly Report are based on current expectations and beliefs concerning future developments and their potential effects on us. There can be no assurance that future developments affecting us will be those that we have anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, those factors described herein under the section entitled “Risk Factors” and in Item 1A of our 2024 Form 10-K. Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. Some of these risks and uncertainties may in the future be amplified by the impact of other macroeconomic factors and there may be additional risks that we currently consider immaterial or which are unknown. It is not possible to predict or identify all such risks. We do not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.

 

2

 

 

PART I. FINANCIAL INFORMATION

 

Item 1. Financial Statements

 

Velo3D, Inc.

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

(In thousands, except share and per share data)

 

   June 30,   December 31, 
   2025   2024 
Assets          
Current assets:          
Cash and cash equivalents  $854   $1,212 
Accounts receivable, net   5,394    3,723 
Inventories, net   38,417    49,953 
Contract assets   1,448    500 
Prepaid expenses and other current assets   2,783    2,336 
Total current assets   48,896    57,724 
Property and equipment, net   15,201    14,270 
Equipment subject to operating lease, net

   3,020    3,673 
Other assets   11,441    13,513 
Total assets  $78,558   $89,180 
Liabilities and Stockholders’ Equity          
Current liabilities:          
Accounts payable  $14,853   $18,538 
Accrued expenses and other current liabilities   4,263    3,511 
Debt – current portion   16,913    5,666 
Contract liabilities   6,712    10,285 
Total current liabilities   42,741    38,000 
Long-term debt – less current portion   5,562     
Contingent earnout liabilities   11    11 
Warrant liabilities   13    2,167 
Other noncurrent liabilities   8,696    9,338 
Total liabilities   57,023    49,516 
Commitments and contingencies (Note 13)   -    - 
Stockholders’ equity:          
Common stock, $0.00001 par value - 500,000,000 shares authorized at June 30, 2025 and December 31, 2024, respectively, 14,067,416 and 12,993,962 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively   4    4 
Additional paid-in capital   491,032    469,994 
Accumulated other comprehensive loss        
Accumulated deficit   (469,501)   (430,334)
Total stockholders’ equity   21,535    39,664 
Total liabilities and stockholders’ equity  $78,558   $89,180 

 

The accompanying notes are an integral part of these unaudited condensed consolidated interim financial statements.

 

3

 

 

Velo3D, Inc.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

(Unaudited)

(In thousands, except share and per share data)

 

   2025   2024   2025   2024 
   Three Months Ended June 30,   Six Months Ended June 30, 
   2025   2024   2025   2024 
Revenue                
3D Printer  $12,082   $8,679   $19,605   $16,339 
Recurring payment   70    292    70    762 
Support services   1,359    1,373    3,149    3,029 
Other   61        68     
Total Revenue   13,572    10,344    22,892    20,130 
Cost of revenue                    
3D Printer   13,994    10,744    21,534    20,138 
Recurring payment       232    12    547 
Support services   1,166    2,265    2,237    5,157 
Total cost of revenue   15,160    13,241    23,783    25,842 
Gross loss   (1,588)   (2,897)   (891)   (5,712)
Operating expenses                    
Research and development   2,845    4,545    5,120    9,588 
Selling and marketing   1,619    4,273    2,831    9,082 
General and administrative   6,037    8,805    15,168    17,588 
Total operating expenses   10,501    17,623    23,119    36,258 
Loss from operations   (12,089)   (20,520)   (24,010)   (41,970)
Interest expense   (1,572)   (5,463)   (2,642)   (9,360)
Gain (loss) on fair value of warrants       25,310    (1,044)   22,690 
Gain on fair value of contingent earnout liabilities       1,824        1,387 
Loss on warrant cancellation           (11,357)    
Other expense, net   (6)   (1,327)   (17)   (1,233)
Loss before income taxes   (13,667)   (176)   (39,070)   (28,486)
(Provision) benefit for income taxes   (89)   4    (97)    
Net loss  $(13,756)  $(172)  $(39,167)  $(28,486)
                     
Net loss per share:                    
Basic  $(0.98)  $(0.30)  $(2.85)  $(53.31)
Diluted  $(0.98)  $(0.30)  $(2.85)  $(53.31)
Shares used in computing net loss per share:                    
Basic   14,041,712    565,026    13,721,680    534,381 
Diluted   14,041,712    565,026    13,721,680    534,381 
                     
Net loss  $(13,756)  $(172)  $(39,167)  $(28,486)
Net unrealized holding gain on available-for-sale investments       42        94 
Total comprehensive loss  $(13,756)  $(130)  $(39,167)  $(28,392)

 

The accompanying notes are an integral part of these unaudited condensed consolidated interim financial statements.

 

4

 

 

Velo3D, Inc.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

(In thousands)

 

   2025   2024 
   Six Months Ended June 30, 
   2025   2024 
Cash flows from operating activities          
Net loss  $(39,167)  $(28,486)
Adjustments to reconcile net loss to net cash used in operating activities          
Depreciation and amortization   1,725    2,707 
Amortization of debt discount and deferred financing costs   2,559    8,281 
Stock-based compensation   6,483    9,334 
(Gain) loss on fair value of warrants   1,044    (22,690)
Gain on fair value of contingent earnout liabilities       (1,387)
Loss on warrant cancellation   11,357     
Non-cash cost of issuance of common stock warrants on BEPO Offering       1,313 
Loss on sale/disposal of fixed assets   2,777     
Realized loss on available for sale securities       21 
Changes in operating assets and liabilities          
Accounts receivable   (1,671)   1,245 
Inventories   5,691    3,891 
Contract assets   (948)   (1,351)
Prepaid expenses and other current assets   (292)   1,871 
Other assets   2,002    1,369 
Accounts payable   (912)   (2,391)
Accrued expenses and other liabilities   2    (595)
Contract liabilities   (3,573)   (345)
Other noncurrent liabilities   (642)   (1,279)
Net cash used in operating activities   (13,565)   (28,492)
Cash flows from investing activities          
Purchase of property and equipment   (1,799)   (8)
Sales of available-for-sale investments       2,474 
Proceeds from maturity of available-for-sale investments       3,500 
Net cash (used in) provided by investing activities   (1,799)   5,966 
Cash flows from financing activities          
Proceeds from secured convertible notes   15,000     
Proceeds from BEPO Offering, net of issuance costs       10,675 
Repayment of secured notes       (10,500)
Issuance of common stock upon exercise of stock options       315 
Net cash provided by financing activities   15,000    490 
Effect of exchange rate changes on cash and cash equivalents   6    4 
Net change in cash and cash equivalents   (358)   (22,032)
Cash and cash equivalents and restricted cash at beginning of period   1,840    25,294 
Cash and cash equivalents and restricted cash at end of period  $1,482   $3,262 
           
Supplemental disclosure of cash flow information          
Cash paid for interest  $750   $762 
Supplemental schedule of non-cash investing and financing activities          
Unpaid liabilities related to property and equipment   160    20 
Transfer between inventory and property and equipment   3,404     
Equipment for lease to customers returned to inventory   653    2,235 

 

The following table provides a reconciliation of cash, cash equivalents, and restricted cash shown on the condensed consolidated statements of cash flows (unaudited):

 

   Six Months Ended June 30, 
   2025   2024 
   (In thousands) 
Cash and cash equivalents  $854   $2,462 
Restricted cash (Other assets)   628    800 
Total cash and cash equivalents and restricted cash  $1,482   $3,262 

 

The accompanying notes are an integral part of these unaudited condensed consolidated interim financial statements.

 

5

 

 

Velo3D, Inc.

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(Unaudited)

(In thousands, except share data)

 

   Shares   Amount   Capital   Income (Loss)   Deficit   Equity 
   Common Stock   Additional Paid-In   Accumulated
Other Comprehensive
   Accumulated   Total Stockholders’ 
   Shares   Amount   Capital   Income (Loss)   Deficit   Equity 
Balance as of March 31, 2024   506,423   $2   $430,843   $(44)  $(385,351)  $           45,450 
Issuance of common stock upon exercise of stock options and release of restricted stock units   2,351        30            30 
Stock-based compensation           4,247            4,247 
Issuance of common stock in connection with BEPO Offering, net   65,307        2,522            2,522 
Net loss                   (172)   (172)
Other comprehensive income               42        42 
Balance as of June 30, 2024   574,081   $2   $437,642   $(2)  $(385,523)  $52,119 
                               
Balance as of March 31, 2025   14,015,517   $4   $488,623   $   $(455,745)  $32,882 
Issuance of common stock upon vesting of RSUs   51,898                     
Stock-based compensation           2,409            2,409 
Net loss                   (13,756)   (13,756)
Balance as of June 30, 2025   14,067,416   $4   $491,032   $   $(469,501)  $21,535 

 

   Common Stock   Additional Paid-In   Accumulated Other Comprehensive   Accumulated  

Total

Stockholders’

 
   Shares   Amount   Capital   Income (Loss)   Deficit   Equity 
Balance as of December 31, 2023   492,223   $2   $425,471   $(96)  $(357,037)  $           68,340 
Issuance of common stock upon exercise of stock options and release of restricted stock units   8,609        315            315 
Stock-based compensation           9,334            9,334 
Issuance of common stock in connection with BEPO Offering, net   65,307        2,522            2,522 
Net loss                   (28,486)   (28,486)
Reclassifications and adjustments due to rounding impact from reverse stock split for fractional shares   7,942                     
Other comprehensive income               94        94 
Balance as of June 30, 2024   574,081   $2   $437,642   $(2)  $(385,523)  $52,119 
                               
Balance as of December 31, 2024   12,993,962   $4   $469,994   $   $(430,334)  $39,664 
Issuance of common stock upon vesting of RSUs   83,295    -                   - 
Stock-based compensation           6,483            6,483 
Issuance of common stock in connection with warrant cancellation   990,159        14,555            14,555 
Net loss                   (39,167)   (39,167)
Balance as of June 30, 2025   14,067,416   $4   $491,032   $   $(469,501)  $21,535 

 

The accompanying notes are an integral part of these unaudited condensed consolidated interim financial statements.

 

6

 

 

Velo3D, Inc.

Notes to Condensed Consolidated Interim Financial Statements

(Unaudited)

 

Note 1. Description of Business and Basis of Presentation

 

Velo3D, Inc., a Delaware corporation (“Velo3D”), formerly known as JAWS Spitfire Acquisition Corporation (“JAWS Spitfire”), produces metal additive three dimensional printers (“3D Printers”) which enable the production of components for space rockets, jet engines, fuel delivery systems and other high value metal parts, which it sells or leases to customers for use in their businesses. The Company also provides support services (“Support Services”) for an incremental fee.

 

Velo3D’s subsidiaries are Velo3D US, Inc., (formerly known as Velo3D, Inc. (“Legacy Velo3D”), founded in June 2014 as a Delaware corporation headquartered in Campbell, California), Velo3D, B.V., (a sales and marketing office located in the Netherlands) and Velo3D, GmbH, (a sales and marketing office located in Germany). The first commercially developed 3D Printer was delivered in the fourth quarter of 2018.

 

On September 29, 2021 (the “Closing Date” or the “Reverse Recapitalization Date”), JAWS Spitfire completed the previously announced merger with Legacy Velo3D, with Legacy Velo3D surviving as a wholly-owned subsidiary of JAWS Spitfire (the “Merger” or the “Reverse Recapitalization”). In connection with the Merger, JAWS Spitfire was renamed “Velo3D, Inc.”, and Legacy Velo3D was renamed “Velo3D US, Inc.”

 

The shares and net loss per share attributable to common stockholders, basic and diluted, prior to the Merger, have been retroactively restated as shares reflecting the exchange ratio (the “Exchange Ratio”) established in the Merger (0.8149 shares of Velo3D common stock for 1 share of Legacy Velo3D common stock, par value $0.00001 (the “common stock”) before the 1-for-35 reverse stock split in 2024 and the 1-for-15 reverse stock split in 2025. All fractional shares were rounded.

 

Unless otherwise stated herein or unless the context otherwise requires, references in these notes to the “Company” refer to (i) Legacy Velo3D prior to the consummation of the Merger; and (ii) Velo3D and its consolidated subsidiaries following the consummation of the Merger.

 

Basis of Presentation

 

The unaudited condensed consolidated interim financial statements include the accounts of the Company and its subsidiaries and have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and the requirements of the U.S. Securities and Exchange Commission (the “SEC”) for interim financial reporting. Intercompany balances and transactions have been eliminated in consolidation. As permitted under those rules, certain footnotes or other financial information that are normally required by U.S. GAAP can be condensed or omitted. Accordingly, these unaudited condensed consolidated interim financial statements should be read in conjunction with the audited consolidated financial statements included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024 (the “2024 Form 10-K”) and the related notes, which provide a more complete discussion of the Company’s accounting policies and certain other information. The condensed consolidated balance sheet as of December 31, 2024 has been derived from the audited consolidated financial statements of the Company. These unaudited condensed consolidated interim financial statements have been prepared on the same basis as the Company’s annual consolidated financial statements and, in the opinion of management, reflect all adjustments, consisting only of normal recurring adjustments, which are necessary for the fair statement of the Company’s consolidated financial information. These interim results are not necessarily indicative of the results to be expected for the fiscal year ended December 31, 2025, or for any other interim period or for any other future year.

 

On June 10, 2024, the stockholders of the Company approved an amendment to the Company’s Certificate of Incorporation to effect a reverse stock split of the issued and outstanding shares of the Company’s common stock, par value $0.00001 per share, at a ratio ranging from 1-for-5 and 1-for-50, with the exact ratio to be set within that range by the Company’s board of directors (the “Board”). On June 10, 2024, the Board approved the reverse stock split at a ratio of 1-for-35 (the “2024 Reverse Stock Split”). On June 12, 2024, the Company filed a Certificate of Amendment to the Company’s Certificate of Incorporation with the Secretary of State of the State of Delaware to effect the 2024 Reverse Stock Split, effective as of June 13, 2024.

 

As a result of the 2024 Reverse Stock Split, every 35 shares of the Company’s common stock were automatically reclassified and converted into one issued and outstanding share of common stock. No fractional shares were issued in connection with the Reverse Stock Split. Any fractional shares resulting from the 2024 Reverse Stock Split were rounded up to the nearest whole share. The par value of the Company’s common stock was not adjusted as a result of the 2024 Reverse Stock Split. All of the Company’s share numbers, per share amounts, and related stockholders’ equity (deficit) balances presented herein have been retroactively adjusted to reflect the 2024 Reverse Stock Split. In addition, the exercise prices, conversion rates and other terms of the Company’s securities that adjusted pursuant to their terms as a result of the 2024 Reverse Stock Split have been presented after giving effect to such adjustments.

 

7

 

 

On June 27, 2025, the stockholders of the Company, approved an amendment to the Company’s Certificate of Incorporation, as amended, to effect a reverse stock split of the issued and outstanding shares of the Company’s common stock, par value $0.00001 per share, at a ratio ranging from 1-for-5 and 1-for-50, with the exact ratio to be set within that range by the Company’s Board. On July 18, 2025, the Board approved the reverse stock split at a ratio of 1-for-15 (the “2025 Reverse Stock Split”). On July 25, 2025, the Company filed a Certificate of Amendment to the Company’s Certificate of Incorporation, as amended, with the Secretary of State of the State of Delaware to effect the 2025 Reverse Stock Split, effective as of July 28, 2025.

 

As a result of the 2025 Reverse Stock Split, every 15 shares of the Company’s common stock were automatically reclassified and converted into one issued and outstanding share of common stock. No fractional shares were issued in connection with the 2025 Reverse Stock Split. Any fractional shares resulting from the 2025 Reverse Stock Split were rounded up to the nearest whole share. The par value of the Company’s common stock was not adjusted as a result of the 2025 Reverse Stock Split nor did it change the total number of the Company’s authorized shares of common stock. All of the Company’s share numbers, per share amounts, and related stockholders’ equity (deficit) balances presented herein have been retroactively adjusted to reflect the 2025 Reverse Stock Split. In addition, the exercise prices, conversion rates and other terms of the Company’s securities that adjusted pursuant to their terms as a result of the 2025 Reverse Stock Split have been presented after giving effect to such adjustments.

 

Delisting from the New York Stock Exchange (“NYSE”) and Trading on Over-the Counter (“OTC”)

 

On September 10, 2024, the Company received written notice from the NYSE that the NYSE had determined to commence proceedings to delist the Company’s common stock and publicly traded warrants and that trading in such securities would be suspended immediately. On September 11, 2024, the Company commenced the trading of its common stock and warrants on the OTCQX Best Market.

 

Going Concern, Financial Condition and Liquidity and Capital Resources

 

The unaudited condensed consolidated interim financial statements have been prepared on the basis of continuity of operations, the realization of assets and satisfaction of liabilities in the ordinary course of business. The Company has incurred losses from operations and negative cash flows from operations in every year since inception and expects this to continue for the foreseeable future. As of June 30, 2025, the Company had an accumulated deficit of $(469.5) million and cash and cash equivalents on hand of approximately $0.9 million.

 

Management believes that substantial doubt exists about the Company’s ability to continue as a going concern. As of the date of the issuance of these unaudited condensed consolidated interim financial statements, the Company does not have sufficient liquidity to meet its operating needs and satisfy its obligations for at least 12 months from the date of issuance of the these unaudited condensed consolidated interim financial statements.

 

On April 1, 2024, the Company entered into a second note amendment (the “Second Note Amendment”) to its Secured Notes with High Trail Investments ON LLC and HB SPV I Master Sub LLC, (“the Note Holders”). Pursuant to the Second Note Amendment, the Company agreed to make and made a cash payment of $5.0 million on April 1, 2024, to redeem approximately $4.2 million of aggregate principal amount of the Secured Notes, together with accrued and unpaid interest, and a cash payment of $5.5 million on April 15, 2024, to repay approximately $4.6 million of principal of the Secured Notes, together with accrued and unpaid interest. In connection with the Second Note Amendment, the Company issued to the Note Holders warrants to purchase 41,808 shares of the Company’s common stock that became exercisable 45 days after the original issuance date at an exercise price of $239.22 per share. The Note Holders may exercise the Warrants by paying the exercise in cash or by reducing the outstanding principal amount under the Secured Notes by an amount equal to the quotient of (A) the amount of the exercise price divided by (B) 1.20.

 

On April 10, 2024, the Company sold (such sale and issuance, the “BEPO Offering”) an aggregate of: (i) 65,307 shares of common stock and (ii) immediately exercisable warrants to purchase up to 65,307 shares of common stock at $183.75 per share. The offering price per share of common stock and accompanying warrant was $183.75 and resulted in gross proceeds to the Company of approximately $12 million. The Company used the net proceeds from the BEPO Offering primarily for funding working capital and capital expenditures and other general corporate purposes, including repayment of portions of the Company’s Secured Notes.

 

On July 1, 2024, we entered into a third note amendment to the Secured Notes with the Note Holders (the “Third Note Amendment”). Pursuant to the Third Note Amendment, the Company and the Note Holders agreed to defer the July 1, 2024 partial redemption payment of $10.5 million (the “July Redemption Payment”) over a period of ten equal monthly payments commencing August 1, 2024. During August and September 2024, we received extensions from the Note Holders for the July Redemption Payment through October 4, 2024.

 

On December 9, 2024, Arrayed Notes Acquisition Corp. (“Arrayed”), a subsidiary of Arrayed Additive, Inc. purchased the Senior Secured Notes due 2026 (the “Secured Notes”) from the Note Holders. Furthermore, on December 9, 2024, the Company and the Note Holders entered into a forbearance agreement where the Note Holders forbore from taking any enforcement action as a result of the occurrence and/or continuation of any specified events of default.

 

On December 24, 2024, the Company and Arrayed entered into a debt for equity exchange transaction where the Company issued 12,343,423 shares of the Company’s common stock, in exchange for the cancellation of $22.4 million in principal amount of the Company’s Secured Notes plus $0.4 million of accrued interest on the Notes. Arrayed continues to hold $5.0 million in principal amount of the Secured Notes, and as a result of the December 2024 Exchange, became the owner of approximately 95% of the Company’s issued and outstanding common stock.

 

In December 2023, the Board of Directors commenced a strategic business review process to explore alternatives in order to maximize stockholder value. The Company’s strategic review was concluded on December 24, 2024, at the close of the debt for equity exchange transaction.

 

On January 7, 2025, the Company issued a Senior Secured Convertible Promissory Note in the principal amount of $5,000,000 (the “January Note”) to Thieneman Properties, LLC, an Indiana limited liability company. The January Note bears interest at a rate of 60.0% per annum and was payable in full on April 7, 2025 in the amount of $5,750,000 and if not paid on or prior to such date, will continue to accrue interest at the same rate until paid. The January Note may be prepaid in whole or in part at any time without penalty or premium and is convertible in the event of default into shares of the Company’s common stock, at a fixed conversion price of $1.56 per share. On April 7, 2025, the Company made a payment of $750,000, covering the first three months of interest on the January Note.

 

8

 

 

On February 10, 2025, the Company issued a Senior Secured Convertible Promissory Note in the principal amount of $10,000,000 (the “February Note”) to Thieneman Construction, Inc, an Indiana corporation, to be funded in two tranches of $5,000,000. The February Note bears interest at a rate of 30.0% per annum, is payable in full on the date that is six months from the date such tranche was funded, in the amount of $5,750,000 and if not paid on or prior to such date, will continue to accrue interest at the same rate until paid. The first tranche (“February Note 1st tranche”) and second tranche (“February Note 2nd tranche”) were received by the Company on February 10, 2025 and March 20, 2025, respectively, which become due on August 10, 2025 and September 20, 2025, respectively. The outstanding principal amount of the February Note is convertible upon the occurrence of the Company’s successful listing of shares of its common stock on a national securities exchange or the occurrence and during the continuation of an event of default, into shares of the Company’s common stock at a fixed conversion price of $15.00 per share. The January Note and February Note are referred to herein collectively as the (the “Secured Convertible Notes”).

 

Further, the Company will need to engage in additional financings to fund its operations and satisfy its obligations in the near-term. The Company is in discussions with multiple financing sources to attempt to secure additional financing. There are no assurances that the Company will be able to obtain financing on acceptable terms, or at all, to provide the necessary interim funding to continue its operations and satisfy its obligations for at least 12 months from the date of issuance of the unaudited condensed consolidated interim financial statements.

 

Note 2. Summary of Significant Accounting Policies

 

For a detailed discussion about the Company’s significant accounting policies and for further information on significant accounting updates adopted in the prior year, see Note 2, Summary of Significant Accounting Policies, to the audited consolidated financial statements in the 2024 Form 10-K. During the six months ended June 30, 2025, there were no significant updates to the Company’s significant accounting policies other than as described below.

 

Recently Issued Accounting Pronouncements

 

In December 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2023-09 (“ASU 2023-09”), Income Taxes (Topic 740): Improvement to Income Tax Disclosures to enhance the transparency and decision usefulness of income tax disclosures. Two primary enhancements related to this ASU include disaggregating existing income tax disclosures relating to the effective tax rate reconciliation and income taxes paid. ASU 2023-09 is effective for annual periods beginning after December 15, 2024 on a prospective basis. Early adoption is permitted. The Company is currently evaluating the impact of this accounting standard update on the Company’s condensed consolidated interim financial statements and related disclosures.

 

In November 2024, the FASB issued ASU 2024-03, Income Statement – Reporting Comprehensive Income – Expense Disaggregation Disclosures (Subtopic 220-40). This update contains amendments that require disclosure, in the notes to financial statements, of specified information about certain costs and expenses. The amendments in this update are effective for public business entities for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027. Early adoption is permitted. The expected impact would only be to the financial statement disclosures. The Company is currently evaluating the impact of this accounting standard update on the Company’s condensed consolidated interim financial statements and related disclosures.

 

Licensing Revenue

 

Our revenue is partially derived from the licensing of computer software products and from their related maintenance contracts. We enter into contracts that include combinations of products, maintenance and services, which are accounted for as separate performance obligations with differing revenue recognition patterns.

 

Revenue from perpetual licenses is classified as software license revenue. Software license revenue is recognized up front upon delivery of the licensed product and/or the utility that enables the customer to access authorization keys, provided that an enforceable contract has been received. Typically, our perpetual licenses are sold with post-contract support (“PCS”), which includes unspecified technical enhancements and customer support. We allocate value in bundled perpetual and PCS arrangements based on the standalone selling prices of the perpetual license and PCS. Revenue from PCS is classified as maintenance revenue and is recognized either (i) ratably over the term of the contract or (ii) as the customer support is used at a specified hourly rate, as we satisfy the PCS performance obligation.

 

9

 

 

In addition to perpetual licenses, we sell time-based subscription licenses. Subscription licenses may be sold as a bundled arrangement that includes the rights to a term software license and PCS. Utilizing observable inputs, we determine a certain percentage of the estimated standalone selling price of the subscription lease license is attributable to the term license and the remainder is attributable to the PCS, based on factors pursuant to each arrangement. This determination considered the value relationship for our products between PCS and time-based subscription lease licenses, the value relationship between PCS and perpetual licenses, the average economic life of our products, software renewal rates and the price of the bundled arrangement in relation to the perpetual licensing approach. Consistent with the perpetual sales, the license component is classified as software license revenue and recognized as revenue up front upon delivery of the licensed product and/or utility that enables the customer to access authorization keys. The PCS is classified as maintenance revenue and is recognized ratably over the term of the contract, as we satisfy the PCS performance obligation.

 

Product Warranties

 

Our 3D printers are sold with a warranty period of typically one year from installation. After the warranty period, we generally offer service contracts that enable our customers to continue service and maintenance coverage. These service contracts are offered with various levels of support and options and are priced accordingly. One entitlement of our service contracts is our service engineers provide periodic preventive maintenance visits to customer sites. Additionally, we provide training to our partners to enable them to also perform these services. Another contract entitlement on certain printer models is proactive remote troubleshooting capability through the Company’s integrated platform. From time to time, we also offer upgrade kits for certain of our printers that enable our existing customers to take advantage of new or enhanced printer capabilities. In some cases, we have discontinued upgrade support and maintenance agreements for certain of our older legacy printers.

 

Printers and certain other products include a warranty that covers workmanship, software, and hardware components under which we provide maintenance for periods up to one year. For these initial product warranties, estimated costs are accrued at the time of the sale of the product. These cost estimates are established using historical information regarding the nature, frequency and average cost of claims for each type of printer or other product, as well as assumptions about future activity and events. Revisions to expense accruals are made as necessary based on changes in these historical and future factors.

 

Information by Segment and Geography

 

The Company manages its operations and allocates resources as a single operating segment. Further, the Company manages, monitors, and reports its financial results as a single reportable segment. The Company’s chief operating decision-maker (“CODM”) is its Chief Executive Officer, who reviews financial information presented on an entity wide basis for purposes of making operating decisions, assessing financial performance, and allocating resources.

 

Specifically, our CODM uses consolidated net income to measure segment profit or loss, allocate resources of the Company as a whole, including investing in future development efforts, customer retention and acquisition, and assessing performance. Further, the CODM reviews and utilizes functional expenses (cost of revenues, sales and marketing, research and development, and general and administrative) at the consolidated level to manage the Company’s operations. Other segment items included in condensed consolidated net income are interest income, other expense, net and the provision for (benefit from) income taxes, which are reflected in the unaudited condensed consolidated statements of comprehensive income (loss).

 

Equipment Subject to Operating Lease

 

We have updated certain naming conventions within our condensed consolidated interim financial statement descriptions to better reflect the nature of our leases. The line item previously labeled “Equipment on lease, net” has been renamed to “Equipment subject to operating lease, net”. Additionally, the related note disclosure has been revised to separately present (i) “Equipment on Lease”, and (ii) “Equipment available on lease”. These changes are intended to improve clarity and more accurately represent the composition and status of our equipment subject to operating lease.

 

For more information, see Note 7, Equipment Subject to Operating Lease, Net, in the notes of the unaudited condensed consolidated interim financial statements included elsewhere in this Quarterly Report.

 

Our 3D printers subject to operating leases are classified using the following criteria:

 

    Equipment on
Lease
  Equipment Available
for Lease
Revenue generation – under contract or not under contract but held for potential redeployment to existing or new customers   Yes (lease income active)   No (not on active lease)
Physical location – remains in a condition, location, and business context rendering it suitable for future lease arrangements   At customer site   At customer site, idle, or warehouse

Intended use – for third party customers and not for internal usage

  On Lease   Available for Lease

Depreciation – the lesser of the useful life of the equipment or the contract period and annually tested for impairment

  Yes, per original schedule   Yes, may accelerate if impaired


 

If the 3D printers does not meet the above criteria, the equipment is classified under property and equipment, net.

 

Revision of Previously Filed Financial Statements

 

During the second quarter of 2025, the Company discovered the initial research and development and sales and marketing operating expenses for the three months ended March 31, 2025, were incorrectly presented on the unaudited condensed consolidated statement of operations and comprehensive loss. The Company initially reported the research and development expenses under the sales and marketing financial statement line item and the sales and marketing expenses under the research and development financial statement line item in the operating expenses section of the unaudited condensed consolidated statement of operations and comprehensive loss. There was no impact to the total operating expenses, net loss or net loss per share on the unaudited condensed consolidated statement of operations and comprehensive loss for the three months ended March 31, 2025.

 

The following table reflects the revisions to the previously issued unaudited condensed consolidated statement of operations and comprehensive loss for the three months ended March 31, 2025:

 

   As Previously Reported   Adjusted   As Revised 
   Three Months Ended March 31, 2025 
   As Previously Reported   Adjusted   As Revised 
   (In thousands) 
             
Research and development  $1,212   $1,063   $2,275 
Selling and marketing  $2,275   $(1,063)  $1,212 

 

During the second quarter of 2025, the Company discovered that the cash paid for interest reported under the supplemental disclosure of cash flow information on the unaudited condensed consolidated statement of cash flows for the three months ended March 31, 2025 was incorrect and should have been zero.

 

10

 

 

The following table reflects the revisions to the previously issued unaudited condensed consolidated statement of cash flows for the three months ended March 31, 2025:

 

   As Previously Reported   Adjusted   As Revised 
   Three Months Ended March 31, 2025 
   As Previously Reported   Adjusted   As Revised 
   (In thousands) 
     
Cash paid for interest  $202   $(202)  $- 

 

Note 3. Basic and Diluted Net Loss per Share

 

The following table sets forth the computation of the Company’s basic and diluted net loss per share attributable to common stockholders:

 

   2025   2024   2025   2024 
   Three Months Ended June 30,   Six Months Ended June 30, 
   2025   2024   2025   2024 
   (In thousands, except share and per share data)   (In thousands, except share and per share data) 
Numerator:                
Net loss  $(13,756)  $(172)  $(39,167)  $(28,486)
Denominator:                    
Basic weighted average shares outstanding   14,041,712    565,026    13,721,680    534,381 
Diluted weighted average shares outstanding   14,041,712    565,026    13,721,680    534,381 
                     
Net loss per share                    
Basic  $(0.98)  $(0.30)  $(2.85)  $(53.31)
Diluted  $(0.98)  $(0.30)  $(2.85)  $(53.31)

 

The following potentially dilutive shares of common stock equivalents “on an as-converted basis” were excluded from the computation of diluted net loss per share for the periods presented because including them would have had an antidilutive effect:

 

    For the Three and Six Months Ended
June 30,
 
    2025     2024  
             
Common stock warrants     36,892       207,417  
Common stock options     9,971       20,808  
Restricted stock units     303,577       36,384  
Total potentially dilutive common share equivalents     350,440       264,609  

 

Total potentially dilutive common share equivalents for the three and six months ended June 30, 2025 and 2024 excludes 41,444 shares related to the earnout liability as these shares are contingently issuable upon meeting certain triggering events.

 

Note 4. Fair Value Measurements

 

The Company’s assets and liabilities that were measured at fair value on a recurring basis were as follows:

 

   Level 1   Level 2   Level 3   Total 
   Fair Value Measured as of June 30, 2025 
   Level 1   Level 2   Level 3   Total 
   (In thousands) 
Assets                
Money market funds (i)  $379   $   $   $379 
Total financial assets  $379   $   $   $379 
Liabilities                    
Common stock warrant liabilities (Placement Agent Warrants) (ii) 

$

  

$

  

$

3  

$

3 
Common stock warrant liabilities (BEPO Warrants) (ii)           6    6 
Common stock warrant liabilities (BEPO Agent Warrants) (ii)           4    4 
Contingent earnout liabilities           11    11 
Total financial liabilities  $   $   $24   $24 

 

   Level 1   Level 2   Level 3   Total 
   Fair Value Measured as of December 31, 2024 
   Level 1   Level 2   Level 3   Total 
   (In thousands) 
Assets                
Money market funds (i)  $215   $   $   $215 
Total financial assets  $215   $   $   $215 
Liabilities                    
Common stock warrant liabilities (2022 Private Warrant) (ii)  $   $   $1   $1 
Common stock warrant liabilities (RDO Warrants) (ii)           90    90 
Common stock warrant liabilities (Placement Agent Warrants) (ii)           16    16 
Common stock warrant liabilities (2024 Private Warrants) (ii)           378    378 
Common stock warrant liabilities (BEPO Warrants) (ii)           18    18 
Common stock warrant liabilities (BEPO Agent Warrants) (ii)           2    2 
Common stock warrant liabilities (July 2024 Private Warrants) (ii)           865    865 
Common stock warrant liabilities (August Inducement Warrants) (ii)           796    796 
Contingent earnout liabilities           11    11 
Total financial liabilities  $   $   $2,177   $2,177 

 

  (i) Included in cash and cash equivalents on the unaudited condensed consolidated balance sheets.
  (ii) Included in warrant liabilities on the unaudited condensed consolidated balance sheets.

 

For more information regarding the Public Warrants, the Private Placement Warrants, the 2022 Private Warrant, the RDO Warrants, the Placement Agent Warrants, the 2024 Private Warrants, the BEPO Warrants, and the BEPO Agent Warrants, July 2024 Private Warrants, August Inducement Warrants and the Contingent earnout liabilities, see Note 10, Equity Instruments.

 

The aggregate fair value of the Company’s money market funds approximated amortized cost and, as such, there were no unrealized gains or losses on money market funds as of June 30, 2025 and December 31, 2024. Realized gains and losses, net of tax, were not material for any of the periods presented.

 

11

 

 

The following table presents a summary of the changes in the fair value of the Company’s Level 3 financial instruments:

 

   Private
placement
warrant
liabilities
   2022
Private
Warrant
   Contingent
earnout
liabilities
   RDO
Warrants
   Placement
Agent
Warrants
   2024 Private Warrants   BEPO Warrants   BEPO Agent Warrants   July 2024 Private Warrants   August Inducement Warrants 
   (In thousands) 
Fair value as of January 1, 2025  $              $1   $11   $90   $16   $2   $378   $18   $865   $796 
Change in fair value       (1)       55    (13)   (1)   176    (14)   441    402 
Change due to exchange                 (145)       (1)   (548)        (1,306)   (1,198)
Fair value as of March 31, 2025  $   $   $11   $   $3   $   $6   $4   $   $ 
Issuance of instruments                                        
Change in fair value                                        
Fair value as of June 30, 2025  $   $   $11   $   $3   $   $6   $4   $   $ 

 

   Private
placement
warrant
liabilities
   2022
Private
Warrant
   Contingent
earnout
liabilities
   RDO
Warrants
   Placement
Agent
Warrants
   2024 Private Warrants   BEPO Warrants   BEPO Agent Warrants   July 2024 Private Warrants   August Inducement Warrants 
   (In thousands) 
Fair value as of January 1, 2024  $127   $23   $1,456   $10,891   $536   $   $   $   $   $ 
Change in fair value   114    5    437    2,162    108                     
Fair value as of March 31, 2024  $241   $28   $1,893   $13,053   $644   $   $   $   $   $ 
Issuance of instruments                       6,321    9,020    446         
Change in fair value   (217)   (23)   (1,824)   (11,016)   (544)   (5,948)   (6,784)   (336)        
Fair value as of June 30, 2024  $24   $5   $69   $2,037   $100   $373   $2,236   $110   $   $ 

 

The fair value of the private placement warrant liabilities, the 2022 Private Warrant, the contingent earnout liabilities, the RDO Warrants, the Placement Agent Warrants, the 2024 Private Warrants, the BEPO Warrants, the BEPO Agent Warrants, the July 2024 Private Warrants and the August Inducement Warrants are based on significant unobservable inputs, which represent Level 3 measurements within the fair value hierarchy.

 

In determining the fair value of the Private Placement Warrant liabilities, contingent earnout liabilities, and 2024 Private Warrants, the Company used the Monte Carlo simulation model using a distribution of potential outcomes on a weekly basis over the applicable periods that assumes optimal exercise of the Company’s redemption option at the earliest possible date (see Note 10, Equity Instruments).

 

In determining the fair value of the 2022 Private Warrant, RDO Warrants, Placement Agent Warrants, BEPO Warrants, BEPO Agent Warrants, July 2024 Private Warrants and August Inducement Warrants the Company used the Black-Scholes option pricing model to estimate the fair value using unobservable inputs including the expected term, expected volatility, risk-free interest rate and dividend yield (see Note 10, Equity Instruments).

 

Note 5. Investments

 

Available-for-sale (“AFS”) Investments

 

There were no AFS investments as of June 30, 2025 and December 31, 2024.

 

There were no material realized gains or losses on AFS investments during the three and six months ended June 30, 2025 and June 30, 2024.

 

12

 

 

Note 6. Balance Sheet Components

 

Accounts Receivable, Net

 

Accounts receivable, net consisted of the following:

 

   June 30,   December 31, 
   2025   2024 
   (In thousands) 
Trade receivables  $7,216   $7,130 
Less: Allowances for credit losses   (1,822)   (3,407)
Total  $5,394   $3,723 

 

Inventories, Net

 

Inventories consisted of the following:

 

   June 30,   December 31, 
   2025   2024 
   (In thousands) 
Raw materials  $30,024   $29,386 
Work-in-progress   3,076    9,660 
Finished goods   5,317    10,907 
Total  $38,417   $49,953 

 

The Company recorded $24.1 million and $27.1 million in inventory reserves related to the valuation of inventory as of June 30, 2025 and December 31, 2024, respectively.

 

Prepaid Expenses and Other Current Assets

 

Prepaid expenses and other current assets consisted of the following:

 

   June 30,   December 31, 
   2025   2024 
   (In thousands) 
Prepaid insurance and other  $1,706   $1,724 
Vendor prepayments   1,077    612 
Total  $2,783   $2,336 

 

Property and Equipment, Net

 

Property and equipment, net consisted of the following:

 

   June 30,   December 31, 
   2025   2024 
   (In thousands) 
Computers and software  $2,525   $2,525 
Lab equipment and other equipment   13,395    11,011 
Furniture and fixtures   206    206 
Leasehold improvements   13,379    13,312 
Construction in progress   88     
Total property, plant and equipment   29,593    27,054 
Less accumulated depreciation and amortization   (14,392)   (12,784)
Property, plant and equipment, net  $15,201   $14,270 

 

Depreciation expense for the three months ended June 30, 2025 and 2024 was $0.8 million and $1.1 million, respectively. Depreciation expense for the six months ended June 30, 2025 and 2024 was $1.7 million and $2.2 million, respectively.

 

13

 

 

Other Assets

 

Other assets consisted of the following:

 

   June 30,   December 31, 
   2025   2024 
   (In thousands) 
Right of use assets  $7,838   $8,774 
Net Investment in sales type lease   2,220    2,712 
Non-current prepaid expenses and other assets   1,383    2,027 
Total Other assets  $11,441   $13,513 

 

Accrued Expenses and Other Current Liabilities

 

Accrued expenses and other current liabilities consisted of the following:

 

    June 30,     December 31,  
    2025     2024  
    (In thousands)  
Accrued expenses   $ 1,759     $ 1,173  
Accrued salaries and benefits     786       560  
Lease liability – current portion     1,718       1,778  
Total Accrued expenses and other current liabilities   $ 4,263     $ 3,511  

 

Other Noncurrent Liabilities

 

Other noncurrent liabilities consisted of the following:

 

    June 30,     December 31,  
    2025     2024  
    (In thousands)  
Lease liabilities – noncurrent portion   $ 7,620     $ 8,475  
Other noncurrent liabilities     1,076       863  
Total other noncurrent liabilities   $ 8,696     $ 9,338  

 

Note 7. Equipment Subject to Operating Lease, Net

 

The equipment subject to operating leases to customers had a cost basis of $3.6 million and accumulated depreciation of $0.5 million as of June 30, 2025. The equipment leased to customers had a cost basis of $4.6 million and accumulated depreciation of $0.9 million as of December 31, 2024.

 

The equipment subject to operating lease consisted of the following:

   June 30,   December 31, 
   2025   2024 
   (In thousands) 
Equipment on Lease  $-   $ 
Equipment Available for Lease   

3,566

    4,622 
Total Equipment Subject to Operating Lease  $3,566   $4,622 
Accumulated Depreciation   (546)   (949)
Total Equipment Subject to Operating Lease, Net  $3,020   $3,673 

 

The total depreciation expense was $0 and $0.2 million included in cost of revenue for the three months ended June 30, 2025 and 2024, respectively. The total depreciation expense was $0 and $0.5 million included in cost of revenue for the six months ended June 30, 2025 and 2024, respectively.

 

Lease payments from customers consisted of the following:

 

   2025   2024   2025   2024 
   Three Months Ended June 30,   Six Months Ended June 30, 
   2025   2024   2025   2024 
   (In thousands) 
Equipment on lease payments  $70   $292   $70   $762 

  

14

 

 

Note 8. Leases

 

The Company leases its office and manufacturing facilities under four non-cancellable operating leases, including options to extend, which expire between 2025 to 2032. The agreements include a provision for renewal at the then prevailing market rate for terms specified in each lease.

 

Total right-of-use (“ROU”) assets and lease liabilities are as follows:

 

   June 30,   December 31, 
   2025   2024 
   (In thousands) 
Right-of-use assets:          
Net book value (Other assets)  $7,838   $8,774 
Operating lease liabilities:          
Current (Accrued expense and other current liabilities)  $1,569   $1,612 
Noncurrent (Other noncurrent liabilities)   7,583    8,361 
Total operating lease liabilities   9,152    9,973 
Financing lease liabilities:          
Current (Accrued expense and other current liabilities)  $149   $142 
Noncurrent (Other noncurrent liabilities)   37    114 
Total financing lease liabilities  $186   $256 
Total lease liabilities  $9,338   $10,229 

 

There were no impairments recorded related to these assets as of June 30, 2025 and December 31, 2024.

 

Information about lease-related balances were as follows:

 

   2025   2024   2025   2024 
   Three Months Ended June 30,   Six Months Ended June 30, 
   2025   2024   2025   2024 
   (In thousands, except years and percentages)   (In thousands, except years and percentages) 
Operating lease expense  $578   $746   $1,156   $1,492 
Financing lease expense   40    43    80    92 
Short-term lease expense   45    40    86    108 
Total lease expense  $663   $829   $1,322   $1,692 
Cash paid for leases  $595   $752   $1,190   $1,498 
Weighted – average remaining lease term – operating leases (years)   6.8    7.5    6.8    7.5 
Weighted – average discount rate – operating leases   9.0%   8.9%   9.0%   8.9%

 

15

 

 

Maturity of operating lease liabilities as of June 30, 2025 are as follows:

 

Year Ending December 31,  (In thousands) 
Remainder of 2025  $1,200 
2026   2,430 
2027   2,400 
2028   2,490 
2029   2,585 
Thereafter   6,195 
Total operating lease payments  $17,300 
Less portion representing imputed interest   (8,148)
Total operating lease liabilities  $9,152 
Less current portion   1,569 
Long-term portion  $7,583 

 

Note 9. Debt

 

Debt consisted of the following:

 

   June 30,   December 31, 
   2025   2024 
   (In thousands) 
January Note  $5,700   $ 
February Note 1st Tranche   5,583     
February Note 2nd Tranche   5,425     
Secured Notes   5,767    5,666 
Total  $22,475   $5,666 
Debt – current portion   16,913    5,666 
Long-term debt – less current portion  $5,562   $ 

 

As of June 30, 2025, the Company’s debt consists of the Secured Notes, the January Note, and the February Note. The Company and Arrayed entered into a forbearance agreement where Arrayed forbore from taking any enforcement action as a result of the occurrences and/or continuation of any specified events of default. For a full description of these debt arrangements, see Note 9, Debt, in the audited consolidated financial statements included in the 2024 Form 10-K.

 

Convertible Secured Note

 

On January 7, 2025, the Company issued the January Note, a Senior Secured Convertible Promissory Note in the principal amount of $5,000,000 to Thieneman Properties, LLC, an Indiana limited liability company. The January Note bears interest at a rate of 60.0% per annum, was initially payable in full on April 7, 2025 in the amount of $5,750,000 and if not paid on or prior to such date, will continue to accrue interest at the same rate until paid. The January Note may be prepaid in whole or in part at any time without penalty or premium and is convertible in the event of default into shares of the Company’s common stock, at a fixed conversion price of $1.56 per share. On April 7, 2025, the Company made a payment of $750,000, which fulfilled its obligations of interest owed through the aforementioned date. The Company continues to accrue interest on the principal amount of the January Note until such time it will be repaid. During the three and six months ended June 30, 2025, the Company incurred total interest expense of $0.8 million and $1.5 million, respectively, which is included in the carrying value of the January Note in the above table.

 

On February 10, 2025, the Company issued a Senior Secured Convertible Promissory Note (the “February Note”) in the principal amount of $10,000,000 to Thieneman Construction, Inc, an Indiana corporation, to be funded in two tranches of $5,000,000. This Note bears interest at a rate of 30.0% per annum, is payable in full on the date that is six months from the time the amounts are received by the Company. The first tranche (“February Note 1st tranche”) and second tranche (“February Note 2nd tranche”) were received by the Company on February 10, 2025 and March 20, 2025, respectively which become due on August 10, 2025 and September 20, 2025, respectively. If the February Notes is not paid on or prior to the aforementioned dates, the February Note will continue to accrue interest at the same rate until paid. The outstanding principal amount of the February Note is convertible at the option of the holder upon the occurrence of the Company’s successful listing of shares of its common stock on a national securities exchange or the occurrence and during the continuation of an Event of Default, into shares of the Company’s common stock, at a fixed conversion price of $1.00 per share. During the three months ended June 30, 2025, the Company incurred total interest expense related to the February Note 1st tranche and February Note 2nd tranche of $0.4 million and $0.4 million, respectively, which is included in the carrying value in the above table. During the six months ended June 30, 2025, the Company incurred total interest expense related to the February Note 1st tranche and February Note 2nd tranche of $0.6 million and $0.4 million, respectively, which is included in the carrying value in the above table.

 

16

 

 

Secured Notes

 

The Secured Notes bear interest at 6.00% per annum, payable quarterly in cash on January 1, April 1, July 1 and October 1 of each year, and will mature on August 1, 2026. When the Company repays principal on the Secured Notes pursuant to the terms of the Secured Notes, it will be required to pay 120% of the principal amount repaid (the “Repayment Price”) plus accrued and unpaid interest.

 

The Secured Notes include terms that provide Arrayed seniority over other unsecured obligations in any settlement negotiations in the event of liquidation. Additionally, the Secured Notes contain redemption features in the event of default or a fundamental change in control that would make the Secured Notes immediately callable at a predetermined rate as described in the Secured Notes. The redemption features are settled in cash.

 

As of June 30, 2025, the unamortized discount was $0.2 million, which includes the difference between the principal and the Repayment Price. For the three and six months ended June 30, 2025, the Company incurred less than $0.1 million and $0.1 million in interest expense, respectively, related to the Secured Notes. The effective interest rate was 8.7% for the three and six months ended June 30, 2025.

 

The future minimum aggregate payments for the above borrowings are equal to the quarterly payments made using the Repayment Price, are as follows as of June 30, 2025:

 

   (In thousands) 
Remainder of 2025  $17,613 
2026   6,122 
Total  $23,735 
Less: Amount of debt discount to be amortized subsequent to June 30, 2025   (231)
Less: Amount of interest to be accrued subsequent to June 30, 2025   (1,029)
Debt as of June 30, 2025  $22,475 

 

 

Note 10. Equity Instruments

 

Common stock

 

Our authorized share capital consists of 500,000,000 shares of common stock, par value $0.00001 per share, and 10,000,000 shares of preferred stock, par value $0.00001 per share. As of June 30, 2025, we had 14,067,416 shares of common stock outstanding. The holders of common stock are entitled to one vote for each share held of record on all matters submitted to a vote of the stockholders but are not entitled to cumulative voting rights, are entitled to receive ratably such dividends as may be declared by the Company’s Board of Directors out of funds legally available therefor subject to preferences that may be applicable to any shares of redeemable convertible preferred stock currently outstanding or issued in the future, are entitled to share ratably in all assets remaining after payment of liabilities and the liquidation preference of any then outstanding redeemable convertible preferred stock in the event of the Company’s liquidation, dissolution, or winding up, have no preemptive rights and no right to convert their common stock into any other securities, and have no redemption or sinking fund provisions applicable to the common stock.

 

April 2024 Securities Purchase Agreement

 

On April 10, 2024, the Company entered into securities purchase agreements (the “BEPO Purchase Agreements”) with certain investors (collectively, the “Purchasers”). The BEPO Purchase Agreements relate to the sale and issuance, on a reasonable best efforts basis (collectively, the “BEPO Offering”), by the Company of an aggregate of: (i) 65,307 shares of the Company’s common stock and (ii) warrants to purchase up to 65,307 shares of common stock (the “BEPO Warrants”). The offering price per share of common stock and the exercise price of the accompanying BEPO Warrants is $183.75.

 

On April 12, 2024, the Company completed the BEPO Offering, resulting in gross proceeds to the Company of approximately $12 million. The Company used the net proceeds from the BEPO Offering primarily for funding working capital and capital expenditures and other general corporate purposes, including repayment of a portion of the Company’s Secured Notes.

 

17

 

 

In connection with the BEPO Offering, on April 10, 2024, the Company also entered into a placement agency agreement (the “BEPO Placement Agency Agreement”) with A.G.P./Alliance Global Partners (the “BEPO Placement Agent”). Pursuant to the terms of the BEPO Placement Agency Agreement, the BEPO Placement Agent agreed to arrange for the sale of the shares of common stock and the warrants. The Company paid the BEPO Placement Agent a cash fee equal to 7.0% of the aggregate purchase price paid by the Purchasers in connection with sales and reimbursed the BEPO Placement Agent for certain of its expenses in an aggregate amount of $150,000. In addition, the Company issued Placement Agent warrants (the “BEPO Agent Warrants”) to purchase such number of shares of common stock equal to 5.0% of the aggregate number of shares of common stock sold in the BEPO Offering, or an aggregate of 3,266 shares of common stock. The BEPO Agent warrants are exercisable immediately upon issuance and have substantially the same terms as the BEPO Warrants, except that the BEPO Agent Warrants have an exercise price of $202.125 per share (representing 110% of the offering price per share of common stock and accompanying warrant) and will expire five years from the commencement of the sales pursuant to the BEPO Offering.

 

February 2025 Securities Purchase Agreement

 

On February 24, 2025, the Company entered into Warrant Exchange Agreements (the “February Warrant Exchange Agreements”) with each of: (i) Highbridge Tactical Credit Master Fund, L.P. (“HM”); (ii) Highbridge Tactical Credit Institutional Fund, Ltd. (collectively with HM, the “Highbridge Holders”); (iii) Anson Investments Master Fund LP (“AMF”); (iv) Anson East Master Fund LP (collectively with AMF, the “Anson Holders”); (v) High Trail Investments ON LLC (“HTI”), and (vi) HB SPV I Master LLC (together with HTI, the “High Trail Holders”), pursuant to which: (a) the Highbridge Holders and the Anson Holders agreed to exchange an aggregate of 60,150 registered warrants issued in April 2024 and an aggregate of 99,048 registered warrants issued in August 2024, and (b) the High Trail Holders agreed to exchange an aggregate of 151,808 unregistered warrants issued in April 2024 and July 2024, and an aggregate of 19,048 registered warrants issued in December 2023, for an aggregate of 990,159 shares (the “Acquired Shares”) of Company’s common stock, respectively, equating in each case to an exchange ratio of three Acquired Shares for each warrant.

 

Common Stock Reserved for Future Issuance

 

Shares of common stock reserved for future issuance on an “as if converted” basis were as follows:

 

   June 30,   December 31, 
   2025   2024 
   (share data) 
Common stock warrants   36,892    366,946 
Shares available for future grant under 2021 Equity Incentive Plan       46,456 
Reserved for At-the-Market offering   5,383    5,383 
Reserved for employee stock purchase plan   148,897    18,958 
Total shares of common stock reserved   191,172    437,743 

 

In February 2023, the Company entered into a sales agreement (the “ATM Sales Agreement”) with Needham & Company, LLC (“Needham”), as agent, pursuant to which the Company may offer and sell, from time to time through Needham, up to $40.0 million shares of its common stock pursuant to a shelf registration statement on Form S-3 (the “Shelf Registration Statement”) and the related prospectus supplement and accompanying base prospectus, and in connection therewith, the Company reserved 38,096 shares of common stock for issuance under the ATM Sales Agreement. On January 31, 2024, the Company filed an amendment to the prospectus supplement increasing the aggregate dollar amount of shares available to be sold from time to time pursuant to the ATM Sales Agreement to $75 million. During six months ended June 30, 2025, the Company sold no shares pursuant to the ATM sales agreement.

 

In April 2024, pursuant to the evergreen provisions of the Company’s 2021 Equity Incentive Plan (the “2021 EIP”), the Company added an additional 24,612 shares of common stock for issuance under the 2021 EIP and 4,917 shares of common stock for issuance under the 2021 ESPP.

 

The shares available for future grant under the 2021 EIP are net of any un-exercised stock options (vested and unvested) and unvested restricted stock units (“RSUs”) outstanding that may convert to common stock in the future upon exercise or vesting as of June 30, 2025 and December 31, 2024.

 

18

 

 

Common Stock Warrant Liabilities

 

In connection with the BEPO Offering, the Company issued BEPO Warrants to purchase up to an aggregate of 65,307 shares of common stock. The BEPO Warrants are immediately exercisable at an exercise price of $183.75 per share and will expire on the five year anniversary of the date of issuance. In connection with the BEPO Placement Agency Agreement, we also issued BEPO Agent Warrants to purchase up to 3,266 shares of common stock. The BEPO Agent Warrants are exercisable at an exercise price of $202.125 per share and will expire on the five year anniversary of the date of issuance.

 

In connection with the Second Note Amendment, on April 1, 2024, the Company also entered into a letter agreement (the “Letter Agreement”) with the Investors pursuant to which the Company issued to the Investors warrants (the “2024 Private Warrants”) to purchase up to an aggregate of 41,808 shares of Common Stock. The 2024 Private Warrants became exercisable 45 days after the original issuance date (the “Initial Exercise Date”), are exercisable at an exercise price of $199.35 per share and will expire on the one year anniversary of the later of (i) the Initial Exercise Date and (ii) the date on which the Resale Registration Statement (as defined in the Letter Agreement) is declared effective by the SEC. The Investors may exercise the 2024 Private Warrants by paying the exercise in cash or by reducing the outstanding principal amount under the Secured Notes by an amount equal to the quotient of (A) the amount of the exercise price divided by (B) 1.20. The 2024 Private Warrants may also be exercised on a cashless basis under certain circumstances.

 

In connection with the Third Note Amendment, on July 1, 2024, the Company also entered into a letter agreement with the Investors pursuant to which the Company issued to the Investors warrants (the “July 2024 Private Warrants”) to purchase up to an aggregate of 110,000 shares of Common Stock. The July 2024 Private Warrants became exercisable 45 days after the original issuance date, are exercisable at an exercise price of $37.50 per share and will expire on the five year anniversary of the issuance date. The Investors may exercise the 2024 Private Warrants by paying the exercise in cash or by reducing the outstanding principal amount under the Secured Notes by an amount equal to the quotient of (A) the amount of the exercise price divided by (B) 1.20. The July 2024 Private Warrants may also be exercised on a cashless basis under certain circumstances.

 

On August 12, 2024, the Company entered into a warrant inducement with certain warrant holders. Pursuant to the Inducement Agreement, the holders of the Existing Warrants agreed to reduce the exercise price of their Existing Warrants totaling 49,524, from $296.70 per share to $34.20 per share. Additionally, the Company agreed to issue registered warrants with an exercise price of $34.20 per share to purchase 99,048 shares of Common Stock (the “August Inducement Warrants”) and will expire on the five year anniversary of the issuance date. The August Inducement Warrants may also be exercised on a cashless basis under certain circumstances.

 

Warrants to purchase an equal number of shares of common stock of 36,892 and 366,946 were exercisable as of June 30, 2025 and December 31, 2024, respectively. The Private Placement Warrants, the Public Warrants, the 2022 Private Warrant, the RDO Warrants, the Placement Agent Warrants, 2024 Private Warrants, BEPO Warrants, BEPO Agent Warrants, July 2024 Private Warrants and August Inducement Warrants to purchase shares of common stock are liability classified and recorded at fair value on the issue date with periodic remeasurement. Warrants for shares of common stock consisted of the following:

 

 

   June 30, 2025
   Issue Date  Expiration
Date
  Number of
Warrants
   Exercise
Price per
warrant
 
Private Placement Warrants - Common Stock  12/02/2020  09/29/2026   8,477   $6,037.50 
Public Warrants – Common Stock  12/02/2020  09/29/2026   16,429   $6,037.50 
2022 Private Warrant – Common Stock  07/25/2022  07/24/2034   134   $1,344.00 
Placement Agent Warrants - Common Stock  12/29/2023  12/29/2028   3,429   $326.29 
BEPO Warrants - Common Stock  4/12/2024  4/12/2029   5,157   $183.75 
BEPO Agent Warrants - Common Stock  4/12/2024  4/12/2029   3,266   $202.13 
          36,892      

 

19

 

 

   December 31, 2024
   Issue Date  Expiration
Date
  Number of
Warrants
   Exercise
Price per
warrant
 
Private placement warrants - Common Stock  12/02/2020  09/29/2026   8,477   $6,037.50 
Public warrants – Common Stock  12/02/2020  09/29/2026   16,429   $6,037.50 
2022 Private Warrant – Common Stock  07/25/2022  07/24/2034   134   $1,344.00 
RDO Warrants - Common Stock  12/29/2023  12/29/2028   19,048   $299.25 
2023 Placement Agent Warrants - Common Stock  12/29/2023  12/29/2028   3,429   $326.29 
2024 Private Warrants - Common Stock  4/1/2024  5/16/2025   41,808   $199.35 
BEPO Warrants - Common Stock  4/12/2024  4/12/2029   65,307   $183.75 
BEPO Agent Warrants - Common Stock  4/12/2024  4/12/2029   3,266   $202.13 
July 2024 Private Warrants - Common Stock  7/01/2024  7/01/2029   110,000   $37.50 
August Inducement Warrants - Common Stock  8/13/2024  08/12/2029   99,048   $34.20 
          366,946      

 

Warrant Liabilities Fair Value

 

The issuance of the Private Placement Warrant and Public Warrant liabilities were accounted for as a reverse recapitalization. The 2022 Private Warrant was issued in connection with the Company’s entry into the joinder and fourth loan modification with Silicon Valley Bank. See Note 9, Debt, in the notes to consolidated financial statements included in the 2024 Form 10-K.

 

The liabilities associated with the Private Placement Warrants, 2022 Private Warrants, RDO Warrants, Placement Agent Warrants, 2024 Private Warrants, BEPO Warrants, BEPO Agent Warrants, July 2024 Private Warrants and August Inducement Warrants were subject to remeasurement at each balance sheet date using the Level 3 fair value inputs and the Public Warrants were subject to remeasurement at each balance sheet date using Level 1 fair value inputs for the three and six months ended June 30, 2025 and June 30, 2024. See Note 4, Fair Value Measurements, in this Report for liability classified warrants recorded at fair value.

 

Each Private Placement Warrant is exercisable to purchase one share of common stock at a price of $6,037.50 per share. Subject to certain exceptions, the Private Placement Warrants have terms and provisions that are identical to those of the Public Warrants. The 2022 Private Warrant is exercisable to purchase one share of common stock at a price of $1,344.00 per share and allows cashless exercise in whole or part. The Public Warrants may only be exercised for a whole number of shares. The Public Warrants became exercisable on December 7, 2021. The RDO Warrants are exercisable to purchase one share of common stock at a price of $299.25 per warrant share. The Placement Agent Warrants are exercisable to purchase one share of common stock at a price of $326.25 per warrant share . The RDO Warrants and 2023 Placement Agent Warrants are exercisable until December 29, 2028 and allows cashless exercise in whole or part.

 

Private Placement Warrants Fair Value Assumptions

 

The fair value of the private placement common stock warrant liability was $0 as of June 30, 2025 and December 31, 2024, as the publicly traded price was $0.00 as of June 30, 2025 and December 31, 2024. The assumptions used in the Monte Carlo simulation model for the recurring valuation of the private placement common stock warrant liability were as follows:

 

   As of
June 30, 2025
   As of
December 31, 2024
 
Current stock price  $   $ 
Expected volatility   %   %
Risk-free interest rate   %   %
Dividend rate   %   %
Expected Term (years)        

 

20

 

 

Expected volatility: The volatility is determined iteratively, such that the concluded value of the Private Placement Warrants are equal to the traded price.

 

Risk-free interest rate: The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for zero-coupon U.S. Treasury notes with maturities corresponding to the expected term of the common stock warrants.

 

Expected dividend yield: The expected dividend rate is zero as the Company currently has no history or expectation of declaring dividends on its common stock.

 

Expected term: The expected term represents the period that the warrants are expected to be outstanding and is determined using the simplified method, which deems the term to be the average of the time to vesting and the contractual life of the common stock warrants.

 

2022 Private Warrants, RDO Warrants, 2023 Placement Agent Warrants - Fair Value Assumptions

 

The fair value assumptions used in the Black-Scholes simulation model for the recurring valuation of the 2022 Private Warrants, the RDO Warrants, and the 2023 Placement Agent Warrants liabilities were as follows:

 

   As of
June 30, 2025
   As of
December 31, 2024
 
Current stock price  $7.20   $10.20 
Expected volatility   154.6%   139.9%
Risk-free interest rate   4.1%   4.3%
Dividend rate   %   %
Expected Term (years)   3.50    4.00 

 

Expected volatility: The expected volatility was derived from the implied volatility of the Company’s publicly traded common stock.

 

Risk-free interest rate: The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for zero-coupon U.S. Treasury notes with maturities corresponding to the expected term of the common stock warrants.

 

Expected dividend yield: The expected dividend rate is zero as the Company currently has no history or expectation of declaring dividends on its common stock.

 

Expected term: The expected term represents the period that the warrant is expected to be outstanding and is determined using the simplified method, which deems the term to be the average of the time to vesting and the contractual life of the warrant.

 

2024 Private Warrants, - Fair Value Assumptions

 

The fair value of the 2024 Private Warrant Liability was $0 and $2,007 as of June 30, 2025 and December 31, 2024, respectively, as the warrants expired on May 16, 2025. The fair value assumptions used in the Monte Carlo simulation model for the valuation of the 2024 Private Warrants liability was as follows:

 

   As of
June 30, 2025
   As of
December 31, 2024
 
Current stock price  $   $10.20 
Expected volatility   %   191.6%
Risk-free interest rate   %   4.2%
Dividend yield   %   %
Expected Term (years)       0.37 

 

Expected volatility: The expected volatility was derived from the implied volatility of the Company’s publicly traded common stock.

 

21

 

 

Risk-free interest rate: The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for zero-coupon U.S. Treasury notes with maturities corresponding to the expected term of the common stock warrants.

 

Expected dividend yield: The expected dividend rate is zero as the Company currently has no history or expectation of declaring dividends on its common stock.

 

Expected term: The expected term represents the period that the warrant is expected to be outstanding and is determined using the simplified method, which deems the term to be the average of the time to vesting and the contractual life of the warrant.

 

BEPO Warrants, BEPO Agent Warrant - Fair Value Assumptions

 

The fair value assumptions used in the Black-Scholes simulation model for the valuation of the BEPO Warrant and the BEPO Agent Warrant liabilities were as follows:

 

   As of
June 30, 2025
   As of
December 31, 2024
 
Current stock price  $7.20   $10.20 
Expected volatility   154.6%   139.9%
Risk-free interest rate   4.1%   4.4%
Dividend yield   %   %
Expected Term (years)   3.78    4.28 

 

Expected volatility: The expected volatility was derived from the implied volatility of the Company’s publicly traded common stock.

 

Risk-free interest rate: The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for zero-coupon U.S. Treasury notes with maturities corresponding to the expected term of the common stock warrants.

 

Expected dividend yield: The expected dividend rate is zero as the Company currently has no history or expectation of declaring dividends on its common stock.

 

Expected term: The expected term represents the period that the warrant is expected to be outstanding and is determined using the simplified method, which deems the term to be the average of the time to vesting and the contractual life of the warrant.

 

August Inducement Warrants - Fair Value Assumptions

 

The fair value assumptions used in the Black-Scholes simulation model for the valuation of the August Inducement Warrant liabilities were as follows:

 

   As of
June 30, 2025
   As of
December 31, 2024
 
Current stock price  $7.20   $10.20 
Expected volatility   154.6%   139.9%
Risk-free interest rate   4.2%   4.4%
Dividend yield   %   %
Expected Term (years)   4.12    4.62 

 

Expected volatility: The expected volatility was derived from the implied volatility of the Company’s publicly traded common stock.

 

Risk-free interest rate: The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for zero-coupon U.S. Treasury notes with maturities corresponding to the expected term of the common stock warrants.

 

Expected dividend yield: The expected dividend rate is zero as the Company currently has no history or expectation of declaring dividends on its common stock.

 

22

 

 

Expected term: The expected term represents the period that the warrant is expected to be outstanding and is determined using the simplified method, which deems the term to be the average of the time to vesting and the contractual life of the warrant.

 

July 2024 Private Warrants - Fair Value Assumptions

 

The fair value assumptions used in the Black-Scholes simulation model for the valuation of the July 2024 Private Warrant liabilities were as follows:

 

   As of
June 30, 2025
   As of
December 31, 2024
 
Current stock price  $7.20   $10.20 
Expected volatility   154.6%   139.9%
Risk-free interest rate   3.9%   4.4%
Dividend yield   %   %
Expected Term (years)   4.00    4.50 

 

Expected volatility: The expected volatility was derived from the implied volatility of the Company’s publicly traded common stock.

 

Risk-free interest rate: The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for zero-coupon U.S. Treasury notes with maturities corresponding to the expected term of the common stock warrants.

 

Expected dividend yield: The expected dividend rate is zero as the Company currently has no history or expectation of declaring dividends on its common stock.

 

Expected term: The expected term represents the period that the warrant is expected to be outstanding and is determined using the simplified method, which deems the term to be the average of the time to vesting and the contractual life of the warrant.

 

Contingent Earnout Liabilities

 

The contingent earnout liability is for Earnout Shares (as defined below) for pre-closing Legacy Velo3D equity holders (“Eligible Legacy Velo3D Equityholders”). During the time period between September 29, 2021 (the “Closing Date”) and the five-year anniversary of the Closing Date, Eligible Legacy Velo3D Equityholders may receive up to 41,444 shares of common stock (the “Earnout Shares”), which is based on two tranches of 20,722 per tranche. The Earnout Shares issuable to holders of employee stock options are accounted as stock-based compensation expense as they are subject to forfeiture based on the satisfaction of certain employment conditions. See Note 11, Equity Incentive Plans & Stock Based Compensation, for further discussion.

 

See Note 4, Fair Value Measurements, in this Report for the liability for contingent earnout liabilities carried at fair value for the six months ended June 30, 2025 and 2024.

 

Fair Value Assumptions Contingent Earnout Liabilities

 

Assumptions used in the fair value of the contingent earnout liabilities are described below.

 

   As of
June 30, 2025
   As of
December 31, 2024
 
Current stock price  $7.20   $10.20 
Expected volatility   161.2%   161.2%
Risk-free interest rate   4.2%   4.2%
Dividend yield   %   %
Expected Term (years)   1.25    1.75 

 

Expected volatility: The expected volatility was derived from the implied volatility of the Company’s publicly traded common stock.

 

Risk-free interest rate: The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for zero-coupon U.S. Treasury notes with maturities corresponding to the expected term of the Earnout Shares.

 

23

 

 

Expected dividend yield: The expected dividend rate is zero as the Company currently has no history or expectation of declaring dividends on its common stock.

 

Expected term: The expected term represents the period that the Company’s stock-based awards are expected to be outstanding and is determined using the simplified method, which deems the term to be the average of the time to vesting and the contractual life of the Earnout Shares.

 

Note 11. Equity Incentive Plans and Stock-Based Compensation

 

As of June 30, 2025, the Company had a remaining allocated reserve of 0 shares of its common stock for issuance under its 2021 EIP, which provides for the granting of stock options, RSUs and stock appreciation rights to employees, directors, and consultants of the Company. As of June 30, 2025, the Company had an allocated reserve of 148,897 shares of its common stock for issuance under its 2021 Employee Stock Purchase Plan (“2021 ESPP”). As of June 30, 2025, the Company had not begun any offering periods for the 2021 ESPP.

 

Stock options

 

Activity under the 2021 EIP is set forth below:

 

   Options   Weighted-
Average
Exercise Price
   Weighted-
Average
Remaining
Contractual
Term in years
 
    (In thousands)    (Per share data)    (Years) 
Outstanding as of December 31, 2023   25   $320.25    6.2 
Granted      $      
Exercised   (3)  $94.50      
Forfeited or expired   (1)  $426.45      
Outstanding as of June 30, 2024   21   $352.95    5.9 
Options vested and expected to vest as of June 30, 2024   21   $352.95      
Vested and exercisable as of June 30, 2024   21   $356.40      
                
Outstanding as of December 31, 2024   18   $380.70    5.0 
Granted      $      
Exercised      $      
Forfeited or expired   (14)  $166.70      
Outstanding as of June 30, 2025   4   $1,022.11    4.8 
Options vested and expected to vest as of June 30, 2025   4   $1,022.11      
Vested and exercisable as of June 30, 2025   4   $1,022.11      

 

As of June 30, 2025 and December 31, 2024, there is no aggregate intrinsic value of options outstanding.

 

As of June 30, 2025, total unrecognized compensation cost related to options was immaterial and is expected to be recognized over a weighted-average period of less than a year.

 

For the six months ended June 30, 2025, there were no options granted.

 

Restricted Stock Units

 

The fair value of RSUs under the Company’s 2021 EIP is estimated using the value of the Company’s common stock on the date of grant.

 

24

 

 

The following table summarizes outstanding and expected to vest RSUs as of June 30, 2025 and 2024 and their activity during the six months ended June 30, 2025 and 2024:

 

   Number
of Shares
   Weighted-
Average
Grant Date
Fair Value
   Aggregate
Intrinsic
Value
 
    (In thousands)    (Per share data)    (In thousands) 
Balance as of December 31, 2023   38   $1,020.00   $7,940 
Granted   9    124.50     
Released   (5)   1,223.10     
Cancelled   (5)   1,003.20     
Balance as of June 30, 2024   37   $766.95   $1,812 
Expected to vest as of June 30, 2024   37   $766.95   $1,812 
                
Balance as of December 31, 2024   13   $714.30   $132 
Granted   1,070    11.05     
Released   (104)   28.07     
Cancelled   (90)   30.91     
Balance as of June 30, 2025   889   $16.51   $6,400 
Expected to vest as of June 30, 2025   889   $16.51   $6,400 

 

The aggregate intrinsic value of outstanding RSUs is calculated based on the closing price of the Company’s common stock as of the date outstanding. As of June 30, 2025, there was $13.9 million of unrecognized compensation cost, which is expected to be recognized over a weighted average period of approximately 3.1 years. As of June 30, 2024, there was $24.6 million of unrecognized compensation cost, which is expected to be recognized over a weighted average period of approximately 2.7 years.

 

Earnout Shares–Employees

 

The Earnout Shares issuable to holders of employee stock options are accounted as stock-based compensation expense as they are subject to forfeiture based on the satisfaction of certain employment conditions. The estimated fair values of the Earnout Shares associated with vested stock options are recognized as an expense and determined by the Monte Carlo simulation valuation model using a distribution of potential outcomes on a monthly basis over the five-year earnout period. The portion of the Earnout Shares associated with unvested stock options are recognized as an expense and considers the vesting continuing employment requirements.

 

Stock-based Compensation Expense

 

The following sets forth the total stock-based compensation expense by type of award included in operating expenses on the statements of operations:

 

   2025   2024   2025   2024 
   Three Months Ended
June 30,
   Six Months Ended
June 30,
 
   2025   2024   2025   2024 
   (In thousands)   (In thousands) 
Restricted stock units  $1,834   $3,101   $5,425   $6,930 
Stock options   1    39    5    99 
Earnout shares–employees   574    1,107    1,053    2,305 
Stock based compensation expense  $2,409   $4,247   $6,483   $9,334 

 

25

 

 

The following sets forth the total stock-based compensation expense for the stock options, RSUs, and earnout shares - employees included in cost of revenue and operating expenses on the statements of operations:

 

   2025   2024   2025   2024 
   Three Months Ended
June 30,
   Six Months Ended
June 30,
 
   2025   2024   2025   2024 
   (In thousands)   (In thousands) 
Cost of 3D Printer  $474   $269   $613   $658 
Cost of Support services   125    138    194    333 
Research and development   613    1,130    1,256    2,680 
Selling and marketing   368    862    607    1,916 
General and administrative   829    1,848    3,813    3,747 
Stock based compensation expense  $2,409   $4,247   $6,483   $9,334 

 

Note 12. Income Taxes

 

The income tax provision is calculated for an interim period by distinguishing between elements recognized in the income tax provision through applying an estimated annual effective tax rate (the “ETR”) to a measure of year-to-date operating results referred to as “ordinary income (or loss),” and discretely recognizing specific events referred to as “discrete items” as they occur. The income tax provision or benefit for each interim period is the difference between the year-to-date amount for the current period and the year-to-date amount for the period prior. Under ASC 740-270-30-36, entities subject to income taxes in multiple jurisdictions should apply one overall ERT instead of separate ETRs for each jurisdiction when calculating the interim-period income tax or benefit related to ordinary income (or loss) for the year-to-date interim period, except in certain circumstances. The Company’s effective tax rates for the three and six months ended June 30, 2025, and 2024 differ from the federal statutory rate of 21% principally as a result of valuation allowances expected to be applied to net operating loss carry-forwards which will not meet the threshold for recognition as deferred tax assets.

 

Note 13. Commitments and Contingencies

 

The Company may be involved in various lawsuits, claims, and proceedings, including intellectual property, commercial, securities, and employment matters that arise in the normal course of business. The Company accrues a liability when management believes information available prior to the issuance of the unaudited condensed consolidated interim financial statements indicates it is probable a loss has been incurred as of the date of the unaudited condensed consolidated interim financial statements and the amount of loss can be reasonably estimated. The Company adjusts its accruals to reflect the impact of negotiations, settlements, rulings, advice of legal counsel, and other information and events pertaining to a particular case. Legal costs are expensed as incurred. As of June 30, 2025, the Company is not aware of any litigation, claim or assessment in which the outcome, individually or in the aggregate, would have a material adverse effect on its consolidated financial positions, results of operations, cash flows or future earnings.

 

The Company’s purchase obligations per terms and conditions with suppliers and vendors are cancellable in whole or in part prior to shipment. Non-cancellable purchase commitments (purchase orders) of $4.4 million for parts and assemblies are due upon receipt and are expected to be delivered throughout the remainder of 2025. If inventory is shipped, the Company will accrue a liability under accrued expenses. The Company has no other commitments and contingencies, except for the operating leases. See Note 8, Leases, for further discussion.

 

Note 14. Employee Defined-Contribution Plans

 

The Company has a defined-contribution plan intended to qualify under Section 401 of the Internal Revenue Code (the “401(k) Plan”). The Company contracted with a third-party provider to act as a custodian and trustee, and to process and maintain the records of participant data. Substantially all of the expenses incurred for administering the 401(k) Plan are paid by the Company. Accrued salaries and benefits included accruals related to the 401(k) plans the Company offers to its employees. In order to qualify for these plans, employees must meet the minimum age requirement (21 years) and begin participating on their entry date which is the first paycheck date in the month following the month of eligibility described above. Employee and employer contributions are immediately 100% fully vested. The plans offer employer contributions of 3.0% of an employee’s eligible compensation following safe-harbor rules. The Company’s contribution to the 401(k) Plan was $0.2 million and $0.3 million for the three months ended June 30, 2025 and 2024, respectively, and $0.3 million and $0.5 million for the six months ended June 30, 2025 and 2024, respectively. The Company has paid all matching contributions as of June 30, 2025.

 

26

 

 

Note 15. Revenue

 

Customer Concentration

 

The customer concentration for balances greater than 10% of revenues and 10% of accounts receivables, net, respectively, are presented below:

 

   Total Revenue   Accounts Receivable, Net 
   Three Months Ended June 30,   Six Months Ended June 30,   June 30,   December 31, 
   2025   2024   2025   2024   2025   2024 
   (as a percentage) 
Customer 1   30.5%   %   18.1%   <10%   %   %
Customer 2   20.1%   <10%   15.9%   <10%   <10%   <10%
Customer 3   14.6%   24.0%   20.6%   25.4%   <10%   <10%
Customer 4   <10%   %   14.3%   <10%   <10%   %
Customer 5   <10%   26.5%   <10%   20.1%   <10%   <10%
Customer 6   %   16.0%   %   <10%   %   <10%
Customer 7   <10%   11.4%   <10%   <10%   <10%   <10%
Customer 8   <10%   <10%   <10%   <10%   17.3%   %
Customer 9   %   %   %   %   12.8%   12.9%
Customer 10   %   %   %   %   <10%   10.8%
Customer 11   %   <10%   %   <10%   %   18.2%

 

Revenue by Geographic Area

 

The Company currently sells its products in the geographic regions as follows:

 

   2025   2024   2025   2024 
   Three Months Ended June 30,   Six Months Ended June 30, 
   2025   2024   2025   2024 
   (In thousands) 
Americas  $10,731   $10,103   $19,020   $19,476 
Europe   2,748    176    3,684    501 
Other   93    65    188    153 
Total  $13,572   $10,344   $22,892   $20,130 

 

Contract Assets and Liabilities

 

There was $0.4 million and $0.9 million of revenue recognized during the three and six months ended June 30, 2025, respectively, included in contract liabilities as of December 31, 2024. The amount of revenue recognized during the three and six months ended June 30, 2024 included in contract liabilities as of December 31, 2023 was $0.8 million and $1.6 million, respectively. The change in contract assets reflects the difference in timing between the Company’s satisfaction of remaining performance obligations and the Company’s contractual right to bill its customers. The Company had no material asset impairment charges related to contract assets in the periods presented.

 

Variable Consideration

 

The Company estimates its variable consideration on a quarterly basis based on the latest data available, and adjusts the transaction price accordingly by recording an adjustment to net revenue and contract assets. The Company has recognized the estimate of variable consideration to the extent that it is probable that a significant reversal will not occur as a result of a change in estimation. There was no revenue related to variable consideration during the three months ended June 30, 2025 and 2024. There was no revenue related to variable consideration during the six months ended June 30, 2025 and 2024.

 

27

 

 

Note 16. Momentus Master Service Agreement

 

On April 12, 2025, the Company entered into a Master Service Agreement (“MSA”) with Momentus, Inc. (“Momentus”). Under the terms of the MSA, for a period of five years, Velo3D will provide consulting and parts production through Velo3D’s Rapid Production Solutions (“RPS”) offering. Momentus is entitled to services equal to the equivalent capacity of two Velo3D Sapphire XC 3D metal printers (or successor or comparable printers) (the “Equivalent Capacity”). Momentus will have first priority to utilize the Equivalent Capacity, and Velo3D will ensure the Equivalent Capacity is available for use as and when required by Momentus. If and when the Equivalent Capacity is not utilized by Momentus, Velo3D may use the Equivalent Capacity to provide services to other customers. Services to be provided under the MSA will be detailed in individual Statements of Work issued by Momentus and accepted by the Company from time to time, specifying the scope, pricing, and delivery schedule for the applicable goods and services

 

On April 14, 2025, Momentus issued an aggregate of 477,455 shares of Class A Common Stock and 673,408 shares of non-voting Momentus Series A Convertible Preferred Stock, par value 0.00001 per share for goods and services that will be delivered over the term of the MSA. Each share of Momentus Series A Convertible Preferred Stock is convertible into ten shares of Class A Common Stock, subject to the limitations in the Momentus Certificate of Designations of Preferences, Rights and Limitations of Momentus Series A Convertible Preferred Stock, including that Velo3D hold no more than 9.99% of the outstanding shares of Momentus’ Common Stock at any time.

 

Furthermore, pursuant to the Momentus Certificate of Designations, the Momentus Series A Convertible Preferred Stock may not be converted into shares of Momentus’ Class A Common Stock if conversion would result in the issuance, in the aggregate with all previous issuances of shares of Momentus’ Common Stock, of greater than 19.9% of the amount of Momentus’ Class A Common Stock outstanding immediately preceding the date of the MSA without first obtaining stockholder approval in compliance with the rules of the Nasdaq Stock Market.

 

Under the MSA, Velo3D promised to use commercially reasonable efforts to sell shares of Momentus Class A Common Stock to establish a prepaid reserve (“Prepaid Reserve”) to hold the net proceeds derived from the sale of Momentus Class A Common Stock. Unless otherwise provided in the Statement of Work, Service Fees will be deducted from the amount of Prepaid Reserve.

 

The MSA includes a refund provision (“Refund Provision”) pursuant to which during the period beginning on the Effective Date and ending on each one year anniversary of the Effective Date, Momentus shall receive 20% of $3,000,000 less Service Fees for Services performed during such period, and for each one year period beginning on the one year anniversary of the Effective Date for the term of the MSA, Momentus shall receive 50% of $3,000,000 less Service Fees for Services performed during each such period. The amount in the Prepaid Reserve shall be reduced by the same amounts paid to Momentus.  Such payments shall be made quarterly throughout the term of the MSA within 30 days following the end of each such quarter; provided however that if the Prepaid Reserve is not sufficient to settle the full amount of such payments when due, such amounts will be paid as soon as funds are deposited into the Prepaid Reserve.  Velo3D shall use commercially reasonable efforts to sell a sufficient number of shares of Momentus Common Stock such that the Prepaid Reserve has sufficient funds to make payments required by this MSA and to cover the Service Fees for the Services requested by Momentus under the MSA.

 

In the event the MSA is terminated, the number of shares that remain unsold by Velo3D shall be forfeited by Velo3D and cancelled by Momentus. Any funds in the Prepaid Reserve and work product shall be returned to the respective parties.

 

The Company evaluated the MSA to determine whether any embedded feature of the MSA potentially qualifies as a derivative required to be separately accounted for in accordance with FASB ASC Topic 815, Derivatives and Hedging. The Refund Provision clause requires the Company to refund a portion of the share-based consideration received if services are not rendered, with the refund amount limited to the lesser of a specified threshold or the net proceeds from the sale of Momentus shares. Management determined that the Refund Provision is required to be bifurcated from the MSA and accounted for separately as a derivative liability. However, based on a valuation analysis as of June 30, 2025, the fair value of the embedded derivative was determined to be de minimis. Accordingly, no separate recognition of the embedded derivative was made in the unaudited condensed consolidated interim financial statements.

 

The Company has evaluated the accounting treatment for the equity received under the MSA with Momentus and determined that the arrangement does not currently meet the criteria to be accounted for under ASC 606 as the Company cannot identify the specific goods and services to be transferred or the related payment terms. The Company will reassess the accounting for the MSA upon the execution of a Statement of Work. For the three and six months ended June 30, 2025, no revenue related to this MSA has been recognized.

 

Note 17. Subsequent Events

 

Subsequent events were evaluated through the filing date of this Form 10-Q, and no events requiring adjustment or disclosure were identified.

 

28

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

The following discussion and analysis provides information which our management believes is relevant to an assessment and understanding of our results of operations and financial condition. This discussion should be read in conjunction with our Annual Report on Form 10-K for the fiscal year ended December 31, 2024 and our unaudited condensed consolidated interim financial statements included elsewhere in this Quarterly Report. This discussion contains forward-looking statements based upon our current expectations, estimates and projections, and involves numerous risks and uncertainties. Actual results may differ materially from those contained in any forward-looking statements due to, among other considerations, the matters discussed in the sections titled “Risk Factors” and “Forward-looking Statements” herein. During the fiscal year ended December 31, 2024, we identified immaterial errors in our previously issued financial statements. We have corrected the amounts as presented in this Item 2 accordingly. Refer to Notes 1 and 16 to the unaudited condensed consolidated interim financial statements included in Part I of this Quarterly Report on Form 10-Q for additional information.

 

Overview

 

We seek to fulfill the promise of additive manufacturing, also referred to as 3D printing (“AM”), to deliver breakthroughs in performance, cost, and lead time in the production of high-value metal parts.

 

We produce a fully integrated hardware and software solution based on our proprietary laser powder bed fusion (“L-PBF”) technology, which greatly reduces and often eliminates the need for support structures. Our technology enables the production of highly complex, mission-critical parts that existing AM solutions cannot produce without the need for redesign or additional assembly.

 

Our Sapphire Family of Printers give our customers who are in space, aviation, defense, automotive, energy and industrial markets the freedom to design and produce metal parts with complex internal features and geometries that had previously been considered impossible for AM. We believe our technology is years ahead of competitors.

 

Our technology is novel compared to other AM technologies because of its ability to deliver high-value metal parts that have complex internal channels, structures, and geometries. This affords a wide breadth of design freedom for creating new metal parts and it enables replication of existing parts without the need to redesign the part to be manufacturable with AM. Because of these features, we believe our technology and product capabilities are highly valued by our customers. Our customers are primarily original equipment manufacturers (“OEMs”) and contract manufacturers (“CMs”) who look to AM to solve issues with traditional metal parts manufacturing technologies. Those traditional manufacturing technologies rely on processes, including casting, stamping and forging, that typically require high volumes to drive competitive costs and have long lead times for production. Our customers look to AM solutions to produce assemblies that are lighter, stronger, and more reliable than those manufactured with traditional technologies. Our customers also expect AM solutions to drive lower costs for low-volume parts and substantially shorter lead times. However, many of our customers have found that other legacy AM technologies failed to produce the required designs for the high-value metal parts and assemblies that our customers wanted to produce with AM. As a result, other AM solutions often require that parts be redesigned so that they can be produced and frequently incur performance losses for high-value applications.

 

In contrast, our technology can deliver complex high value metal parts with the design advantages, lower costs and faster lead times associated with AM, and generally avoids the need to redesign the parts. As a result, our customers have increasingly adopted our technology into their design and production processes. We believe our value is reflected in our sales patterns, as most of our customers initially purchased a single machine to validate our technology and have purchased additional systems over time as they have embedded our technology in their product roadmap and manufacturing infrastructure. We consider this approach a “land and expand” strategy, oriented around a demonstration of our value proposition followed by increasing penetration with key customers.

 

Recent Developments

 

Recent Debt and Equity Transactions and Change in Majority Ownership

 

On December 24, 2024, the Company and Arrayed Note Acquisition Corp., a subsidiary of Arrayed Additive, Inc. (“Arrayed”), entered into a debt for equity exchange transaction where the Company issued 12,343,423 shares of the Company’s common stock, in exchange for the cancellation of $22.4 million in principal amount of the Company’s Secured Notes (the “Notes”) plus $0.4 million of accrued interest on the Notes. Arrayed continues to hold $5.0 million in principal amount of the Secured Notes, and as a result of the December 2024 Exchange, became, at the time of the transaction, the owner of approximately 95% of our issued and outstanding common stock.

 

29

 

 

On February 24, 2025, the Company entered into February Warrant Exchange Agreements with each of: (i) Highbridge Tactical Credit Master Fund, L.P. (“HM”); (ii) Highbridge Tactical Credit Institutional Fund, Ltd. (collectively with HM, the “Highbridge Holders”); (iii) Anson Investments Master Fund LP (“AMF”); (iv) Anson East Master Fund LP (collectively with AMF, the “Anson Holders”); (v) High Trail Investments ON LLC (“HTI”), and (vi) HB SPV I Master LLC (together with HTI, the “High Trail Holders”), pursuant to which: (a) the Highbridge Holders and the Anson Holders agreed to exchange an aggregate of 60,150 registered warrants issued in April 2024 and an aggregate of 99,048 registered warrants issued in August 2024, and (b) the High Trail Holders agreed to exchange an aggregate of 151,808 unregistered warrants issued in April 2024 and July 2024, and an aggregate of 19,048 registered warrants issued in December 2023, for an aggregate of 990,159 shares (the “Acquired Shares”) of Company’s common stock, respectively, equating in each case to an exchange ratio of three Acquired Shares for each warrant.

 

On January 7, 2025, the Company issued a Senior Secured Convertible Promissory Note in the principal amount of $5,000,000 (the “January Note”) to Thieneman Properties, LLC, an Indiana limited liability company. The January Note bears interest at a rate of 60.0% per annum, was payable in full on April 7, 2025 in the amount of $5,750,000 and if not paid on or prior to such date, would continue to accrue interest at the same rate until paid. The January Note may be prepaid in whole or in part at any time without penalty or premium and is convertible in the event of default into shares of the Company’s common stock, at a fixed conversion price of $23.40 per share. On April 7, 2025, the Company made a payment of $750,000, covering the first three months of interest on the January Note.

 

On February 10, 2025, the Company issued a Senior Secured Convertible Promissory Note in the principal amount of $10,000,000 (the “February Note”) to Thieneman Construction, Inc, an Indiana corporation, to be funded in two tranches of $5,000,000. The February Note bears interest at a rate of 30.0% per annum, is payable in full on the date that is six months from the date such tranche was funded, (the first tranche and second tranche were received by the Company on February 10, 2025 and March 20, 2025, respectively), in the amount of $5,750,000 and if not paid on or prior to such date, will continue to accrue interest at the same rate until paid. The outstanding principal amount of the February Note is convertible into shares of the Company’s common stock upon the occurrence of the Company’s successful listing of shares of its common stock on a national securities exchange or the occurrence and during the continuation of an event of default, into common stock at a fixed conversion price of $15.00 per share.

 

2025 Reverse Stock Split

 

Effective July 28, 2025, we implemented a 1-for-15 reverse stock split of our issued and outstanding common stock. The reverse stock split was effected by the filing of a certificate of amendment (the “Amendment”) to our Certificate of Incorporation with the Secretary of State of the State of Delaware, without any change to par value or the number of authorized shares of common stock. The Amendment became effective upon such filing. No fractional shares were issued in connection with the reverse stock split as all fractional shares were rounded up to the next whole share. All share and per share amounts of our common stock listed in this Quarterly Report have been adjusted, as applicable, to give effect to the reverse stock split.

 

See Note 2, Summary of Significant Accounting Policies, for additional information on the 2025 reverse stock split in the notes to our unaudited condensed consolidated interim financial statements included elsewhere in this Quarterly Report.

 

Notwithstanding the recent debt and equity transactions, as described in “—Liquidity and Capital Resources” and in Note 1 Description of Business and Basis of Presentation—Going Concern, Financial Condition and Liquidity and Capital Resources in the notes to the unaudited condensed consolidated interim financial statements included elsewhere in this Quarterly Report, management believes that substantial doubt exists about the Company’s ability to continue as a going concern. We do not have sufficient liquidity to meet our operating needs and satisfy our debt obligations for at least the next 12 months. The Company will need to engage in additional financings to fund our operations, continue to fund payroll for employees, and satisfy our obligations in the near term. Without such additional funding, we will not be able to continue operations and may be required to sell assets, liquidate and/or file for bankruptcy.

 

Amendment to Company’s Certificate of Incorporation allowing stockholders to act by written consent

 

On June 27, 2025, the stockholders of the Company, approved an amendment (“the Written Consent Amendment”) to the Company’s Certificate of Incorporation, as amended (the “Certificate of Incorporation’), to remove Section 1 of Article VIII of the Certificate of Incorporation, which prohibited stockholder action by written consent without a stockholder meeting. On July 1, 2025, the Written Consent Amendment was filed with the Secretary of State of the State of Delaware. As a result of the Written Consent Amendment, stockholders will be permitted to act by written consent to the extent permitted under the General Corporation Law of the State of Delaware.

 

Key Financial and Operational Metrics

 

We believe that our performance and future success depend on many factors that present significant opportunities for us but also pose risks and challenges, including those discussed herein and in the section of the 2024 Form 10-K titled “Risk Factors.”

 

We regularly evaluate several metrics, including the metrics presented in the table below, to measure our performance, identify trends affecting our business, prepare financial projections, make strategic decisions, and establish performance goals for compensation and we periodically review and revise these metrics to reflect changes in our business.

 

   As of and for the
Three Months Ended June 30,
   As of and for the
Six Months Ended June 30,
 
   2025   2024   2025   2024 
Revenue ($ in millions)  $14   $10   $23   $20 
Bookings ($ in millions)  $12   $5   $20   $22 
Backlog ($ in millions)  $16   $17   $16   $17 

 

30

 

 

Bookings ($ in millions): Bookings ($ in millions) are defined as a confirmed order for a 3D printer system and printed parts in contracted dollars.

 

Backlog ($ in millions): Backlog ($ in millions) is defined as the unfulfilled 3D printer systems and printed parts to be delivered to customers in contracted dollars as of period end.

 

Customer Concentration

 

Our operating results for the foreseeable future will continue to depend on sales to a small group of customers. For the three months ended June 30, 2025 and 2024, sales to the top three customers accounted for 65.2% and 66.4%, respectively, of our revenue. Of the top three customers for the three months ended June 30, 2025, two customers were different from the top three customers for the comparable period in 2024. For the six months ended June 30, 2025 and 2024, sales to the top three customers accounted for 54.6% and 53.7%, respectively, of our revenue. Of the top three customers for the six months ended June 31, 2025, two customers were different from the top three customers for the comparable period in 2024.

 

While our objective is to diversify our customer base, we continue to be susceptible to risks associated with customer concentration.

 

Continued Investment and Innovation

 

We continue to be a customer-focused company working to develop innovative solutions to address customers’ needs and focus on our customers to identify the most impactful areas for research and development as we seek to further improve the capabilities of our AM solutions. We believe this process has contributed significantly to our development of the most advanced metal AM systems in the world. We believe that continued investments in our products are important to our future growth and, as a result, we will invest in enhancing our portfolio of AM solutions through certain research and development projects based on customer demand.

 

Macroeconomic Conditions and Other World Events

 

General economic and political conditions such as recessions, interest rates, fuel prices, inflation, foreign currency fluctuations, international tariffs, social, political and economic risks and acts of war or terrorism (including, for example, the ongoing military conflicts in Israel and in Ukraine and the economic sanctions related thereto), have added uncertainty in timing of customer orders and supply chain constraints. In 2024, we implemented a number of supply chain and manufacturing improvements in response and intend to continue to focus on driving further operational improvements during 2025 to reduce operating costs.

 

Climate Change

 

Material pending or existing climate change-related legislation, regulations, and international accords could have an adverse effect on our business, financial condition, and results of operations, including: (1) material past and/or future capital expenditures for climate-related projects, (2) material indirect consequences of climate-related regulation or business trends, such as the following: decreased/increased demand for goods or services that produce significant greenhouse gas emissions or are related to carbon-based energy sources; increased competition to develop innovative new products that result in lower emissions; increased demand for generation and transmission of energy from alternative energy sources; and any anticipated reputational risks resulting from operations or products that produce material greenhouse gas emissions and (3) material increased compliance costs related to climate change. In addition, extreme weather and other natural disasters may become more intense or more frequent, which may disrupt our operations or the operations of our suppliers and customers.

 

Components of Results of Operations

 

Revenue

 

Our revenue is primarily derived from our AM fully integrated hardware and software solution based on our proprietary L-PBF technology. Our products include Sapphire, Sapphire 1MZ, Sapphire XC and Sapphire XC 1MZ metal AM printer using our L-PBF technology and Assure quality validation software (collectively referred to as the “3D Printer”). Contracts for 3D Printers also include post-sale customer support services (“Support Services”), except for our distributor partners, which are qualified to perform support services.

 

31

 

 

We sell our fully integrated hardware and software AM solutions through two types of transaction models: a 3D Printer sale transaction and a recurring payment transaction (“Recurring Payment”). Support services are included with a 3D Printer sale transaction and a Recurring Payment transaction. For 3D Printer sale transactions where the support service period has expired, customers may purchase extended support service contracts.

 

3D Printer sale transactions - fixed purchase price model. The timeframe from order to completion of the site acceptance test usually occurs over three to nine months. As we scale our production, we expect to reduce this timeframe. Contract consideration allocated to the 3D Printer is recognized at a point in time, which occurs upon transfer of control to the customer at shipment.

 

The initial sales of 3D Printers and Support Services are included in one contract and are invoiced together. Contract consideration is allocated between the two performance obligations based on relative fair value. This allocation involves judgment and is periodically updated as new relevant information becomes available.

 

Other revenue included under 3D Printer sales includes parts and consumables, such as filters, powder or build plates, that are sold to customers and recognized upon transfer of control to the customer at shipment.

 

Recurring Payment transactions - are our leased 3D Printer transactions. We define our Recurring Payment transactions as operating leases. Under the leased 3D Printer transaction, the customer typically pays an amount for a lease which entitles the customer to a base number of hours of usage. For usage above that level, the customer typically pays an hourly usage fee. Most of our leases have a 12-month term, though in some instances the lease term is longer.

 

Under this model, the customer typically pays a base rent and variable payments based on usage in excess of a defined threshold. Most of our leases have a 12-month term, though in certain cases the lease term is longer.

 

Rapid Production Solutions (“RPS”) - RPS utilizes our deep engineering expertise, cutting-edge technology and a fleet of Sapphire XC large-format metal 3D printers to manufacture custom metal components in order to accelerate path to production for our customers. RPS revenue is included under 3D Printer revenue.

 

Support Services - are included with most 3D Printer sale transactions and Recurring Payment transactions. Support services consist of field service engineering, phone and email support, preventative maintenance, and limited on and off-site consulting support. A subsequent Extended Support Agreement is available for renewal after the initial contract period based on the then-fair value of the service, which is paid for separately. Support Service revenue is recognized over the contract period beginning with customer performance test acceptance.

 

Cost of Revenue

 

Our cost of revenue includes the “Cost of 3D Printers,” “Cost of Recurring Payment” and “Cost of Support Services.”

 

Cost of 3D Printers includes the manufacturing cost of our components and subassemblies purchased from vendors for the assembly, as well as raw materials and assemblies, shipping costs and other directly associated costs. Cost of 3D Printers also includes allocated overhead costs from headcount-related costs, such as salaries, stock-based compensation, depreciation of manufacturing related equipment and facilities, and information technology costs.

 

Cost of Recurring Payment includes depreciation of the leased equipment over the useful life of five years less the residual value, and an allocated portion of Cost of Support Services.

 

Cost of RPS includes cost of raw materials, typically metal powder feedstock, direct and indirect labor, depreciation of 3D printers and other related equipment and facilities, utilities such as electricity and specialty gases, shipping costs and other directly associated costs. Cost of RPS is included under 3D Printer cost of revenue.

 

Cost of Support Services includes the cost of spare or replacement parts for preventive maintenance, installation costs, headcount-related costs such as salaries, stock-based compensation, depreciation of manufacturing related equipment and facilities, and information technology costs. The headcount-related costs are directly associated with the engineers dedicated to remote and on-site support, training, travel costs and other services costs.

 

32

 

 

Gross Profit and Gross Margin

 

Our gross profit is revenue less cost of revenue and our gross margin is gross profit as a percentage of revenue. The gross profit and gross margin for our products are varied and are expected to continue to vary from period to period due to the mix of products and services sold through a 3D Printer sale transaction, a Recurring Payment transaction, RPS offerings, services contracts, new product introductions and efforts to optimize our operational costs. Other factors affecting our gross profit include changes to our material costs, assembly costs that are themselves dependent upon improvements to yield, and any increase in assembly overhead to support a greater number of 3D Printers sold and markets served.

 

Research and Development Expenses

 

Our research and development expenses represent costs incurred to support activities that advance the development of innovative AM technologies, new product platforms and consumables, as well as activities that enhance the capabilities of our existing product platforms. Our research and development expenses consist primarily of salaries and related personnel costs for individuals working in our research and development departments, including stock-based compensation, prototypes, design expenses, information technology costs and software license amortization, consulting and contractor costs, and an allocated portion of overhead costs, including depreciation of property and equipment used in research and development activities.

 

Selling and Marketing Expenses

 

Sales and marketing expenses consist primarily of salaries and related personnel costs for individuals working in our sales and marketing departments, including stock-based compensation, costs related to trade shows and events, advertising, marketing promotions, travel costs and an allocated portion of overhead costs, including information technology costs and costs for customer validation.

 

General and Administrative Expenses

 

General and administrative expenses consist primarily of salaries and related personnel costs for individuals associated with our executive, administrative, finance, legal, information technology and human resources functions, including stock-based compensation, professional fees for legal, audit and compliance, accounting and consulting services, general corporate costs, facilities, rent, information technology costs, insurance, bad debt expenses and an allocated portion of overhead costs, including equipment and depreciation and other general and administrative expenses.

 

Interest Expense

 

Interest expense primarily consists of interest incurred under our outstanding debt and finance leases.

 

Gain (Loss) on Fair Value of Warrants

 

Gain (loss) on valuation of warrant liabilities relates to the changes in the fair value of warrant liabilities which are subject to remeasurement at each balance sheet date.

 

Gain (Loss) on Fair value of Contingent Earnout Liabilities

 

Gain (loss) on valuation of contingent earnout liabilities relates to the changes in fair value of the contingent earnout liabilities in connection with the earnout shares, which are subject to remeasurement at each balance sheet date.

 

Loss on warrant cancellation

 

Loss on warrant cancellation relates to the loss recognized in conjunction with the February 2025 Warrant Exchange Agreements.

 

Other Income (Expense), Net

 

Other income (expense), net includes interest earned on our bank sweep account, gains and losses on disposals of fixed assets, transaction costs related to the warrant inducement transaction and other miscellaneous income/expenses.

 

33

 

 

Income Taxes

 

No provision for federal and state income taxes was recorded for any periods presented due to projected losses, and we maintained a full valuation allowance on the deferred tax assets as of June 30, 2025 and 2024.

 

We will continue to review our conclusions about the appropriate amount of the valuation allowance on a quarterly basis. If we were to generate profits, the U.S. valuation allowance position could be reversed in the foreseeable future. We expect a benefit to be recorded in the period the valuation allowance reversal is recorded and a higher effective tax rate in periods following the valuation allowance reversal.

 

Results of Operations

 

Comparison of the Three Months Ended June 30, 2025 and 2024:

 

The following table summarizes our historical results of operations for the periods presented:

 

   Three Months Ended June 30,         
   2025   2024   Change   % 
   (In thousands, except for percentages) 
Revenue                
3D Printer  $12,082   $8,679   $3,403    39.2%
Recurring payment   70    292    (222)   (76.0)%
Support services   1,359    1,373    (14)   (1.0)%
Other   61        61    100.0%
Total Revenue   13,572    10,344    3,228    31.2%
Cost of revenue                    
3D Printer   13,994    10,744    3,250    30.2%
Recurring payment       232    (232)   (100.0)%
Support services   1,166    2,265    (1,099)   (48.5)%
Total cost of revenue   15,160    13,241    1,919    14.5%
Gross loss   (1,588)   (2,897)   1,309    (45.2)%
Operating expenses                    
Research and development   2,845    4,545    (1,700)   (37.4)%
Selling and marketing   1,619    4,273    (2,654)   (62.1)%
General and administrative   6,037    8,805    (2,768)   (31.4)%
Total operating expenses   10,501    17,623    (7,122)   (40.4)%
Loss from operations   (12,089)   (20,520)   8,431    (41.1)%
Interest expense   (1,572)   (5,463)   3,891    (71.2)%
Gain on fair value of warrants       25,310    (25,310)   (100.0)%
Gain on fair value of contingent earnout liabilities       1,824    (1,824)   (100.0)%
Other expense, net   (6)   (1,327)   1,321    (99.5)%
Loss before (provision) benefit for income taxes   (13,667)   (176)   (13,491)   7665.3%
(Provision) benefit for income taxes   (89)   4    (93)   (2325.0)%
Net loss  $(13,756)  $(172)  $(13,584)   7897.7%

 

Revenue

 

The following table presents the revenue disaggregated by products and service type, as well as the percentage of total revenue.

 

  Three Months Ended June 30,         
  2025   2024   Change   % 
  (In thousands, except for percentages) 
3D Printer sales  $12,082    89.0%  $8,679    83.9%  $3,403    39.2%
Recurring payment   70    0.5%   292    2.8%   (222)   (76.0)%
Support services   1,359    10.0%   1,373    13.3%   (14)   (1.0)%
Other   61    0.5%           61    100.0%
Total Revenue  $13,572    100.0%  $10,344    100.0%  $3,228    31.2%

 

34

 

 

Total revenue for the three months ended June 30, 2025 and 2024 was $13.6 million and $10.3 million, respectively, an increase of $3.2 million, or 31.2%.

 

3D Printer sales were $12.1 million and $8.7 million for the three months ended June 30, 2025 and 2024, respectively, an increase of $3.4 million. The increase in revenue was primarily attributed to the product mix and the number of systems sold. The 3D Printer sales also included printed parts and consumables revenue.

 

Recurring Payment revenue, structured as an operating lease, was less than $0.1 million for the three months ended June 30, 2025 and $0.3 million for the three months ended June 30, 2024. The decrease was primarily attributable to a revenue reduction related to fewer operating lease transactions.

 

Our Support Services revenue was $1.4 million and $1.4 million for the three months ended June 30, 2025 and 2024, respectively, a decrease of less than $0.1 million. Support Services revenue remained consistent primarily due to services provided to customers.

 

Other revenue was less than $0.1 million and $0.0 for the three months ended June 30, 2025 and 2024, respectively.

 

Cost of Revenue

 

The following table presents the Cost of Revenue disaggregated by product and service type, as well as the percentage of total cost of revenue.

 

   Three Months Ended June 30,         
  2025   2024   Change   % 
  (In thousands, except for percentages) 
Cost of Revenue                        
Cost of 3D Printers  $13,994    92.3%  $10,744    81.1%  $3,250    30.2%
Cost of Recurring Payment           232    1.8%   (232)   (100.0)%
Cost of Support Services   1,166    7.7%   2,265    17.1%   (1,099)   (48.5)%
Total Cost of Revenue  $15,160    100.0%  $13,241    100.0%  $1,919    14.5%

 

Total cost of revenue for the three months ended June 30, 2025 and 2024 was $15.2 million and $13.2 million, respectively, an increase of $1.9 million, or 14.5%.

 

Cost of 3D Printers was $14.0 million and $10.7 million for the three months ended June 30, 2025 and 2024, respectively. The increase of $3.3 million was due to the higher overhead and labor absorption to manufacture the systems which were started in 2024 and sold in 2025 for the three months ended June 30, 2025, compared to the three months ended June 30, 2024. We expect the cost to manufacture new systems in 2025 to improve as a result of overhead and fixed cost reduction efforts implement in late 2024.

 

Cost of Recurring Payment was $0.0 and $0.2 million for the three months ended June 30, 2025 and 2024, respectively. This decrease of $0.2 million was primarily due to a decrease in depreciation of the equipment subject to operating lease and allocable Cost of Support Services as a result of fewer 3D Printers in service in the three months ended June 30, 2025, compared to the three months June 30, 2024.

 

Cost of Support Services was $1.2 million and $2.3 million for the three months ended June 30, 2025 and 2024, respectively. Cost of Support Services decreased by $1.1 million, due to reliability improvement efforts that the Company undertook in 2024 leading to lower field service engineering labor and overhead in June 30, 2025, compared to June 30, 2024. We expect this to decrease on a per unit basis as the Sapphire XC, Sapphire 1MZ and Sapphire XC 1MZ system reliability improves. We also expect our Cost of Support Services will increase with the delivery of more 3D Printer systems to customers.

 

35

 

 

Cost of revenue as a percentage of revenue was 111.7% and 128.0% for the three months ended June 30, 2025 and 2024, respectively. The decrease in the cost of revenue as a percentage of revenue was primarily driven by product mix and improvements in the average selling price of 3D Printers.

 

We may experience increasing component costs from our suppliers due to international tariffs and our current financial situation. We are currently unable to secure credit terms and volume discounts with our suppliers, causing us to pay a premium, in advance, or source from alternate suppliers at unfavorable terms for our products. This has negatively impacted our cost of revenue and will continue to negatively impact our cost of revenue until our financial conditions improve and costs associated with tariffs ease.

 

Gross Profit and Gross Margin

 

Total gross profit (loss) was $(1.6) million and $(2.9) million for the three months ended June 30, 2025 and 2024, respectively. As a percentage of revenue, the gross margin was (11.7)% and (28.0)% for the three months ended June 30, 2025 and 2024, respectively. The increase in gross profit for the three months ended June 30, 2025 was primarily attributable to product mix and improvements in the average selling price of 3D Printers, offset by the historical higher manufacturing cost of systems started in 2024 but sold in 2025 during the three months ended June 30, 2025, as compared to the three months ended June 30, 2024.

 

Our gross profit and gross margin are influenced by a number of factors, including:

 

Product mix of Sapphire, and Sapphire XC systems;
   
Average selling prices for our systems;
   
Trends in materials and shipping costs;
   
Production volumes that may impact factory overhead absorption;
   
System reliability performance; and
   
Impact of product mix changes, including new product introductions, and other factors, on our Cost of Support Services.

 

Due to the aforementioned trends in customer orders and component costs, our gross profit and gross margin have been and will continue to be negatively impacted until our financial conditions improve.

 

Research and Development Expenses

 

Research and development expenses were $2.8 million and $4.5 million for the three months ended June 30, 2025 and 2024, respectively, a decrease of $1.7 million. The decrease in research and development expenses was driven by a $1.0 million decrease in headcount, salaries and employee-related expenses, a decrease of $0.5 million in stock-based compensation, a decrease of $0.2 million in research and development expenses.

 

We expect research and development costs to remain at similar levels for the remainder of 2025 due to the maturation of our Sapphire family of systems and certain investments in improvements current product line and to increase in the long term as we continue to invest in enhancing and advancing our portfolio of AM solutions.

 

Selling and Marketing Expenses

 

Selling and marketing expenses were $1.6 million and $4.3 million for the three months ended June 30, 2025 and 2024, respectively, a decrease of $2.7 million. The decrease was attributable to a decrease of $2.2 million in headcount, salaries and employee-related expenses, and a $0.5 million decrease in stock-based compensation. Marketing costs and initiatives spending remained consistent for three months ended June 30, 2025 and 2024.

 

We expect selling and marketing expenses to increase for the remainder of 2025 as we re-engage with key customers and drive RPS traction. During the remainder of 2025, we intend to continue our focus on certain markets that show strong attendance at additive manufacturing conferences to build product awareness.

 

36

 

 

General and Administrative Expenses

 

General and administrative expenses were $6.0 million and $8.8 million for the three months ended June 30, 2025 and 2024, respectively, a decrease of $2.8 million. The decrease was attributable to a decrease of $0.6 million in headcount, salaries and employee-related expenses, a $1.0 million decrease in stock-based compensation, and a decrease of $1.2 million in legal, professional fees and general and administrative expenses.

 

We expect general and administrative expenses to decrease as a result of savings from our reduction in force implemented in late 2024. We continue to focus on our company-wide initiatives to reduce operating costs for the remainder of 2025 as we continue to reducing our general and administrative expenses through reducing our reliance on outside consultants, managing facility costs, negotiating with vendors for improved pricing and enterprise level efficiency improvements.

 

Interest Expense

 

Interest expense was $1.6 million and $5.5 million for the three months ended June 30, 2025 and 2024, respectively, due to the reduction in Senior Secured Notes and offset by the issuance of the Secured Convertible Notes.

 

We expect our interest expense will continue to decrease as a result of our reduced debt.

 

Gain (loss) on Fair Value of Warrants

 

The gain on fair value of warrants was $0.0 and $25.3 million for the three months ended June 30, 2025 and 2024, respectively, and was related to the non-cash fair value change of the warrant liabilities driven by the relative change in our stock price.

 

Gain (loss) on Fair value of Contingent Earnout Liabilities

 

The change in fair value of the contingent earnout liability was $0.0 and $1.8 million for the three months ended June 30, 2025 and 2024, respectively, and was related to the non-cash fair value change of the earnout liabilities driven by the relative change in our stock price.

 

Other Income (Expense), Net

 

Other income (expense), net was less than $(0.1) million and $(1.3) million for the three months ended June 30, 2025 and 2024, respectively.

 

Income Taxes

 

No provision for federal and state income taxes was recorded for both the three months ended June 30, 2025 and 2024 due to projected losses, and we maintained a full valuation allowance on the deferred tax assets as of June 30, 2025 and December 31, 2024.

 

We will continue to review our conclusions about the appropriate amount of the valuation allowance on a quarterly basis. If we were to generate profits in the remainder of 2025 and beyond, the U.S. valuation allowance position could be reversed in the foreseeable future. We expect a benefit to be recorded in the period the valuation allowance reversal is recorded and a higher effective tax rate in periods following the valuation allowance reversal.

 

37

 

 

Comparison of the Six Months Ended June 30, 2025 and 2024:

 

The following table summarizes our historical results of operations for the periods presented:

 

   Six Months Ended June 30,         
   2025   2024   Change   % 
   (In thousands, except for percentages) 
Revenue                
3D Printer  $19,605   $16,339   $3,266    20.0%
Recurring payment   70    762    (692)   (90.8)%
Support services   3,149    3,029    120    100.0%
Other   68        68     
Total Revenue   22,892    20,130    2,762    13.7%
Cost of revenue                    
3D Printer   21,534    20,138    1,396    6.9%
Recurring payment   12    547    (535)   (97.8)%
Support services   2,237    5,157    (2,920)   (56.6)%
Total cost of revenue   23,783    25,842    (2,059)   (8.0)%
Gross loss   (891)   (5,712)   4,821    (84.4)%
Operating expenses                    
Research and development   5,120    9,588    (4,468)   (46.6)%
Selling and marketing   2,831    9,082    (6,251)   (68.8)%
General and administrative   15,168    17,588    (2,420)   (13.8)%
Total operating expenses   23,119    36,258    (13,139)   (36.2)%
Loss from operations   (24,010)   (41,970)   17,960    (42.8)%
Interest expense   (2,642)   (9,360)   6,718    (71.8)%
Gain (loss) on fair value of warrants   (1,044)   22,690    (23,734)   (104.6)%
Gain on fair value of contingent earnout liabilities       1,387    (1,387)   (100.0)%
Loss on warrant cancellation   (11,357)       (11,357)    
Other expense, net   (17)   (1,233)   1,216    (98.6)%
Loss before (provision) benefit for income taxes   (39,070)   (28,486)   (10,584)   37.2%
(Provision) benefit for income taxes   (97)       (97)    
Net loss  $(39,167)  $(28,486)  $(10,681)   37.5%

 

Revenue

 

The following table presents the revenue disaggregated by products and service type, as well as the percentage of total revenue.

 

  Six Months Ended June 30,         
  2025   2024   Change   % 
  (In thousands, except for percentages) 
3D Printer sales  $19,605    85.6%  $16,339    81.2%  $3,266    20.0%
Recurring payment   70    0.3%   762    3.8%   (692)   (90.8)%
Licensing   3,149    13.8%   3,029    15.0%   120    100.0%
Support services   68    0.3%           68     
Total Revenue  $22,892    100.0%  $20,130    100.0%  $2,762    13.7%

 

Total revenue for the six months ended June 30, 2025 and 2024 was $22.9 million and $20.1 million, respectively, an increase of $2.8 million, or 13.7%.

 

3D Printer sales were $19.6 million and $16.3 million for the six months ended June 30, 2025 and 2024, respectively, an increase of $3.3 million. The increase in revenue was primarily attributed to product mix and the number of systems sold. The 3D Printer sales also included printed parts and consumables revenue.

 

38

 

 

Recurring Payment revenue, structured as an operating lease, was less than $0.1 million for the six months ended June 30, 2025 and $0.8 million for the six months ended June 30, 2024. The decrease was primarily attributable to a revenue reduction related to fewer operating lease transactions.

 

Our Support Services revenue was $3.1 million and $3.0 million for the six months ended June 30, 2025 and 2024, respectively, an increase of $0.1 million. The increase in Support Services revenue was primarily due to services provided to customers as a result of the increased installed base.

 

Other revenue was less than $0.1 million and $0.0 for the six months ended June 30, 2025 and 2024, respectively.

 

Cost of Revenue

 

The following table presents the Cost of Revenue disaggregated by product and service type, as well as the percentage of total cost of revenue.

 

   Six Months Ended June 30,         
  2025   2024   Change   % 
  (In thousands, except for percentages) 
Cost of Revenue                        
Cost of 3D Printers  $21,534    90.5%  $20,138    77.9%  $1,396    6.9%
Cost of Recurring Payment   12    0.1%   547    2.1%   (535)   (97.8)%
Cost of Support Services   2,237    9.4%   5,157    20.0%   (2,920)   (56.6)%
Total Cost of Revenue  $23,783    100.0%  $25,842    100.0%  $(2,059)   (8.0)%

 

Total cost of revenue for the six months ended June 30, 2025 and 2024 was $23.8 million and $25.8 million, respectively, a decrease of $2.1 million, or 8.0%.

 

Cost of 3D Printers was $21.5 million and $20.1 million for the six months ended June 30, 2025 and 2024, respectively. The increase of $1.4 million was due to the higher overhead and labor absorption to manufacture the systems which were started in 2024 and sold in 2025, offset by the product mix and decrease in the number of systems sold, for the six months ended June 30, 2025, compared to the six months ended June 30, 2024. The Cost of 3D Printer also included cost for printed parts and consumables.

 

Cost of Recurring Payment was less than $0.1 million and $0.5 million for the six months ended June 30, 2025 and 2024, respectively. This decrease of $0.5 million was primarily due to a decrease in depreciation of the equipment subject to operating lease and allocable Cost of Support Services as a result of fewer 3D Printers in service in the six months ended June 30, 2025, compared to the six months June 30, 2024.

 

Cost of Support Services was $2.2 million and $5.2 million for the six months ended June 30, 2025 and 2024, respectively. Cost of Support Services decreased by $2.9 million, due to reliability improvement efforts that the Company undertook in 2024 leading to lower field service engineering labor and overhead in June 30, 2025, compared to June 30, 2024. We expect this to decrease on a per unit basis as the Sapphire XC, Sapphire 1MZ and Sapphire XC 1MZ system reliability improves. We also expect our Cost of Support Services will increase with the delivery of more 3D Printer systems to customers.

 

Cost of revenue as a percentage of revenue was 103.9% and 128.4% for the six months ended June 30, 2025 and 2024, respectively. The decrease in the cost of revenue as a percentage of revenue was primarily driven by product mix and improvements in the average selling price of 3D Printers.

 

We may experience increasing component costs from our suppliers due to international tariffs and our current financial situation. We are currently unable to secure credit terms and volume discounts with our suppliers, causing us to pay a premium, in advance, or source from alternate suppliers at unfavorable terms for our products. This has negatively impacted our cost of revenue and will continue to negatively impact our cost of revenue until our financial conditions improve and costs associated with tariffs ease.

 

39

 

 

Gross Profit and Gross Margin

 

Total gross profit (loss) was $(0.9) million and $(5.7) million for the six months ended June 30, 2025 and 2024, respectively. As a percentage of revenue, the gross margin was (3.9)% and (28.4)% for the six months ended June 30, 2025 and 2024, respectively. The increase in gross profit for the six months ended June 30, 2025 was primarily attributable to product mix and improvements in the average selling price of 3D Printers, offset by the historical higher manufacturing cost of systems started in 2024 but sold in 2025 during the six months ended June 30, 2025, as compared to the six months ended June 30, 2024.

 

Our gross profit and gross margin are influenced by a number of factors, including:

 

Product mix of Sapphire, and Sapphire XC systems;
   
Average selling prices for our systems;
   
Trends in materials and shipping costs;
   
Production volumes that may impact factory overhead absorption;
   
System reliability performance; and
   
Impact of product mix changes, including new product introductions, and other factors, on our Cost of Support Services.

 

Due to the aforementioned trends in customer orders and component costs, our gross profit and gross margin have been and will continue to be negatively impacted until our financial conditions improve.

 

Research and Development Expenses

 

Research and development expenses were $5.1 million and $9.6 million for the six months ended June 30, 2025 and 2024, respectively, a decrease of $4.5 million. The decrease in research and development expenses was driven by a $2.5 million decrease in headcount, salaries and employee-related expenses, a decrease of $1.4 million in stock-based compensation, a decrease of $0.6 million in other research and development expenses.

 

We expect research and development costs to remain at similar levels for the remainder of 2025 due to the maturation of our Sapphire family of systems and certain investments in improvements current product line and to increase in the long term as we continue to invest in enhancing and advancing our portfolio of AM solutions.

 

Selling and Marketing Expenses

 

Selling and marketing expenses were $2.8 million and $9.1 million for the six months ended June 30, 2025 and 2024, respectively, a decrease of $6.3 million. The decrease was attributable to a decrease of $5.0 million in headcount, salaries and employee-related expenses and a $1.3 million decrease in stock-based compensation.

 

We expect selling and marketing expenses to increase for the remainder of 2025 as we re-engage with key customers and drive RPS traction. During the remainder of 2025, we intend to continue our focus on certain markets that show strong attendance at additive manufacturing conferences to build product awareness.

 

General and Administrative Expenses

 

General and administrative expenses were $15.2 million and $17.6 million for the six months ended June 30, 2025 and 2024, respectively, a decrease of $2.4 million. The decrease was attributable to a $1.7 million decrease in headcount, salaries and employee-related expenses, a $1.0 million decrease in facilities related expenses and a $0.9 million decrease in legal and other professional services, offset by a $0.7 million increase in other miscellaneous expenses and $0.5 million increase in state taxes.

 

We expect general and administrative expenses to decrease as a result of savings from our reduction in force implemented in late 2024. We continue to focus on our company-wide initiatives to reduce operating costs for the remainder of 2025 as we continue to reducing our general and administrative expenses through reducing our reliance on outside consultants, managing facility costs, negotiating with vendors for improved pricing and enterprise level efficiency improvements.

 

40

 

 

Interest Expense

 

Interest expense was $2.6 million and $9.4 million for the six months ended June 30, 2025 and 2024, respectively, due to the reduction in Senior Secured Notes and offset by the issuance of the Secured Convertible Notes.

 

We expect our interest expense will continue to decrease as a result of our reduced debt.

 

Gain (loss) on Fair Value of Warrants

 

The change in fair value of warrants resulted in a gain (loss) of $(1.0) and $22.7 million for the six months ended June 30, 2025 and 2024, respectively, and was related to the non-cash fair value change of the warrant liabilities driven by the relative change in our stock price.

 

Gain (loss) on Fair value of Contingent Earnout Liabilities

 

The change in fair value of the contingent earnout liability was $0.0 and $1.4 million for the six months ended June 30, 2025 and 2024, respectively, and was related to the non-cash fair value change of the earnout liabilities driven by the relative change in our stock price.

 

Loss on Warrant Cancellation

 

Loss on warrant cancellation was $11.4 million and $0.0 for the six months ended June 30, 2025 and 2024 and related to the loss recognized in conjunction with the February 2025 Warrant Exchange transaction.

 

Other Income (Expense), Net

 

Other (expense) and income, net was less than $(0.1) million and $(1.2) million for the six months ended June 30, 2025 and 2024, respectively.

 

Income Taxes

 

No provision for federal and state income taxes was recorded for both the six months ended June 30, 2025 and 2024 due to projected losses, and we maintained a full valuation allowance on the deferred tax assets as of June 30, 2025 and December 31, 2024.

 

We will continue to review our conclusions about the appropriate amount of the valuation allowance on a quarterly basis. If we were to generate profits in the remainder of 2025 and beyond, the U.S. valuation allowance position could be reversed in the foreseeable future. We expect a benefit to be recorded in the period the valuation allowance reversal is recorded and a higher effective tax rate in periods following the valuation allowance reversal.

 

Liquidity and Capital Resources

 

As of June 30, 2025, the Company had approximately $0.9 million in cash and short-term investments and $5.4 million in accounts receivable. Our business requires substantial amounts of cash for operating activities, including salaries and wages paid to our employees, component and sub-assembly purchases, general and administrative expenses, and others.

 

Our purchase commitments per terms and conditions with suppliers and vendors are cancellable in whole or in part prior to shipment. Purchase commitments (purchase orders) of $4.4 million for parts and assemblies are due upon receipt and will primarily be delivered throughout the remainder of 2025. If inventory is shipped, we will accrue a liability under accrued expenses. We have no other commitments and contingencies, except for the operating leases and the Secured Notes, the January Note, and the February Note. See Note 8, Leases, in the unaudited condensed consolidated interim financial statements included elsewhere in this Quarterly Report for further discussion.

 

During the six months ended June 30, 2025, we experienced less revenue growth than expected due to our focus on high-value customers, resulting in a small decrease in system sales as compared to the first quarter in 2025. As of June 30, 2025, we do not have sufficient working capital to meet our financial needs for the twelve-month period following the filing date of these unaudited condensed consolidated interim financial statements. As such, we believe that there is substantial doubt about our ability to continue as a going concern for the twelve-month period following the issuance of these unaudited condensed consolidated interim financial statements. See Note 1, Description of Business and Basis of Presentation—Going Concern, Financial Condition and Liquidity and Capital Resources, in the unaudited condensed consolidated interim financial statements included elsewhere in this Quarterly Report.

 

41

 

  

We will need to engage in additional financings to fund our operations and satisfy our debt obligations in the near-term as well as to respond to business challenges and opportunities, including the need to repay the Secured Notes, provide working capital, continue to fund payroll for employees, improve our operating infrastructure, and continue to sustain operations. Accordingly, subject to our compliance with the covenants in the Secured Notes, to fund our operations, we will need to engage in equity or debt financings to secure additional funds, including seeking additional capital from public or private offerings of our equity or debt securities, electing to repay, restructure or refinance our existing indebtedness, or electing to borrow additional amounts under new credit lines or from other sources. We may also seek to raise additional capital, including from offerings of our equity or debt securities, on an opportunistic basis when we believe there are suitable opportunities for doing so.

 

Additionally, our recent and projected financial results, and the related conditions that raise substantial doubt about our ability to continue as a going concern, and general concerns among potential investors and creditors about our financial well-being, may make securing additional financing and cost cutting activities on commercially reasonable terms or in an amount sufficient to fund our operations for at least 12 months especially difficult.

 

More generally, our ability to meet our cash requirements depends on, among other things, our operating performance, competitive and industry developments, and financial market conditions, all of which are significantly affected by business, financial, economic, political, and other factors, many of which we may not be able to control or influence. To the extent that our actual operating results or other developments differ from our expectations, our liquidity will continue to be adversely affected.

 

Debt Facilities

 

As of June 30, 2025, our debt arrangements comprised the Secured Notes, the January Notes, and the February Notes, of which we had approximately $22 million aggregate principal amount outstanding as of June 30, 2025.

 

See our other debt facilities as described in the “Liquidity and Capital Resources” section above. 

 

We do not hedge our exposure to changes in interest rates. A 10% change in interest rates would not have a material impact on annualized interest expense.

 

For more information, see Note 9, Debt, in the notes of the unaudited condensed consolidated interim financial statements included elsewhere in this Quarterly Report.

 

42

 

 

Cash Flow Summary

 

The following table summarizes our cash flows for the six months ended June 30, 2025 and 2024:

 

   Six Months Ended
June 30,
     
   2025   2024   Change 
   (In thousands)    
Net cash used in operating activities  $(13,565)  $(28,492)  $14,927 
Net cash (used in) provided by investing activities  $(1,799)  $5,966   $(7,765)
Net cash provided by financing activities  $15,000   $490   $14,510 

 

Operating Activities

 

Net cash used in operating activities for the six months ended June 30, 2025 was $13.6 million, consisting primarily of a net loss of $39.2 million, non-cash loss of $25.9 million described below, and a decrease in net operating assets of less than $0.3 million. The cash used from net operating assets was comprised of a decrease from accounts receivable of $1.7 million, a decrease from contract liabilities of $3.6 million, a decrease from accounts payable of $0.9 million, a decrease from other net operating assets of $1.8 million, and offset by an increase from inventories of $5.7 million, and an increase from other assets of $2.0 million. The non-cash loss of $25.9 million primarily consisted of the loss on cancellation of warrants of $11.4 million, stock-based compensation expense of $6.5 million, the loss on the disposal of fixed assets of $2.7 million, and the loss on fair value of warrants of $1.0 million.

 

Net cash used in operating activities for the six months ended June 30, 2024 was $28.5 million, consisting primarily of a net loss of $28.5 million, non-cash gain of $2.4 million described below, and an increase in net operating assets of $2.3 million. The increase in net operating assets was comprised of an increase from accounts receivable of $1.2 million due to timing of customer payments, an increase from inventories of $3.9 million for Sapphire XC, Sapphire 1MZ and Sapphire XC 1MZ system production, and an increase from prepaid expenses of $1.9 million related to insurance and vendor prepayments, offset by a decrease from accounts payable of $2.4 million, a decrease from contract liabilities of $0.3 million, a decrease from other net operating assets of $1.3 million, and a decrease in accrued expenses and other current liabilities of $0.6 million. The noncash gain of $2.4 million primarily consisted of the gain on fair value of warrants of $22.7 million, and the gain on fair value of contingent earnout liabilities of $1.4 million, offset by the stock-based compensation expense of $9.3 million, depreciation and amortization of $2.7 million, amortization of debt discount and deferred financing costs of $8.3 million and non-cash cost of issuance of common stock warrants in connection with the BEPO Offering of $1.3 million.

 

We expect our cash used in operating activities to decrease, driven by our efforts to stabilize our working capital requirements through our expense reduction efforts and overall enterprise efficiency improvement programs.

 

Investing Activities

 

Net cash used by investing activities during the six months ended June 30, 2025 was $1.8 million, consisting of purchases of property and equipment of $1.8 million.

 

Net cash provided by investing activities during the six months ended June 30, 2024 was $6.0 million, consisting of the sale of available for sale securities of $2.5 million, and maturities of available-for-sale investment securities of $3.5 million.

 

We expect our capital expenditures to increase in 2025 compared to 2024 as we invest in printer capacity and related facilities for RPS.

 

Financing Activities

 

Net cash provided by financing activities during the six months ended June 30, 2025 was $15.0 million, consisting of proceeds of $15.0 million from the issuance of the January Note and the February Note.

 

Net cash provided by financing activities during the six months ended June 30, 2024 was $0.5 million, consisting of proceeds of $10.7 million from the capital raise, and $0.3 million from the issuance of common stock upon exercise of stock options, offset by the repayment of the secured notes of $10.5 million.

 

43

 

 

We expect cash provided by financing activities to increase by issuing new equity or incurring new debt to continue operations, subject to our compliance with the covenants in the Secured Notes. Our future cash requirements and the adequacy of available funds will depend on many factors, including our operating performance, competitive and industry developments, and financial market conditions.

 

Off-Balance Sheet Arrangements

 

As of June 30, 2025 and December 31, 2024, except as discussed below, we did not have any off-balance sheet arrangements.

 

See Note 16, Momentus Master Service Agreement, in the notes to our unaudited condensed consolidated interim financial statements included elsewhere in this Quarterly Report for additional information.

 

Recent Accounting Pronouncements

 

For a description of recent accounting pronouncements, including the expected dates of adoption and estimated effects, if any, on Velo3D’s unaudited condensed consolidated interim financial statements, see Note 2, Summary of Significant Accounting Policies, in the notes to the unaudited condensed consolidated interim financial statements in this Quarterly Report.

 

Implications of Being an Emerging Growth Company

 

Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can choose not to take advantage of the extended transition period and comply with the requirements that apply to non-emerging growth companies, and any such election to not take advantage of the extended transition period is irrevocable. We are an “emerging growth company” as defined in Section 2(a)(19) of the Securities Act of 1933, as amended (the “Securities Act”) and have elected to take advantage of the benefits of this extended transition period.

 

We will elect to use this extended transition period for complying with new or revised accounting standards that have different effective dates for public business entities and nonpublic business entities until the earlier of the date we (a) are no longer an emerging growth company or (b) affirmatively and irrevocably opt out of the extended transition period provided in the JOBS Act. This may make it difficult or impossible to compare our financial results with the financial results of another public company that is either not an emerging growth company or an emerging growth company that has chosen not to take advantage of the extended transition period exemptions because of the potential differences in accounting standards used. Please refer to Note 2. Summary of Significant Accounting Policies, of the unaudited condensed consolidated interim financial statements included elsewhere in this Quarterly Report for the recent accounting pronouncements adopted and the recent accounting pronouncements not yet adopted for the six months ended June 30, 2025 and 2024.

 

We will remain an emerging growth company under the JOBS Act until the earliest of (a) December 31, 2025, (b) the last date of our fiscal year in which we have total annual gross revenue of at least $1.235 billion, (c) the last date of our fiscal year in which we are deemed to be a “large accelerated filer” under the rules of the SEC or (d) the date on which we have issued more than $1.0 billion in nonconvertible debt securities during the previous three years.

 

Implications of Being a Smaller Reporting Company

 

We are a “smaller reporting company” as defined in Item 10(f)(1) of Regulation S-K. Smaller reporting companies may take advantage of certain reduced disclosure obligations, including, among other things, providing only two years of audited consolidated financial statements.

 

We may continue to be a smaller reporting company even after we are no longer an emerging growth company. We will remain a smaller reporting company and may take advantage of certain scaled disclosures available to smaller reporting companies until the last day of the fiscal year in which (a) the market value of our voting and nonvoting common stock held by non-affiliates equals or exceeds $250.0 million measured on the last business day of that year’s second fiscal quarter and (b) our annual revenue equals or exceeds $100.0 million during the most recently completed fiscal year or our voting and nonvoting common stock held by non-affiliates equals or exceeds $700.0 million measured on the last business day of that year’s second fiscal quarter.

 

44

 

 

Critical Accounting Policies and Significant Estimates

 

Our discussion and analysis of our financial condition and results of operations are based upon our unaudited condensed consolidated interim financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). We evaluated the development and selection of our critical accounting policies and estimates and believe that the following involve a higher degree of judgment or complexity and are most significant to reporting our results of operations and financial position and are therefore discussed as critical. The following critical accounting policies reflect the significant estimates and judgments used in the preparation of our unaudited condensed consolidated interim financial statements. Actual results could differ materially from those estimates and assumptions, and those differences could be material to our unaudited condensed consolidated interim financial statements. We re-evaluate our estimates on an ongoing basis. For more information, see Note 2, Summary of Significant Accounting Policies, included in the notes to the unaudited condensed consolidated interim financial statements in this Quarterly Report, and Critical Accounting Policies and Significant Estimates in Part II, Item 7 “Management’s Discussion and Analysis of Financial Condition and Results of Operations” of our Annual Report on Form 10-K for the fiscal year ended December 31, 2024.

 

Item 3. Quantitative and Qualitative Disclosures about Market Risk

 

We are a smaller reporting company as defined in Rule 12b-2 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). As a result, pursuant to Item 305(e) of Regulation S-K, we are not required to provide the information required by this Item.

 

Item 4. Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures

 

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed by us in reports filed or submitted under the Exchange Act, is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports filed or submitted under the Exchange Act is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.

 

Our management, with participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act as of June 30, 2025. Based upon this evaluation our Chief Executive Officer and Chief Financial Officer concluded that, as of June 30, 2025, our disclosure controls and procedures were not effective due to the material weaknesses in internal control over financial reporting described below.

 

Material Weaknesses in Internal Control over Financial Reporting

 

As described Part II, Item 9A. “Controls and Procedures” of our Annual Report on Form 10-K for the fiscal year ended December 31, 2024, we identified material weaknesses in our internal control over financial reporting. These material weaknesses have not been remediated as of June 30, 2025. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of the annual or interim consolidated financial statements will not be prevented or detected on a timely basis. The material weaknesses are as follows:

 

  We did not design and maintain an effective control environment commensurate with our financial reporting requirements. Specifically, we did not maintain a sufficient complement of personnel with an appropriate degree of internal controls and accounting knowledge, experience, and training commensurate with our accounting and financial reporting requirements. Additionally, the lack of a sufficient complement of personnel resulted in an inability to consistently establish appropriate authorities and responsibilities in pursuit of our financial reporting objectives, as demonstrated by, among other things, insufficient segregation of duties in our finance and accounting functions. This material weakness contributed to the following additional material weaknesses.
     
  We did not design and maintain effective controls over the segregation of duties related to journal entries and account reconciliations. Specifically, certain personnel have the ability to both (i) create and post journal entries within our general ledger system and (ii) prepare and review account reconciliations.

 

45

 

 

  We did not design and maintain effective controls over the accounting and disclosure for debt and equity instruments. Specifically, we did not design and maintain effective controls over the accounting for the issuance and extinguishment of convertible note arrangements, warrants, common stock, and the accounting for earnout liabilities.
     
  We did not design and maintain effective controls over the accounting for inventory and related accounts. Specifically, we did not design and maintain effective controls over verifying the existence of inventory, the accuracy of purchases, manufacturing costs, and write-offs and the financial statement presentation of inventory and related accounts.
     
  We did not design and maintain effective controls over the accounting for contract assets and liabilities. Specifically, we did not design and maintain effective controls over the accuracy and the financial statement presentation of contract assets and liabilities, including variable consideration.
     
  We did not design and maintain effective controls over financial statement preparation, presentation and disclosure commensurate with our financial reporting requirements. Specifically, we did not design and maintain effective controls over the appropriate classification and presentation of accounts and disclosures in the consolidated financial statements.

 

These material weaknesses resulted in adjustments to accounts receivable, inventory, other current assets, current and non-current contract liabilities, accrued expenses and other current liabilities which were recorded prior to the issuance of the consolidated financial statements as of and for the years ended December 31, 2019, 2020 and 2021 and as of and for the interim periods ended September 30, 2021 and December 31, 2021. These material weaknesses also resulted in the revision of our consolidated financial statements for the year ended December 31, 2022 and as of and for the interim periods ended March 31, 2022, June 30, 2022, September 30, 2022, March 31, 2023, June 30, 2023, and September 30, 2023. Also, these material weaknesses resulted in an uncorrected misstatement to inventories and cost of revenue and adjustments to debt – current portion and long-term debt, other income, additional paid in capital, gain on fair value of warrants, interest expense, revenue and contract assets, and loss on debt extinguishment which were recorded prior to the issuance of the consolidated financial statements as of and for the year ended December 31, 2023 and accounts receivable and contract assets as of and for the interim period ended June 30, 2025. These material weaknesses also resulted in adjustments to interest expense, debt – current portion, additional paid-in capital, warrant liabilities, contingent earnout liabilities and gain (loss) on fair value of contingent earnout liabilities, which were recorded prior to the issuance of the unaudited condensed consolidated interim financial statements as of and for the interim period ended June 30, 2025. Additionally, these material weaknesses could result in a misstatement of substantially all of our accounts or disclosures that would result in a material misstatement to the annual or interim consolidated financial statements that would not be prevented or detected.

 

  We did not design and maintain effective controls over certain information technology (“IT”) general controls for information systems that are relevant to the preparation of our consolidated financial statements. Specifically, we did not design and maintain effective:

 

  user access controls to ensure appropriate segregation of duties and that adequately restrict user and privileged access to financial applications, programs, and data to appropriate company personnel; and
     
  program change management controls to ensure that information technology program and data changes affecting certain financial IT applications and underlying accounting records are identified, tested, authorized and implemented appropriately.

 

These IT deficiencies did not result in a misstatement to the consolidated financial statements, however, the deficiencies, when aggregated, could impact maintaining effective segregation of duties, as well as the effectiveness of IT dependent controls (such as automated controls that address the risk of material misstatement to one or more assertions, along with the IT controls and underlying data that support the effectiveness of system-generated data and reports) that could result in misstatements potentially impacting all consolidated financial statement accounts and disclosures that would not be prevented or detected. Accordingly, management has determined these deficiencies in the aggregate constitute a material weakness.

 

Remediation Measures for Remaining Material Weaknesses in Internal Control over Financial Reporting

 

We have taken measures to remediate the material weaknesses remaining as of June 30, 2025, including the following: hired additional accounting and IT personnel to bolster our reporting, technical accounting and IT capabilities; provided ongoing training for our personnel on accounting, financial reporting and internal control over financial reporting; engaged a third-party to assist in designing and implementing controls, including controls related to segregation of duties and IT general controls; designing and implementing controls to formalize roles and review responsibilities to align with our team’s skills and experience and designing and implementing controls over segregation of duties; and designing and implementing controls over the preparation and review of journal entries and account reconciliations. Additionally, we will need to hire and train additional accounting and IT personnel to further bolster our technical accounting and IT capabilities. We have also begun planning for measures to remediate the material weaknesses related to designing and implementing controls over accounting and disclosure for debt and equity instruments, the accounting for the issuance and extinguishment of convertible note arrangements, warrants and common stock; designing and implementing controls over the accounting for inventory and related accounts, the accuracy of inventory, purchases, manufacturing costs, and write-offs and the financial statement presentation of inventory and related accounts; designing and implementing controls over the accounting for contract assets and liabilities, the accuracy and the financial statement presentation and disclosure of contract assets and liabilities, including variable consideration; designing and implementing controls over controls over financial statement preparation, presentation and disclosure commensurate with our financial reporting requirements, the appropriate classification and presentation of accounts and disclosures in the consolidated financial statements; and designing and implementing IT general controls, including controls over the review and update of user access rights and privileges and program change management controls.

 

We believe we are making progress toward the effectiveness of our internal control over financial reporting and disclosure controls and procedures. The measures that we are taking are subject to continued testing, ongoing senior management review, as well as audit committee oversight. We will not be able to conclude whether the measures we are taking will fully remediate these material weaknesses in our internal control over financial reporting until we have completed our remediation efforts and subsequent evaluation of their effectiveness. We may also conclude that additional measures may be required to remediate the material weaknesses in our internal control over financial reporting, which may necessitate additional implementation and evaluation time. We will continue to assess the effectiveness of our internal control over financial reporting and take steps to remediate the known material weaknesses expeditiously.

 

Changes in Internal Control over Financial Reporting

 

Other than as described above, there were no changes in internal control over financial reporting during the quarter ended June 30, 2025 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

 

46

 

 

PART II. OTHER INFORMATION

 

Item 1. Legal Proceedings

 

From time to time, we may be involved in various disputes and litigation matters that arise in the ordinary course of business. We are currently not a party to any material legal proceedings.

 

Item 1A. RISK FACTORS

 

There are numerous factors that affect our business and results of operations, many of which are beyond our control. Refer to Item 1A in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024, which contains descriptions of significant risks that have the potential to affect our business, financial condition, results of operations, cash flows, strategies or prospects in a material and adverse manner. Except as set forth below, there have been no material changes to risk factors previously disclosed in Item 1A of our Annual Report on Form 10-K for the fiscal year ended December 31, 2024.

 

Risks Related to Our Financial Position and Need for Additional Capital

 

There is substantial doubt about our ability to continue as a going concern, which is having a material adverse impact on our business.

 

As of June 30, 2025, the Company had approximately $0.9 million in cash and short-term investments and $5.4 million in accounts receivable. This amount is insufficient to satisfy the Company’s short term obligations including accounts payable of $14.9 million and $22.5 million in Secured and Convertible Notes as of June 30, 2025.

 

As described in Note 1, Description of Business and Basis of Presentation—Going Concern, Financial Condition and Liquidity and Capital Resources, in the notes to the unaudited condensed consolidated interim financial statements included elsewhere in this Quarterly Report, we believe there is substantial doubt about our ability to continue as a going concern for the twelve-month period following the filing date of this Quarterly Report.

 

Our conclusion that there is substantial doubt about our ability to continue as a going concern may be viewed unfavorably by current and prospective investors, as well as by analysts and creditors. As a result, this conclusion may make it more difficult for us to raise the additional financing necessary to continue to operate our business and satisfy our obligations. In addition, this conclusion may make it more difficult for us to sell our products and meet our sales forecasts or retain employees, which may further impede our ability to raise additional financing. If we become unable to continue as a going concern, we may find it necessary to file a petition for reorganization under Title 11 of the U.S. Code in order to provide us additional time to identify an appropriate solution to our financial situation and implement a plan of reorganization aimed at improving our capital structure.

 

This conclusion has caused customers to delay 3D printer orders until our financial condition improves, resulting in delays in 3D printer sales and difficulty building our bookings and backlog pipeline. Additionally, due to our inability to satisfy our accounts payable obligations, we are unable to secure credit terms and volume discounts with our suppliers, causing us to have to pay a premium and/or in advance, for components of our products and/or source components from alternate suppliers at unfavorable terms. Further delaying payments to our suppliers may cause them to terminate our business relationship or pursue legal action against our Company for amounts owed. The Company will need to consider and implement significant cost cutting measures, including further reductions in force. These activities may limit our ability to conduct or grow our business, and may make retaining our employees more difficult, resulting in further employee attrition.

 

47

 

 

We expect to require additional capital to fund our operations in the near-term, and such capital might not be available on acceptable terms, if at all.

 

We expect that we will need to engage in additional financings to fund our operations and satisfy our substantial debt obligations in the near-term as well as to respond to business challenges and opportunities, including the need to repay our Secured Notes, provide working capital, continuing to fund payroll, develop new features or enhance our products, expand our manufacturing capacity, improve our operating infrastructure or acquire complementary businesses and technologies. Accordingly, subject to our compliance with the covenants in the Secured Notes, we need to engage in equity or debt financings to secure additional funds, including seeking additional capital from public or private offerings of our equity or debt securities, electing to repay, restructure or refinance our existing indebtedness, or electing to borrow additional amounts under new credit lines or from other sources. However, our recent and projected financial results, and the related conditions that raise substantial doubt about our ability to continue as a going concern, and general concerns among potential investors and creditors about our financial well-being may make taking such actions on commercially reasonable terms especially difficult.

 

If we raise additional funds through future issuances of equity or convertible debt securities, our existing stockholders could suffer significant dilution, and any new equity securities we issue could have rights, preferences and privileges superior to those of holders of our common stock. Any debt financing that we may secure in the future could involve restrictive covenants relating to our capital raising activities and other financial and operational matters, which may make it more difficult for us to obtain additional capital and to pursue business opportunities, including potential acquisitions. We may not be able to obtain additional financing on terms favorable to us, if at all. Our ability to raise additional capital may be adversely affected by external factors beyond our control, including changes in the political climate, geopolitical actions, changes in market interest rates or foreign exchange rates, market volatility in the trading prices for our common stock and other technology companies, a recession, depression, high inflation or other sustained adverse market event, and the outbreak of epidemic disease. If we are unable to obtain adequate financing or financing on terms satisfactory to us in the near term, we will not be able to continue operations. If we are otherwise unable to obtain additional financing, our ability to respond to business challenges and opportunities could be significantly impaired, and our business may be adversely affected and we may be required to liquidate and/or file for bankruptcy protection.

 

Risks Related to our Business and Industry

 

There is uncertainty regarding U.S. tariffs and support for existing treaty and trade relationships, and implementation of new legislative or regulatory policies by the U.S. government could impose additional costs on the Company, result in delayed timelines, or otherwise negatively impact the Company, which could have a material adverse impact on the Company’s business.

 

The recent imposition by the United States of tariffs, sanctions and other restrictions on goods imported into the United States, and countermeasures imposed by foreign countries in response to such government actions, if not significantly and promptly moderated or eliminated, may increase the cost of goods for our products or reduce our ability to sell products, which may, in turn, adversely affect our operating results and financial condition. The ultimate impact of these trade measures on our business operations and financial results is uncertain and may be affected by various factors, including whether and when such trade measures are implemented, the timing of when such measures may become effective, and the amount, scope, or nature of such trade measures, and our ability to execute strategies to mitigate the negative impacts.

 

Political tensions as a result of trade policies could reduce trade volume, investment, technological exchange, and other economic activities between major international economies, resulting in a material adverse effect on global economic conditions and the stability of global financial markets, which could, in turn, have a material adverse impact on our business and financial condition.

 

48

 

 

Risks Related to Compliance Matters

 

We are subject to U.S. and other anti-corruption laws, trade controls, economic sanctions and similar laws and regulations. Our failure to comply with these laws and regulations could subject us to civil, criminal and administrative penalties and harm our reputation.

 

Doing business on a worldwide basis requires us to comply with the laws and regulations of the U.S. government and various foreign jurisdictions. These laws and regulations place restrictions on our operations, trade practices, partners and investments.

 

In particular, our operations are subject to U.S. and foreign anti-corruption and trade control laws and regulations, such as the Foreign Corrupt Practices Act (“FCPA”) and the Bribery Act, export controls and economic sanctions programs, including those administered by the U.S. Treasury Department’s Office of Foreign Assets Control (“OFAC”), the State Department’s Directorate of Defense Trade Controls (“DDTC”) and the Bureau of Industry and Security (“BIS”) of the Department of Commerce. As a result of doing business in foreign countries and with foreign customers, we are exposed to a heightened risk of violating anti-corruption and trade control laws and sanctions regulations. In February 2025, President Donald J.  Trump issued an executive order directing the U.S. Department of Justice to pause enforcement of the FCPA and to issue new enforcement guidelines that take into consideration U.S. national security and the competitiveness of U.S. companies abroad. On June 10, 2025, the U.S. Department of Justice issued new enforcement guidelines which set forth an approach to FCPA enforcement that is explicitly aimed at promoting U.S. economic interests and national security. It is unclear how these new guidelines may affect our industry as a whole or our business in particular.

 

Notwithstanding these new guidelines, as part of our business, we may deal with state-owned business enterprises, the employees of which are considered foreign officials for purposes of the FCPA’s prohibition on providing anything of value to foreign officials for the purposes of obtaining or retaining business or securing any improper business advantage. In addition, the provisions of the Bribery Act extend beyond bribery of foreign public officials and also apply to transactions with individuals that a government does not employ. Some of the international locations in which we operate lack a developed legal system and have higher than normal levels of corruption. Our continued expansion outside the U.S., primarily in Europe, South-East Asia and Oceania, and our development of new partnerships worldwide, could increase the risk of FCPA, OFAC or Bribery Act violations in the future.  

 

As an exporter, we must comply with various laws and regulations relating to the export of products and technology from the U.S. and other countries having jurisdiction over our operations. In the United States, these laws include the International Traffic in Arms Regulations (“ITAR”) administered by the DDTC, the Export Administration Regulations (“EAR”) administered by the BIS and trade sanctions against embargoed countries and destinations administered by OFAC. The EAR governs products, parts, technology and software which present military or weapons proliferation concerns, so-called “dual use” items, and ITAR governs military items listed on the United States Munitions List. Prior to shipping certain items, we must obtain an export license or verify that license exemptions are available. Any failures to comply with these laws and regulations could result in fines, adverse publicity and restrictions on our ability to export our products, and repeat failures could carry more significant penalties.

 

49

 

 

Violations of anti-corruption and trade control laws and sanctions regulations are punishable by civil penalties, including fines, denial of export privileges, injunctions, asset seizures, debarment from government contracts and revocations or restrictions of licenses, as well as criminal fines and imprisonment and could harm our reputation, create negative shareholder sentiment and affect the value of our securities. We have established policies and procedures designed to assist our compliance with applicable U.S. and international anti-corruption and trade control laws and regulations, including the FCPA, the Bribery Act and trade controls and sanctions programs administered by OFAC, the DDTC and BIS, and have trained our employees to comply with these laws and regulations. However, there can be no assurance that all of our employees, consultants, agents or other associated persons will not take actions in violation of our policies and these laws and regulations. Additionally, there can be no assurance that our policies and procedures will effectively prevent us from violating these regulations in every transaction in which we may engage or provide a defense to any alleged violation. In particular, we may be held liable for the actions that our joint venture partners take inside or outside of the United States, even though our partners may not be subject to these laws. Such a violation, even if our policies prohibit it, could have an adverse effect on our reputation, business, financial condition and results of operations. In addition, various state and municipal governments, universities and other investors maintain prohibitions or restrictions on investments in companies that do business with sanctioned countries, persons and entities, which could adversely affect our reputation, business, financial condition and results of operations.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

None.

 

Item 3. Defaults Upon Senior Securities

 

Not applicable.

 

Item 4. Mine Safety Disclosures

 

Not applicable.

 

Item 5. Other Information

 

During the three months ended June 30, 2025, no director or Section 16 officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.

 

50

 

 

Item 6. Exhibits

 

Exhibit Number   Description
3.1  

Certificate of Incorporation of Velo3D, Inc. (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed on October 5, 2021)

3.1.1  

Certificate of Amendment to the Certificate of Incorporation of Velo3D, Inc. (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed on June 9, 2023)

3.1.2   Certificate of Amendment to the Certificate of Incorporation of Velo3D, Inc. (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed on June 12, 2024)
3.1.3   Certificate of Amendment to the Certificate of Incorporation of Velo3D, Inc. (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed on July 2, 2025)
3.1.4   Certificate of Amendment to the Certificate of Incorporation of Velo3D, Inc. (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed on July 25, 2025)
31.1**   Certification of the Chief Executive Officer required by Rule 13a-14(a) or rule 15d-14(a)
31.2**   Certification of the Chief Financial Officer required by Rule 13a-14(a) or rule 15d-14(a)
32.1*   Certification of the Chief Executive Officer required by Rule 13a-14(b) or Rule 15d-14(b) and 18 U.S.C. 1350
32.2*   Certification of the Chief Financial Officer required by Rule 13a-14(b) or Rule 15d-14(b) and 18 U.S.C. 1350
101.INS   Inline XBRL Instance Document - the instance document does not appear in the Interactive Data file because its XBRL tags are embedded within the Inline XBRL document
101.SCH   Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

* Furnished herewith. This certification is not deemed “filed” for purposes of Section 18 of the Exchange Act or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act.

** Filed herewith.

 

51

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized, in the City of Fremont, State of California.

 

  VELO3D, INC.
     
Date: August 6, 2025 By: /s/ Hull Xu
  Name: Hull Xu
  Title: Chief Financial Officer, Principal Financial Officer and Authorized Officer

 

52